0001493152-24-019229.txt : 20240514 0001493152-24-019229.hdr.sgml : 20240514 20240514160549 ACCESSION NUMBER: 0001493152-24-019229 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 67 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240514 DATE AS OF CHANGE: 20240514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CEA Industries Inc. CENTRAL INDEX KEY: 0001482541 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE SERVICES [0700] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 273911608 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41266 FILM NUMBER: 24944236 BUSINESS ADDRESS: STREET 1: 1780 55TH STREET, SUITE C CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 303-993-5271 MAIL ADDRESS: STREET 1: 1780 55TH STREET, SUITE C CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: Surna Inc. DATE OF NAME CHANGE: 20100128 10-Q 1 form10-q.htm
false --12-31 Q1 0001482541 Yes Yes 0001482541 2024-01-01 2024-03-31 0001482541 CEAD:CommonStock0.00001ParValueMember 2024-01-01 2024-03-31 0001482541 CEAD:WarrantsToPurchaseCommonStockMember 2024-01-01 2024-03-31 0001482541 2024-05-14 0001482541 2024-03-31 0001482541 2023-12-31 0001482541 2023-01-01 2023-03-31 0001482541 us-gaap:CommonStockMember 2023-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001482541 us-gaap:RetainedEarningsMember 2023-12-31 0001482541 us-gaap:CommonStockMember 2022-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001482541 us-gaap:RetainedEarningsMember 2022-12-31 0001482541 2022-12-31 0001482541 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001482541 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001482541 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001482541 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001482541 us-gaap:CommonStockMember 2024-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001482541 us-gaap:RetainedEarningsMember 2024-03-31 0001482541 us-gaap:CommonStockMember 2023-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001482541 us-gaap:RetainedEarningsMember 2023-03-31 0001482541 2023-03-31 0001482541 2022-02-15 2022-02-15 0001482541 2023-01-01 2023-12-31 0001482541 us-gaap:SeriesBPreferredStockMember 2024-01-01 2024-03-31 0001482541 us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-03-31 0001482541 CEAD:DirectorAndStaffMember 2024-01-01 2024-03-31 0001482541 CEAD:DirectorAndStaffMember 2023-01-01 2023-03-31 0001482541 srt:MaximumMember 2024-03-31 0001482541 CEAD:OneCustomerMember 2023-12-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerOneMember 2024-01-01 2024-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerTwoMember 2024-01-01 2024-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerThreeMember 2024-01-01 2024-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerOneMember 2023-01-01 2023-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerTwoMember 2023-01-01 2023-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerThreeMember 2023-01-01 2023-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerOneMember 2024-01-01 2024-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerTwoMember 2024-01-01 2024-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerThreeMember 2024-01-01 2024-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerOneMember 2023-01-01 2023-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerTwoMember 2023-01-01 2023-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerThreeMember 2023-01-01 2023-03-31 0001482541 CEAD:EquipmentAndSystemsSalesMember 2024-01-01 2024-03-31 0001482541 CEAD:EquipmentAndSystemsSalesMember 2023-01-01 2023-03-31 0001482541 CEAD:EngineeringAndOtherServicesMember 2024-01-01 2024-03-31 0001482541 CEAD:EngineeringAndOtherServicesMember 2023-01-01 2023-03-31 0001482541 us-gaap:ShippingAndHandlingMember 2024-01-01 2024-03-31 0001482541 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-03-31 0001482541 CEAD:ForfeitedNonRefundableCustomerDepositsMember 2024-01-01 2024-03-31 0001482541 CEAD:ForfeitedNonRefundableCustomerDepositsMember 2023-01-01 2023-03-31 0001482541 CEAD:TwoThousandAndTwentyFourMember 2024-03-31 0001482541 us-gaap:CostOfSalesMember 2024-01-01 2024-03-31 0001482541 us-gaap:CostOfSalesMember 2023-01-01 2023-03-31 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2024-01-01 2024-03-31 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2023-01-01 2023-03-31 0001482541 CEAD:ProductDevelopmentCostsMember 2024-01-01 2024-03-31 0001482541 CEAD:ProductDevelopmentCostsMember 2023-01-01 2023-03-31 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-01-01 2024-03-31 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-03-31 0001482541 CEAD:NewFacilityLeaseMember 2021-07-28 0001482541 CEAD:NewFacilityLeaseMember 2021-07-26 2021-07-28 0001482541 us-gaap:FurnitureAndFixturesMember 2024-03-31 0001482541 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001482541 us-gaap:VehiclesMember 2024-03-31 0001482541 us-gaap:VehiclesMember 2023-12-31 0001482541 us-gaap:PropertyPlantAndEquipmentMember us-gaap:CostOfSalesMember 2024-01-01 2024-03-31 0001482541 us-gaap:PropertyPlantAndEquipmentMember CEAD:InventoryMember 2024-01-01 2024-03-31 0001482541 2023-10-20 2023-10-20 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2023-01-03 0001482541 CEAD:DirectorsMember CEAD:TwoThousandTwentyOneEquityPlanMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-03 2023-01-03 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2024-01-02 0001482541 CEAD:DirectorsMember CEAD:TwoThousandTwentyOneEquityPlanMember us-gaap:RestrictedStockUnitsRSUMember 2024-01-02 2024-01-02 0001482541 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-12 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember 2022-01-12 2022-01-17 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember 2024-01-01 2024-03-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-12-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember 2024-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2021-03-22 0001482541 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:NonQualifiedStockOptionMember 2024-01-01 2024-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2024-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember us-gaap:RestrictedStockMember 2024-01-01 2024-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:NonQualifiedStockOptionMember 2024-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:IncentiveStockOptionMember 2024-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2024-01-01 2024-03-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2024-01-01 2024-03-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2023-01-01 2023-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:NonQualifiedStockOptionsMember CEAD:DirectorsMember 2024-01-01 2024-03-31 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2024-01-01 2024-03-31 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-03-31 0001482541 CEAD:ThreeDirectorsMember us-gaap:RestrictedStockUnitsRSUMember 2024-01-02 2024-01-02 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:EmployeesDirectorsandConsultantsMember 2024-01-01 2024-03-31 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:EmployeesDirectorsandConsultantsMember 2023-01-01 2023-03-31 0001482541 CEAD:TwoThousandSeventeenAndTwoThousandTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2024-01-01 2024-03-31 0001482541 CEAD:TwoThousandSeventeenAndTwoThousandTwentyOneEquityPlanMember CEAD:DirectorsMember 2024-01-01 2024-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-12-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-12-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2024-01-01 2024-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2024-03-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-12-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-12-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2024-01-01 2024-03-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2024-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-12-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2024-01-01 2024-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2024-03-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:DirectorsMember us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:DirectorsMember us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-03-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:DirectorsMember us-gaap:RestrictedStockUnitsRSUMember 2024-03-31 0001482541 CEAD:WarrantsRangeOneMember 2024-03-31 0001482541 CEAD:WarrantsRangeOneMember 2024-01-01 2024-03-31 0001482541 CEAD:WarrantsRangeTwoMember 2024-03-31 0001482541 CEAD:WarrantsRangeTwoMember 2024-01-01 2024-03-31 0001482541 CEAD:WarrantsRangeThreeMember 2024-03-31 0001482541 CEAD:WarrantsRangeThreeMember 2024-01-01 2024-03-31 0001482541 CEAD:WarrantsRangeFourMember 2024-03-31 0001482541 CEAD:WarrantsRangeFourMember 2024-01-01 2024-03-31 0001482541 CEAD:OwnershipMember 2024-03-31 0001482541 CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember srt:ChiefExecutiveOfficerMember 2022-10-13 0001482541 CEAD:LoneStarBioscienceIncMember srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember 2022-12-31 0001482541 CEAD:ConsultingAgreementMember 2022-12-20 0001482541 CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember srt:ChiefExecutiveOfficerMember 2023-03-01 2023-03-31 0001482541 CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember srt:ChiefExecutiveOfficerMember 2023-01-01 2023-03-31 0001482541 CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember srt:ChiefExecutiveOfficerMember 2024-01-01 2024-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares utr:sqft CEAD:integer CEAD:Segment xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2024

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 001-41266

 

CEA INDUSTRIES INC.

(Exact name of registrant as specified in its charter)

 

Nevada   27-3911608

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

385 South Pierce Avenue, Suite C

Louisville, Colorado 80027

  80027
(Address of principal executive offices)   (Zip code)

 

(303) 993-5271

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.00001 par value   CEAD   Nasdaq Capital Markets
Warrants to purchase common stock   CEADW   Nasdaq Capital Markets

 

Securities registered pursuant to Section 12(g) of the Act:

 

None

 

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days. YES ☒ NO ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YES ☒ NO ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer Accelerated Filer
Non-accelerated Filer Smaller Reporting Company
    Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO

 

As of May 14, 2024, the number of outstanding shares of common stock of the registrant was 8,212,737.

 

 

 

   
 

 

CEA Industries Inc.

Quarterly Report on Form 10-Q

For the Quarterly Period Ended March 31, 2024

 

Table of Contents

 

  Page
Cautionary Statement ii
   
PART I — FINANCIAL INFORMATION  
   
Item 1. Financial Statements (Unaudited)  
   
Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023 1
   
Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2024 and March 31, 2023 2
   
Condensed Consolidated Statements of Changes in Shareholders’ Equity for the Three Months Ended March 31, 2024 and March 31, 2023 3
   
Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2024 and March 31, 2023 4
   
Notes to the Condensed Consolidated Financial Statements 5
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 22
   
Item 3. Quantitative and Qualitative Disclosures About Market Risk 29
   
Item 4. Controls and Procedures 29
   
PART II — OTHER INFORMATION  
   
Item 1. Legal Proceedings 30
   
Item 1A. Risk Factors 30
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 30
   
Item 3. Defaults Upon Senior Securities 30
   
Item 4. Mine Safety Disclosures 30
   
Item 5. Other Information 30
   
Item 6. Exhibits 31
   
SIGNATURES 32
   
EXHIBIT INDEX 33

 

 i 

 

 

In this Quarterly Report on Form 10-Q, unless otherwise indicated, the “Company”, “we”, “us” or “our” refer to CEA Industries Inc. and, where appropriate, its wholly owned subsidiary.

 

CAUTIONARY STATEMENT

 

This Quarterly Report on Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2, contains forward-looking statements that involve substantial risks and uncertainties. These forward-looking statements are not historical fact but are based on current management expectations that involve substantial risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed in, or implied by, these forward-looking statements. Forward-looking statements relate to future events or our future financial performance. We generally identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these terms or other similar words. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements including, but not limited to, any projections of revenue, gross profit, earnings or loss, tax provisions, cash flows or other financial items; any statements of the plans, strategies or objectives of management for future operations; any statements regarding current or future macroeconomic or industry-specific trends or events and the impact of those trends and events on us or our financial performance; any statements regarding pending investigations, legal claims or tax disputes; any statements of expectation or belief; and any statements of assumptions underlying any of the foregoing.

 

These forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that could cause our actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry results, as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested by, these forward-looking statements. These forward-looking statements are based on assumptions regarding our present and future business strategies and the environment in which we operate. Important factors that could cause those differences include, but are not limited to:

 

  our business prospects and the prospects of our existing and prospective customers, including the decrease in new client contracts;
     
  our overall financial condition, including declining revenues, the impact of higher interest rates and inflation, business disruption due to the COVID-19 pandemic, the Ukraine war, Israeli conflict, and the supply chains on which we depend:
     
  the impact on our business from our restructuring and cost containment actions taken in the first quarter of 2023 and continuing thereafter;
     
  the inherent uncertainty of product development and product selection to meet client requirements, meeting client expectations, and whether there are or will be warranty claims;
     
  regulatory, legislative and judicial developments, especially those related to changes in, and the enforcement of, cannabis laws;
     
  increasing competitive pressures in the CEA (Controlled Environment Agriculture) industry and our engineering service and product supply position within the CEA and, in particular, the cannabis growers industry;
     
  the ability to effectively operate our business, including servicing our existing customers and obtaining new business;
     
  our relationships with our customers and suppliers and reliance on a limited number of customers and suppliers;
     
  the continuation of normal payment terms and conditions with our customers and suppliers, including our ability to obtain advance payments from our customers;

 

 ii 

 

 

  general economic conditions, our customers’ operations and access to capital, and market and business disruptions including severe weather conditions, natural disasters, health hazards, terrorist activities, financial crises, political crises or other major events, or the prospect of these events, adversely affecting demand for the products and services offered by us in the markets in which we operate;
     
  the business disruptions that are happening in the CEA industry, including bankruptcies and shifting market demands, that are having an adverse impact on the demand for our engineering services and construction solutions and, consequently, our revenues;
     
  the supply of products from our suppliers and our ability to complete contracts, some of which depend on other actors for a comprehensive project completion;
     
  changes in our business strategy and development plans, and in our plans for seeking strategic alternatives;
     
  our ability to attract and retain qualified personnel;
     
  our ability to raise equity and debt capital, as needed from time to time, to fund our operations and business strategy, including possible strategic alternatives and acquisitions;
  The potential for delisting from NASDAQ, and the impact that may have on the price and trading of our shares of common stock and warrants;
     
  our ability to identify, complete and integrate potential strategic alternatives and acquisitions;
     
  future revenue being lower than expected;
     
  the substantial changes in the amount and current size of our backlog and our ability to convert backlog into revenue in a timely manner, or at all; and
     
  our intention not to pay regular dividends.

 

These factors should not be construed as exhaustive and should be read with the other cautionary statements in this report.

 

Although we believe that we use reasonable assumptions for these forward-looking statements, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this Quarterly Report on Form 10-Q should not be regarded as a representation by us that our plans and objectives will be achieved. These risks and uncertainties include those described or identified in “Item 1A – Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023, as updated from time to time in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”). You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Quarterly Report on Form 10-Q. Except as required by the federal securities laws, we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, to reflect events or circumstances occurring after the date of this Quarterly Report on Form 10-Q. The forward-looking statements and projections contained in this Quarterly Report on Form 10-Q are intended to be within the meaning of “forward-looking statements” in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”).

 

 iii 

 

 

PART I — FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

CEA Industries Inc.

Condensed Consolidated Balance Sheets

(in US Dollars except share numbers)

 

   March 31,   December 31, 
   2024   2023 
    (Unaudited)      
ASSETS          
Current Assets          
Cash and cash equivalents  $11,598,836   $12,508,251 
Accounts receivable, net   20,126    18,655 
Contract assets, net   224,414    224,414 
Inventory, net   245,894    296,404 
Prepaid expenses and other   227,514    313,115 
Total Current Assets   12,316,784    13,360,839 
Noncurrent Assets          
Property and equipment, net   19,019    38,558 
Intangible assets, net   1,830    1,830 
Deposits   14,747    14,747 
Operating lease right-of-use asset   328,792    356,109 
Total Noncurrent Assets   364,388    411,244 
           
TOTAL ASSETS  $12,681,172   $13,772,083 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
           
LIABILITIES          
Current Liabilities          
Accounts payable and accrued liabilities  $361,876   $624,724 
Deferred revenue   539,956    499,800 
Current portion of operating lease liability   128,839    126,724 
Total Current Liabilities   1,030,671    1,251,248 
           
Noncurrent Liabilities          
Operating lease liability, net of current portion   228,927    259,627 
Total Noncurrent Liabilities   228,927    259,627 
           
TOTAL LIABILITIES   1,259,598    1,510,875 
           
Commitments and Contingencies (Note 6)   -    - 
           
SHAREHOLDERS’ EQUITY          
Preferred stock, $0.00001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding   -    - 
Common stock, $0.00001 par value; 200,000,000 authorized; 8,212,737 and 8,076,372 shares issued and outstanding, respectively   82    81 
Additional paid in capital   49,528,387    49,451,419 
Accumulated deficit   (38,106,895)   (37,190,292)
Total Shareholders’ Equity   11,421,574    12,261,208 
           
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY  $12,681,172   $13,772,083 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 1 

 

 

CEA Industries Inc.

Condensed Consolidated Statements of Operations

(in US Dollars except share numbers)

(Unaudited)

 

   2024   2023 
  

For the Three Months Ended

March 31,

 
   2024   2023 
Revenue  $234,506   $4,682,573 
           
Cost of revenue   388,881    3,829,297 
           
Gross (loss) profit   (154,375)   853,276 
           
Operating expenses:          
Advertising and marketing expenses   9,324    202,323 
Product development costs   -    76,413 
Selling, general and administrative expenses   760,110    1,020,702 
Total operating expenses   769,434    1,299,438 
           
Operating loss   (923,809)   (446,162)
           
Other income (expense):          
Other income (expense), net   -    5,704 
Interest income (expense), net   7,206    9,020 
Total other income (expense)   7,206    14,724 
           
Loss before provision for income taxes   (916,603)   (431,438)
           
Income taxes   -    - 
           
Net loss   (916,603)   (431,438)
           
Loss per common share – basic and diluted  $(0.11)  $(0.05)
           
Weighted average number of common shares outstanding, basic and diluted   8,209,730    8,071,731 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 2 

 

 

CEA Industries Inc.

Condensed Consolidated Statements of Changes in Shareholders’ Equity

For the Three Months Ended March 31, 2024 and March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

   Number of
Shares
   Amount   Paid in
Capital
   Accumulated
Deficit
   Shareholders’
Equity
 
   Common Stock   Additional         
   Number of
Shares
   Amount   Paid in
Capital
   Accumulated
Deficit
   Shareholders’
Equity
 
Balance December 31, 2023   8,076,372   $  81   $49,451,419   $(37,190,292)  $12,261,208 
Fair value of vested stock options granted to employees   -    -   $1,969    -    1,969 
Common shares issued in settlement of restricted stock units issued to directors   136,365    1    (1)   -    - 
Fair value of restricted stock units issued to directors   -    -    75,000         75,000 
Net loss   -    -    -    (916,603)   (916,603)
Balance March 31, 2024   8,212,737   $82   $49,528,387   $(38,106,895)  $11,421,574 

 

   Common Stock   Additional         
   Number of
Shares
   Amount   Paid in
Capital
   Accumulated
Deficit
   Shareholders’
Equity
 
Balance December 31, 2022   7,953,974   $  80   $49,173,836   $(34,278,741)  $14,895,175 
Fair value of vested stock options granted to employees   -    -    135,748    -    135,748 
Common shares issued in settlement of restricted stock units issued to directors   123,398    1    (1)   -    - 
Fair value of restricted stock units issued to directors   -    -    101,316    -    101,316 
Net loss   -    -    -    (431,438)   (431,438)
Balance March 31, 2023   8,077,372   $81   $49,410,899   $(34,710,179)  $14,700,801 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 3 

 

 

CEA Industries Inc.

Condensed Consolidated Statements of Cash Flows

(in US Dollars except share numbers)

(Unaudited)

 

   2024   2023 
  

For the Three Months Ended

March 31,

 
   2024   2023 
Cash Flows From Operating Activities:          
Net loss  $(916,603)  $(431,438)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and intangible asset amortization expense   6,914    7,500 
Share-based compensation   76,969    147,094 
Provision for doubtful accounts   (34,566)   (1,705)
Provision for excess and obsolete inventory   38,360    33,638 
Loss on disposal of assets   12,625    100 
Operating lease expense   27,317    26,325 
           
Changes in operating assets and liabilities:          
Accounts receivable   33,096    (57,420)
Inventory   12,151    (126,360)
Prepaid expenses and other   85,600    1,018,785 
Accounts payable and accrued liabilities   (262,849)   (43,124)
Deferred revenue   40,156    (3,235,970)
Operating lease liability, net   (28,585)   (26,662)
Net cash used in operating activities   (909,415)   (2,689,237)
           
Cash Flows From Investing Activities          
Proceeds from the sale of property and equipment   -    200 
Net cash provided by investing activities   -    200 
           
Net change in cash and cash equivalents   (909,415)   (2,689,037)
Cash and cash equivalents, beginning of period   12,508,251    18,637,114 
Cash and cash equivalents, end of period  $11,598,836   $15,948,077 
           
Supplemental cash flow information:          
Interest paid  $-   $- 
Income taxes paid  $-   $- 
           
Non-cash investing and financing activities:          
Options issued for accrued equity compensation liability  $-   $89,970 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 4 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

Note 1 – Nature of Operations and Significant Accounting Policies

 

Description of Business

 

CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the fastest-growing sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide CEA facilities with (i) air handling equipment and systems, (ii) air sanitation products, (iii) LED lighting, and (iv) benching and racking solutions for indoor cultivation. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.

 

We are evaluating merger and acquisition opportunities and other alternatives for our future. As part of that evaluative process, we are also considering the legal procedure and practical steps for dissolving ourselves, which would include a distribution of cash assets after creditors and other corporate obligations have been accounted for and satisfied. For any plan of dissolution, management and the board of directors will need to formulate and adopt a plan of dissolution. Certain transaction opportunities, depending on their structure, and any plan of dissolution will require shareholder approval through a proxy solicitation process.

 

Impact of the COVID-19 Pandemic on Our Business

 

The impact of the government and the business economic response to the COVID-19 pandemic affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. We believe we continue to see adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, costs, and working capital.

 

Due to this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the long-term impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2023, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.

 

Impact of Ukrainian Conflict

 

We believe that the conflicts involving Ukraine and Israel do not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflicts will have only a general impact on our operations in the same manner as it is having a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from countries involved in the conflicts, supply chain challenges, and the international and US domestic inflation resulting from the conflict and government spending in relation to the conflicts. As our operations are related only to the North American controlled agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to the conflicts. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflicts will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the conflicts.

 

Inflation

 

Our operations are being influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build CEA facilities in which we operate. We believe that we will continue to face inflationary increases in the cost of products and our operations, which will adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment, delivery and transportation costs, and general operational expenses. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.

 

 5 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

Financial Statement Presentation

 

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.

 

Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2024. The balance sheet information as of December 31, 2023 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2023.

 

Liquidity

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are available to be issued. The Company continues to experience recurring losses since its inception. As a result, in order to continue as a going concern, the Company has been reliant on the ability to obtain additional sources of financing to fund growth. On February 15, 2022, the Company received approximately $21,711,000 in net proceeds from completion of an equity offering. Based on management’s evaluation, the proceeds from the Offering will be more than sufficient to fund any deficiencies in working capital or cash flow from operations, and the Company is confident that it will be able to meet its obligations as they come due, and fund operations for at least 12 months after the issuance of these consolidated financial statements. Accordingly, the conditions around liquidity and limited working capital necessary to fund operations have been addressed.

 

However, we are continuing to evaluate merger and acquisition opportunities and other alternatives for our future. As part of that evaluative process, and as disclosed in the Form 8-K filed on April 10, 2024, we are also considering the legal procedure and practical steps for dissolving ourselves, which would include a distribution of cash assets after creditors and other corporate obligations have been accounted for and satisfied. For any plan of dissolution, management and the board of directors will need to formulate and adopt a plan of dissolution. Certain transaction opportunities, depending on their structure, and any plan of dissolution will require shareholder approval through a proxy solicitation process.

 

In the event our Board of Directors decides to implement a plan of dissolution, and such plan is approved by our shareholders, we then will not be continuing as a going concern. Accordingly, at such time, it would be management’s position that the Company would no longer be a going concern.

 

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.

 

Use of Estimates

 

Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets as it applies to impairment analysis, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, inventory allowances, and legal contingencies.

 

Cash, Cash Equivalents, and Restricted Cash

 

All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company maintains deposits in financial institutions that exceed the federally insured amount of $250,000. As of March 31, 2024, the balance in the Company’s accounts was approximately $11,599,000, consequently approximately $11,349,000 of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.

 

 6 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

Accounts Receivable and Allowance for Accounts Receivable.

 

Accounts receivables are recorded at the invoiced amount or based on revenue earned for items not yet invoiced, and generally do not bear interest. In accordance with ASU No. 2016-13 (as amended), Measurement of Credit Losses on Financial Instruments, which the Company adopted on a prospective basis effective January 1, 2023, an allowance for doubtful accounts is recorded against the Company’s receivables by applying an expected credit loss model. Each period, management assesses the appropriateness of the level of allowance for credit losses by considering credit risk inherent within its receivables as of the end of the period. The Company considers a receivable past due when a debtor has not paid us by the contractually specified payment due date. Account balances are written off against the allowance for credit losses if collection efforts are unsuccessful and the receivable balance is deemed uncollectible (debtor default), based on factors such as the debtor’s credit rating as well as the length of time the amounts are past due. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required.

 

As of March 31, 2024, and December 31, 2023, the allowance for doubtful accounts was $91,000 and $125,000, respectively. During the three months ended March 31, 2024, the Company received payment on certain accounts receivable which it had considered may have been uncollectible and had provided against in full. Accordingly, we wrote back $34,566 during the period in respect of these balances that no longer needed to be allowed against. Similarly, during the three months ended March 31, 2023, we wrote back $1,705 in respect payments received on accounts receivable balances that had previously been fully allowed against in prior periods.

 

Income (Loss) Per Common Share

 

Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.

 

As of March 31, 2024 and 2023, there were respectively, 7,942,220 and 8,010,956, potentially dilutive equity instruments outstanding in respect of warrants, options and restricted stock units that were convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, 7,623,772 related to warrants outstanding at both March 31, 2024 and 2023 issued in connection with the sale of our shares of series B Preferred stock and common stock. The remaining 318,448 and 387,184 potentially dilutive equity instruments outstanding as of March 31, 2024 and 2023, respectively, related to options that were convertible into shares of the Company’s common stock that had been issued to our directors and staff as compensation.

 

Revenue Recognition

 

On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) 2014-09 (Topic 606), Revenue from Contracts with Customers and all the related amendments (“ASC 606” or the “revenue standard”) to all contracts and elected the modified retrospective method.

 

Revenue Recognition Accounting Policy Summary

 

The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.

 

 7 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.

 

Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.

 

The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.

 

The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.

 

Disaggregation of Revenue

 

In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).

 

 8 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by equipment sales, engineering and other services, shipping and handling, and forfeited non-refundable customer deposits was required.

 

The following table sets forth the Company’s revenue by source:

 

   2024   2023 
  

For the Three Months Ended

March 31,

 
   2024   2023 
Equipment and systems sales  $113,172   $4,396,827 
Engineering and other services   88,165    124,410 
Shipping and handling   1,904    12,560 
Forfeited non-refundable customer deposits   31,265    148,776 
Total revenue  $234,506   $4,682,573 

 

Other Judgments and Assumptions

 

The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.

 

Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.

 

Contract Assets and Contract Liabilities

 

Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.

 

Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. Contract assets increased by $224,414 in 2023, due to revenue recognition related to the partial satisfaction of performance obligations, on three contracts with one customer, for which we have not yet billed out customer. In accordance with ASU No. 2016-13 (as amended), Measurement of Credit Losses on Financial Instruments, which the Company adopted on a prospective basis effective January 1, 2023, an allowance for doubtful accounts is recorded against the Company’s contract assets by applying an expected credit loss model. Each period, management assesses the appropriateness of the level of allowance for credit losses by considering credit risk inherent within its contract assets as of the end of the period. As of March 31, 2024, and December 31, 2023, the allowance for doubtful accounts was $1,436. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. We expect to complete our performance obligations and bill the customer for this contract asset during 2024. As of March 31, 2024, and December 31, 2023, the Company had contract assets of $224,414.

 

 9 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited and a period of three years has passed. As of March 31, 2024, and December 31, 2023, deferred revenue, which was classified as a current liability, was $539,956 and $499,800, respectively.

 

For the three months ended March 31, 2024, the Company recognized revenue of $47,440 related to the deferred revenue at January 1, 2024. For the three months ended March 31, 2023, the Company recognized revenue of $3,852,906 related to the deferred revenue at January 1, 2023.

 

Remaining Performance Obligations

 

Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.

 

Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, t and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.

 

As of March 31, 2024, the Company’s remaining performance obligations, or backlog, was approximately $535,000, a decrease of $1,334,000 from the March 31, 2023 backlog of $1,869,000. The decline was primarily the result of lower bookings. The Company has entered into fewer new contracts generally, and they have been for smaller amounts. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. Subsequent to March 31, 2024, a portion of one contract was cancelled. The amount cancelled was $170,000.

 

 10 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

The remaining performance obligations expected to be recognized through 2024 are as follows:

   

   2024   Total 
Remaining performance obligations related to partial equipment & engineering paid contracts   535,000    535,000 
Total remaining performance obligations  $535,000   $535,000 

 

Product Warranty

 

The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.

 

The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of March 31, 2024, and December 31, 2023, the Company had an accrued warranty reserve amount of $99,470 and $191,338, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.

 

Accounting for Share-Based Compensation

 

The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.

 

The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year.

 

The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.

 

The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.

 

 11 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2024 and March 31, 2023:

 

   2024   2023 
  

For the Three Months Ended

March 31,

 
   2024   2023 
Share-based compensation expense included in:          
Cost of revenue  $-   $4,898 
Advertising and marketing expenses   -    1,113 
Product development costs   -    3,570 
Selling, general and administrative expenses   76,969    137,513 
Total share-based compensation expense included in consolidated statement of operations  $76,969   $147,094 

 

Concentrations

 

Three customers accounted for 24%, 16%, and 13% of the Company’s revenue, respectively, for the three months ended March 31, 2024. Three customers accounted for 39%, 28%, and 17% of the Company’s revenue, respectively, for the three months ended March 31, 2023.

 

Three customers accounted for 60%, 29%, and 11% of the Company’s accounts receivable, respectively, as of March 31, 2024. Three customers accounted for 59%, 29%, and 12% of the Company’s accounts receivable, respectively, as of December 31, 2023.

 

Recently Issued Accounting Pronouncements

 

In March 2024, the Financial Accounting Standards Board (FASB) issued ASU 2024-01 to clarify how an entity should determine whether a profits interest or similar award should be accounted for as a share-based payment arrangement or similar to a cash bonus or profit-sharing arrangement. The amendments are effective in annual periods beginning after December 15, 2024, and interim periods within those annual periods, with early adoption permitted. The Company is currently evaluating the new guidance and the impact on its future consolidated statements.

 

In December 2023, FASB issued Accounting Standards Update 2023-09, Improvements to Income Tax Disclosures (ASU 2023-09). ASU 2023-09 includes requirements that an entity disclose specific categories in the rate reconciliation and provide additional information for reconciling items that are greater than five percent of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate. The standard also requires that entities disclose income (or loss) from continuing operations before income tax expense (or benefit) and income tax expense (or benefit) each disaggregated between domestic and foreign. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. The Company is currently assessing the impact of ASU 2023-09 on its disclosures.

 

In November 2023, the FASB issued Accounting Standards Update 2023-07, Improvements to Reportable Segment Disclosures (ASU 2023-07). ASU 2023-07 includes requirements that an entity disclose the title of the chief operating decision maker (CODM) and on an interim and annual basis, significant segment expenses and the composition of other segment items for each segment’s reported profit. The standard also permits disclosure of additional measures of segment profit. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company is currently assessing the impact of ASU 2023-07 on its disclosures.

 

 12 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

 

Note 2 – Leases

 

The Louisville Facility Lease

 

On July 28, 2021, the Company entered into an agreement to lease 11,491 square feet of office and manufacturing space (the “New Facility Lease”), in Louisville, CO. The New Facility lease commenced on November 1, 2021 and continues through January 31, 2027. From November 2021 through January 2022, the monthly rent was abated. Beginning February 2022, the monthly rent is $10,055 and will increase by 3% annually every November through the end of the New Facility Lease term. Pursuant to the New Facility Lease, the Company made a security deposit of $14,747. The Company has the option to renew the New Facility Lease for an additional five years. Additionally, the Company pays the actual amounts for property taxes, insurance, and common area maintenance. The New Facility Lease agreement contains customary events of default, representations, warranties, and covenants.

 

Upon commencement of the New Facility Lease, the Company recognized on the balance sheet an operating lease right-of-use asset and lease liability in the amount of $582,838. The lease liability was initially measured as the present value of the unpaid lease payments at commencement and the ROU asset was initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The renewal option to extend the New Facility Lease is not included in the right-of-use asset or lease liability, as the option is not reasonably certain to be exercised. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal period in its lease term.

 

The Company’s operating and finance right-of-use assets and lease liabilities are as follows:

  

  

As of

March 31, 2024

 
Operating lease right-of-use asset  $328,792 
Operating lease liability, current  $128,839 
Operating lease liability, long-term  $228,927 
      
Remaining lease term   2.8 years 
Discount rate   3.63%

 

  

For the

Three Months

Ended

March 31, 2024

 
Cash paid for operating lease  $32,001 

 

 13 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

Future annual minimum under non-cancellable operating leases as of March 31, 2024 were as follows:

  

As of March 31, 2024    
     
Years ended December 31,    
2024 (excluding the three months ended March 31, 2024)   96,643 
2025   132,503 
2026   136,473 
Thereafter   11,654 
Total minimum lease payments   377,273 
Less imputed interest   (19,507)
Present value of minimum lease payments  $357,766 

 

Note 3 – Inventory

 

Inventory consisted of the following:

 

   March 31,   December 31, 
   2024   2023 
Finished goods  $355,138   $366,844 
Raw materials   121,814    122,258 
Allowance for excess & obsolete inventory   (231,058)   (192,698)
Inventory, net  $245,894   $296,404 

 

Overhead expenses of $11,475 and $13,679 were included in the inventory balance as of March 31, 2024, and December 31, 2023, respectively.

 

Advance payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses included approximately $13,000 and $6,000 in advance payments for inventory as of March 31, 2024, and December 31, 2023, respectively.

 

 14 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

Note 4 – Property and Equipment

 

Property and equipment consisted of the following:

 

   March 31,   December 31, 
   2024   2023 
Furniture and equipment  $249,511   $275,994 
Vehicles   15,000    15,000 
Property and equipment, gross    264,511    290,994 
Accumulated depreciation   (245,492)   (252,436)
Property and equipment, net  $19,019   $38,558 

 

Depreciation expense was $6,914 for the three months ended March 31, 2024. For the three months ended March 31, 2024, $535 was allocated to cost of sales, $134 was allocated to inventory with the remainder recorded as selling, general, and administrative expense.

 

Note 5 – Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities consisted of the following:

 

   March 31,   December 31, 
   2024   2023 
Accounts payable  $101,591   $183,359 
Sales commissions payable   1,706    1,710 
Accrued payroll liabilities   143,165    189,829 
Product warranty accrual   99,470    191,338 
Other accrued expenses   15,944    58,488 
Total  $361,876   $624,724 

 

Note 6 – Commitments and Contingencies

 

Litigation

 

On October 20, 2023, Sweet Cut Grow, LLC and Green Ice, LLC (collectively, “Claimant”) a client of the Company with which it had an equipment contract and engineering contract, filed a demand for arbitration asserting claims for breach of contract, breach of warranty, and unjust enrichment, and a demand for $1,049,280 in damages, plus interest (“Claims”). The Company continues to deny all the Claims and has asserted a counterclaim. The Company believes Claimant is owed nothing as the Company fulfilled all its obligations under the contracts to Claimant, and further, that the negligence of a third-party supplier is the basis of the Claims. We intend to generally defend the claims on the basis that we promptly addressed all problems, and that any issues with defective HVAC equipment are the responsibility of our third-party equipment manufacturer. The Company’s equipment contract with Claimant requires the parties to arbitrate their disputes under the rules of the American Arbitration Association (“AAA”). The arbitration will be heard in Denver, Colorado. The matter is in the preliminary phase. The parties will pay their own legal fees and expenses. The Company intends to defend itself vigorously, believing there are no merits to the claims as currently presented.

 

Given the current uncertainty around estimability and success of claims, we have not recorded an accrual for any potential loss related to this matter.

 

 15 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

From time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.

 

Leases

 

The Company has a lease agreement for its manufacturing and office space. Refer to Note 2 Leases above.

 

Other Commitments

 

In the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.

 

Note 7 – Stockholders’ Equity

 

As of March 31, 2024, the Company had 200,000,000 shares of common stock and 25,000,000 shares of preferred stock authorized at a $0.00001 par value.

 

As of March 31, 2024, 8,212,737 shares of common stock were issued and outstanding and no shares of preferred stock were issued and outstanding.

 

Directors Remuneration

 

On January 3, 2023, the Company issued an RSU grant of 29,758 shares of common stock under the 2021 Equity Incentive Plan to each of its four independent directors. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors effective January 17, 2022 and vested immediately on the grant date. A total of 119,032 shares of the Company’s common stock were issued in settlement of the RSUs.

 

On January 2, 2024, the Company issued an RSU grant of 45,455 shares of common stock under the 2021 Equity Incentive Plan to three of its four independent directors. Mr. Shipley declined to receive the RSUs which he was entitled to receive. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors effective January 17, 2022 and vested immediately on the grant date. A total of 136,365 shares of the Company’s common stock were issued in settlement of the RSUs.

 

Revised Compensation Plan for Directors

 

On January 17, 2022, the Board of Directors revised the previously adopted compensation plan. This plan supersedes the plan adopted on August 20, 2021. The Plan is effective retroactively for the current independent directors and for independent directors elected or appointed after the Effective Date.

 

 16 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

At the time of initial election or appointment, each independent director received an equity retention award in the form of restricted stock units (“RSUs”). The aggregate value of the RSUs at the time of grant was to be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date.

 

In addition, on the first business day of January each year, each independent director will also receive an equity retention award in the form of RSUs. The aggregate value of the RSUs at the time of grant will be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. These RSUs will be fully vested at date of grant.

 

There is no additional compensation paid to members of any committee of the Board. Interested (i.e. Executive directors) serving on the Board do not receive compensation for their Board service.

 

All independent directors, Messrs. Shipley, Etten, Reisner, and Mariathasan are subject to the Plan.

 

Each independent director is responsible for the payment of any and all income taxes arising with respect to the issuance of any equity awarded under the plan, including the exercise of any non-qualified stock options.

 

Note 8 – Equity Incentive Plans

 

2017 Equity Incentive Plan

 

Under the Company’s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the “2017 Equity Plan”), the Board of Directors (the “Board”) (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates 333,333 shares of the Company’s common stock (“Plan Shares”) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.

 

During the three months ended March 31, 2024, no shares or options were issued and 6,134 options were forfeited under the 2017 Plan.

 

As of March 31, 2024, of the 333,333 shares authorized under the 2017 Plan for equity awards, 163,692 shares have been issued, awards relating to 139,378 options remain outstanding, and 30,263 shares remain available for future equity awards.

 

2021 Equity Incentive Plan

 

On March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the “2021 Equity Plan”), which was approved by the stockholders on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to 666,667 shares of common stock. The 2021 Equity Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), non-qualified stock options, stock appreciation rights (“SARs”), restricted stock awards and restricted stock unit awards and other equity linked awards to our employees, consultants, and directors. If an equity award (i) expires or otherwise terminates without having been exercised in full or (ii) is settled in cash (i.e., the holder of the award receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant to this Plan.

 

 17 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

During the three months ended March 31, 2024:

 

  - The Company issued 136,365 shares of its common stock in settlement of restricted stock units issued to three of its independent directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted on January 17, 2022.
     
  - 34,563 non-qualified stock options were forfeited that had previously been issued under the 2021 Equity Incentive Plan.

 

As of March 31, 2024, of the 666,667 shares authorized under the 2021 Equity Plan, 268,933 shares have been issued in settlement of restricted stock units, awards relating to 138,252 non-qualified stock options, and 40,816 incentive stock options remain outstanding, and 218,665 shares remain available for future equity awards.

 

There was $3,429 in unrecognized compensation expense for unvested non-qualified as of March 31, 2024 which will be recognized over approximately the next 12 months.

 

Non-Qualified and Incentive Stock Options

 

A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended March 31, 2024, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value

 
                 
Outstanding, December 31, 2023   302,022   $5.87    6.6   $       - 
Granted   -   $-    -   $- 
Exercised   -   $-    -   $- 
Forfeited   (40,697)  $3.36    -   $- 
Expired   -   $-    -   $- 
Outstanding, March 31, 2024   261,325   $6.26    7.2   $- 
Exercisable, March 31, 2024   256,325   $6.34    7.2   $- 

 

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the three months ended March 31, 2024, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

  

Grant-Date

Fair Value

 
                 
Nonvested, December 31, 2023   10,000   $2.18   $     -   $21,800 
Granted   -   $-   $-   $- 
Vested   (5,000)  $2.18   $-   $(10,900)
Forfeited   -   $-   $-   $- 
Expired   -   $-   $-   $- 
Nonvested, March 31, 2024   5,000   $2.18   $-   $10,900 

 

 18 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

For the three months ended March 31, 2024 and March 31, 2023, the Company recorded $1,969 and $45,778 as compensation expense related to vested options issued to employees and consultants, net of forfeitures, respectively.

 

A summary of the non-qualified stock options granted to directors under the 2017 and 2021 Equity Plans, during the three months ended March 31, 2024, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value ($000)

 
                 
Outstanding, December 31, 2023   57,122   $9.44    5.0   $     - 
Granted   -   $-    -   $- 
Exercised   -   $-    -   $- 
Forfeited/Cancelled   -   $-    -   $- 
Expired   -   $-    -   $- 
Outstanding, March 31, 2024   57,122   $9.44    4.7   $- 
Exercisable, March 31, 2024   57,122   $9.44    4.7   $- 

 

There were no non-vested, non-qualified stock options issued to directors under the 2017 Equity Plan and the 2021 Equity Plan, for the three months ended March 31, 2024.

 

During the three months ended March 31, 2024 and March 31, 2023, the Company incurred no compensation expense related to options issued to directors.

 

Restricted Stock Units

 

Effective January 2, 2024, the Company issued a total of 136,365 restricted stock units (RSUs) under the 2021 Equity Plan to three of its independent directors. These RSUs vested upon grant.

 

During the three months ended March 31, 2024 and March 31, 2023, the Company recorded $75,000 and $101,316, respectively, as compensation expense related to vested RSUs issued to directors.

 

 

Number of

Units

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

 
           
Outstanding, December 31, 2023   -   $-   $- 
Granted   136,365   $0.55   $27,274 
Vested and settled with share issuance   (136,365)  $0.55   $- 
Forfeited/canceled   -   $-   $- 
Outstanding, March 31, 2024   -   $-   $- 

 

 19 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

Note 9 - Warrants

 

The following table summarizes information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2024:

 

           Weighted   Weighted     
           Average   Average   Aggregate 
   Warrants   Exercise   Remaining Life   Intrinsic 
   Outstanding   Exercisable   Price   In Months   Value 
                     
Outstanding at December 31, 2023   7,623,772    7,623,772   $5.14    37       - 
                          
Granted   -    -    -    -    - 
                          
Exercised   -    -    -    -    - 
                          
Expired   -    -    -    -    - 
                          
Outstanding at March 31, 2024   7,623,772    7,623,772   $

 5.14

    34    - 

 

The following table summarizes information about warrants outstanding at March 31, 2024:

 

    Warrants   Weighted Average 
Exercise price   Outstanding   Exercisable   Months Outstanding 
              
$9.45    192,982    192,982    6 
                  
$10.40    34,737    34,737    7 
                  
$5.00    7,105,496    7,105,496    35 
                  
$5.16    290,557    290,557    35 
                  
      7,623,772    7,623,772    34 

 

Note 10 – Income Taxes

 

As of March 31, 2024, the Company has U.S. federal and state net operating losses (“NOLs”) of approximately $29,757,000, of which $11,196,000 will expire, if not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to 80%.

 

In addition, pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company’s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than 50% within a three-year period. In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), and corresponding provisions of state law, if a corporation undergoes an “ownership change,” which is generally defined as a greater than 50% change, by value, in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. Our sale of securities, both in September 2021 and February 2022, will need to be considered for determination of any “ownership change” that we have undergone during a determination period. If an ownership change occurs and our ability to use our net operating loss carryforwards is materially limited, it would harm our future bottom-line operating results by effectively increasing our future tax obligations.

 

 20 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

The Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes that recovery is not likely, the Company establishes a valuation allowance. Management’s judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against the net deferred tax assets. The Company recorded a full valuation allowance as of March 31, 2024 and December 31, 2023. Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions that are consistent with the Company’s plans. Should the actual amounts differ from the Company’s estimates, the carrying value of the Company’s deferred tax assets could be materially impacted.

 

Note 11 – Related Party Transactions

 

Agreements and Transaction with a Company Director

 

The Company entered into a manufacturer representative agreement with RSX Enterprises (“RSX”) in March 2021 to become a non-exclusive representative for the Company to assist in marketing and soliciting orders. James R. Shipley, one of our independent directors, has a significant ownership interest in RSX.

 

Under the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada and Mexico and may receive a commission for qualified customer leads. The agreement had an initial term through December 31, 2021 with automatic one-year renewal terms unless notice is given 90 days prior to each annual expiration. During the three months ended March 31, 2024 and March 31, 2023, the Company paid $0 and $18,273, respectively, in commissions under this agreement.

 

On October 13, 2022, the Company entered into an agreement with Lone Star Bioscience, Inc. (Lone Star) to provide engineering design services. Nicholas Etten, one of our independent directors, is the Chief Executive Officer of Lone Star. The balance due under this agreement totaled $2,500 with $1,250 received as a deposit in 2022. Another agreement for engineering services was signed on December 20, 2022, in the amount of $10,900. We entered into positive change orders in March 2023 of $3,577 increasing the total of the second sales order to $14,477. During the three months ended March 31, 2023, the Company received $14,035 in cash payments for these contracts. Revenue of $16,977 was recorded in the three months ended March 31, 2023 in respect of these agreements. No transactions were recorded in the three months ended March 31, 2024 in respect of this agreement.

 

Note 12 – Subsequent Events

 

In accordance with ASC 855, Subsequent Events, the Company has evaluated all subsequent events through the date the financial statements were available to be issued. No material subsequent events occurred after March 31, 2024, other than as set out below:

 

As previously disclosed, on April 10, 2023 the Company received notice from The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between February 24, 2023, through April 6, 2023, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The notice indicated that the Company may submit an update to its existing plan to regain compliance with the Listing Rule no later than October 9, 2023, and, following receipt of the update, Nasdaq would consider granting an extension of 180 calendar days to regain compliance. On October 11, 2023, Nasdaq formally determined to grant the Company a second 180-day compliance period, which allowed the Company until April 7, 2024, to satisfy the Listing Rule 5550(a)(2) deficiency. During that time, the Company was unable to satisfy the Listing Rule 5550(a)(2) deficiency.

 

On April 9, 2024, the Company received a second notice from Nasdaq indicating that the Listings Qualifications Staff would be delisting the shares of common stock and common stock warrants from Nasdaq at the opening of business on April 18, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission, which would remove the Company’s securities from listing and registration on The Nasdaq Stock Market.

 

On April 16, 2024, the Company filed an appeal with Nasdaq’s Listing Committee, which temporarily stays the delisting of the Company’s securities and the filing of the Form 25-NSE, pending the decision of the Nasdaq’s Listing Committee. As part of this process the Company will be provided a hearing, at which it will be asked to provide a plan to regain compliance and a commitment to effect a reverse stock split, if necessary.

 

As a result, until further notice, the Company’s shares and common stock warrants continue to trade on the Nasdaq under the tickers “CEA” and “CEADW”.

 

On May 2, 2024, the employment services of Mr. Ian Patel under his employment agreement were ended, with the effective date of contract termination being June 4, 2024. Mr. Patel had served as the Chief Financial Officer of the Company.

 

 21 

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report, which include additional information about our accounting policies, practices, and the transactions underlying our financial results, as well as with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the SEC. In addition to historical information, the following discussion and other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under “Cautionary Statements” appearing elsewhere herein and the risks and uncertainties described or identified in “Item 1A – Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023, as updated from time to time in the Company’s filings with the SEC, and Part II, Item 1A of this Quarterly Report entitled “Risk Factors.”

 

Non-GAAP Financial Measures

 

To supplement our financial results on U.S. generally accepted accounting principles (“GAAP”) basis, we use non-GAAP measures including net bookings, backlog, as well as adjusted net income (loss) which reflects adjustments for certain non-cash expenses such as stock-based compensation, certain debt-related items and depreciation expense. We believe these non-GAAP measures are helpful in understanding our past performance and are intended to aid in evaluating our potential future results. The presentation of these non-GAAP measures should be considered in addition to our GAAP results and are not intended to be considered in isolation or as a substitute for financial information prepared or presented in accordance with GAAP. We believe these non-GAAP financial measures reflect an additional way to view aspects of our operations that, when viewed with our GAAP results, provide a more complete understanding of factors and trends affecting our business. For purposes of this Quarterly Report, (i) “adjusted net income (loss)” and “adjusted operating income (loss)” mean GAAP net income (loss) and operating income (loss), respectively, after adjustment for non-cash equity compensation expense, debt-related items and depreciation expense, and (ii) “net bookings” means new sales contracts executed during the quarter for which we received an initial deposit, net of any adjustments including cancellations and change orders during the quarter.

 

Our backlog, remaining performance obligations and net bookings may not be indicative of future operating results, and our customers may attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project financing or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in the backlog or remaining performance obligations will actually generate revenues or when the actual revenues will be generated.

 

Overview

 

CEA Industries, through our subsidiary, Surna Cultivation Technologies LLC, is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture (“CEA”) industry. The CEA industry aims to optimize the use of horticultural resources such as water, energy, space, capital, and labor, to create an agriculture business that is more efficient and more productive than those that use traditional farming methods. Typically, the CEA industry is focused on indoor agriculture and vertical farming.

 

Headquartered in Colorado, we aim to provide customers with a variety of value-added technology solutions that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. We do this by offering our customers a variety of service and product offerings that include: (i) air handling equipment and systems, (ii) air sanitation products, (iii) LED lighting, and (iv) benching and racking solutions for indoor cultivation.

 

CEA growers currently face a challenging business environment that includes high energy costs, water usage and conservation issues, continuously evolving waste removal regulations, inflationary pressures, and labor shortages. In addition to these issues, our cannabis growing customers face increasingly rigorous quality standards and declining cannabis prices in a growing industry whose standards are constantly evolving. The part of the CEA industry focused on food related crops is also facing disruption from evolving market demand, competition, and reorganization, including the lack of growth capital and several noteworthy bankruptcies.

 

 22 

 

 

NASDAQ Continued Listing - Delisting Notice

 

As stated in Note 12 (Subsequent Events) above, on April 10, 2023 the Company received notice from The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between February 24, 2023, through April 6, 2023, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The notice indicated that the Company may submit an update to its existing plan to regain compliance with the Listing Rule no later than October 9, 2023, and, following receipt of the update, Nasdaq would consider granting an extension of 180 calendar days to regain compliance. On October 11, 2023, Nasdaq formally determined to grant the Company a second 180-day compliance period, which allowed the Company until April 7, 2024, to satisfy the Listing Rule 5550(a)(2) deficiency. During that time, the Company was unable to satisfy the Listing Rule 5550(a)(2) deficiency.

 

On April 9, 2024, the Company received a second notice from Nasdaq indicating that the Listings Qualifications Staff would be delisting the shares of common stock and common stock warrants from Nasdaq at the opening of business on April 18, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission, which would remove the Company’s securities from listing and registration on The Nasdaq Stock Market.

 

On April 16, 2024, the Company filed an appeal with Nasdaq’s Listing Committee, which temporarily stays the delisting of the Company’s securities and the filing of the Form 25-NSE, pending the decision of the Nasdaq’s Listing Committee. As part of this process the Company will be provided a hearing, at which it will be asked to provide a plan to regain compliance and a commitment to effect a reverse stock split, if necessary.

 

As a result, until further notice, the Company’s shares and common stock warrants continue to trade on the Nasdaq under the tickers “CEA” and “CEADW”.

 

Impact of the COVID-19 Pandemic on Our Business

 

The impact of the government and the business economic response to the COVID-19 pandemic affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. We believe we continue to have adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, costs, and working capital, as a result of the pandemic. Due to this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the long-term impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the years ended December 31, 2023 and December 31, 2022, and continuing since then, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.

 

Impact of Ukrainian and Israeli Conflicts

 

We believe that the conflicts involving Ukraine and Israel do not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflicts will have only a general impact on our operations in the same manner as it is having a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from countries involved in the conflicts, supply chain challenges, and the international and US domestic inflation resulting from the conflict and government spending in relation to the conflicts. As our operations are related only to the North American controlled agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to the conflicts. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflicts will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the conflicts.

 

 23 

 

 

Our Bookings, Backlog and Revenue

 

During the three months ended March 31, 2024, we executed new sales contracts with a total contract value of $223,000. During this same period, we had positive change orders of $80,000. Consequently, our net bookings in the three months ended March 31, 2024 were $303,000, representing an increase of $165,000 (or 119%) from net bookings of $138,000 in the fourth quarter of 2023.

 

Our backlog at March 31, 2024 was $535,000, an increase of $100,000, or 23%, from our backlog of $435,000 at December 31, 2023. The increase in backlog is the result of higher bookings and slightly lower revenue in the first quarter of 2024. Subsequent to March 31, 2024, a portion of one contract was cancelled. The amount cancelled was $170,000. While we expect to recognize all revenue from the remaining backlog in 2024, there is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. Therefore, investors should not view backlog as earned revenue.

 

Our backlog has significantly declined since the beginning of 2023. The primary reason for the decline has been fewer new order bookings and contract cancellations.

 

The following table sets forth: (i) our beginning backlog (the remaining contract value of outstanding sales contracts for which we have received an initial deposit as of the previous period), (ii) our net bookings for the period (new sales contracts executed during the period for which we received an initial deposit, net of any adjustments including cancellations and change orders during the period), (iii) our recognized revenue for the period, and (iv) our ending backlog for the period (the sum of the beginning backlog and net bookings, less recognized revenue). Based on the current economic climate and our cost cutting measures, there is no assurance that we will be able to continue to obtain the level of bookings that we have had in the past and or fulfill our current backlog, and we may experience contract cancellations, project scope reductions and project delays.

 

Our recognized revenue for the quarters ended March 31, 2023, June 30, 2023, September 30, 2023, December 31, 2023, and March 31, 2024, in the table below, excludes $149,000, $56,000, $29,000, $0, and $31,000, respectively, in revenue arising from the forfeiture of non-refundable deposits from former customers on previously cancelled contracts. The contracts were removed from the backlog at the time of cancellation. Subsequent to March 31, 2024, a portion of one contract was cancelled. The amount cancelled was $170,000.

 

   For the quarter ended 
   March 31, 2023   June 30, 2023   September 30, 2023   December 31, 2023   March 31, 2024 
Backlog, beginning balance  $5,577,000   $1,869,000   $1,066,000   $548,000   $435,000 
Net bookings, current period   826,000    205,000    366,000    138,000    303,000 
Recognized revenue, current period   (4,534,000)   (1,008,000)   (884,000)   (251,000)   (203,000)
Backlog, ending balance  $1,869,000   $1,066,000   $548,000   $435,000   $535,000 

 

The completion of a customer’s new build facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for these customers to complete a new build project, which corresponds to when we are able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation systems; (vii) the availability of power; and (viii) delays that are typical in completing any construction project.

 

 24 

 

 

As has historically been the case for the Company at each quarter-end, there remains significant uncertainty regarding the timing of revenue recognition of our backlog as of March 31, 2024.

 

We have provided an estimate in our condensed consolidated financial statements for when we expect to recognize revenue on our remaining performance obligations (i.e., our Q1 2024 backlog), using separate time bands, with respect to engineering only paid contracts and partial equipment paid contracts. There continues to be significant uncertainty regarding the timing of our recognition of revenue on our Q1 2024 backlog. Refer to the Revenue Recognition section of Note 1 in our condensed consolidated financial statements, included as part of this Quarterly Report for additional information on our estimate of future revenue recognition on our remaining performance obligations.

 

Our backlog, remaining performance obligations, and net bookings may not be indicative of future operating results, and our customers may attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project financing or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in backlog or remaining performance obligations will generate revenues or when the revenues will be generated. Net bookings and backlog are considered non-GAAP financial measures, and therefore, they should be considered in addition to, rather than as a substitute for, our GAAP measures for recognized revenue, deferred revenue, and remaining performance obligations. Further, we can provide no assurance as to the profitability of our contracts reflected in remaining performance obligations, backlog and net bookings.

 

Results of Operations

 

Comparison of the Three Months Ended March 31, 2024 and March 31, 2023

 

Revenues and Cost of Goods Sold

 

Revenue for the three months ended March 31, 2024 was $235,000, compared to $4,683,000 for the three months ended March 31, 2023, representing a decrease of $4,448,000, or 95%. The decrease was primarily due to a decrease in bookings in the last 18 months. We believe the lower bookings are due to the suppression of capital expenditures in the cannabis market environment as a result of the prolonged effects of pricing and inflationary pressure, in addition to a reduced sales effort by the Company.

 

Cost of revenue decreased by $3,440,000 or 90%, from $3,829,000 for the three months ended March 31, 2023 to $389,000 for the three months ended March 31, 2024. The decrease was primarily due to a decrease in revenue, along with a decrease in fixed and variable costs, as discussed below.

 

During the three months ended March 31, 2024 we recognized a gross loss of $154,000 compared to a gross profit of $853,000 for the three months ended March 31, 2023, a loss increase of 118%. Our gross profit margin decreased by 84 percentage points from a gross profit margin of 18% for the three months ended March 31, 2023 to a gross loss margin of 66% for the three months ended March 31, 2024 primarily due to lower revenue and an increase in fixed costs as a percentage of revenue, as described below. Additionally, total revenue in the three months ended March 31, 2024 and March 31, 2023 included $31,000 and $149,000, respectively, from forfeited, non-refundable deposits from former customers on previously cancelled contracts.

 

Our fixed costs (which include engineering, service, manufacturing and project management salaries and benefits and manufacturing overhead) totaled $254,000, or 108% of total revenue, for the three months ended March 31, 2024 as compared to $391,000, or 8% of total revenue, for the three months ended March 31, 2023. The decrease of $137,000 was primarily due to a decrease in salaries and benefits (including stock-based compensation) of $123,000 and a decrease in fixed overhead of $14,000.

 

Our variable costs (which include the cost of equipment, outside engineering costs, shipping and handling, travel and warranty costs) totaled $135,000, or 58% of total revenue, during the three months ended March 31, 2024, as compared to $3,439,000, or 73% of total revenue, in the three months ended March 31, 2023. The decrease in variable costs was primarily due to: (i) a decrease in equipment costs of $3,170,000 driven by lower revenue, partially offset by lower equipment margins, (ii) a decrease in warranty of $119,000 due to a reduction in the warranty accrual as a result of lower revenue during the past 18 months, (iii) a decrease in travel of $6,000, (iv) a decrease in shipping and handling expense of $5,000, and (v) a reduction in other expenses of $4,000.

 

 25 

 

 

Operating Expenses

 

Operating expenses decreased to $769,000 for the three months ended March 31, 2024, from $1,299,000 for the three months ended March 31, 2023, a decrease of $530,000, or 41%. The operating expense decrease consisted of: (i) a decrease in selling, general and administrative expenses (“SG&A expenses”) of $261,000, (ii) a decrease in advertising and marketing expenses of $193,000, and (iii) a decrease in product development of $76,000. These decreases are the result of our cost-cutting measures.

 

Our decrease in SG&A expenses for the three months ended March 31, 2024 compared to the three months ended March 31, 2023, was primarily due to: (i) a decrease of $195,000 in salaries and benefits (including stock-based compensation) and other employee related costs, (ii) a decrease in bad debt expense of $33,000, (iii) a decrease in commissions of $30,000, (iv) a decrease of $20,000 for facilities expenses and office supplies, (v) a decrease in travel of $10,000, (vi) a decrease in insurance of $6,000, (vii) a decrease of $5,000 for business taxes and licenses, (viii) a reduction in investor relations expense of $4,000, offset by, (ix) an increase in accounting and other professional fees of $30,000, and (x) an increase of $12,000 for loss on asset disposals.

 

The decrease in advertising and marketing expenses was primarily due to (i) a decrease in salaries and benefits (including stock compensation of $130,000), (ii) a decrease in advertising and promotion of $48,000, (iii) a decrease in outside services and other marketing expenses of $10,000, and (iv) a reduction in trade show related costs of $5,000.

 

The decrease in product development costs was due to (i) a decrease in salaries and benefits (including stock-based compensation) of $70,000, (ii) a decrease of $4,000 for materials and other R&D costs, and (iii) a decrease in travel of $2,000.

 

Operating Loss

 

We recognized an operating loss of $924,000 for the three months ended March 31, 2024, as compared to an operating loss of $446,000 for the three months ended March 31, 2023, an increase of $478,000 or 107%. The operating loss for the three months ended March 31, 2024 included $77,000 of non-cash, stock-based compensation, and $6,000 of depreciation expense, compared to $147,000 of non-cash, stock-based compensation, and $6,000 of depreciation expense for the three months ended March 31, 2023. Excluding these non-cash items, our operating loss increased by $548,000.

 

Other Income (Expense)

 

We recognized other income (net) of $7,000 for the three months ended March 31, 2024, compared to other income (net) of $15,000 for the three months ended March 31, 2023. Other income for the three months ended March 31, 2024 consisted of interest income on our money market account. Other income for three months ended March 31, 2023 primarily consisted of interest income on a money market account of $10,000 and an adjustment to our ERC credit of $5,000.

 

Net Loss

 

Overall, we recognized a net loss of $917,000 for the three months ended March 31, 2024, as compared to a net loss of $431,000 for the three months ended March 31, 2023, an increase of $485,000 or 113%. The net loss for the three months ended March 31, 2024 included $77,000 of non-cash, stock-based compensation, and $6,000 of depreciation expense, compared to $147,000 of non-cash, stock-based compensation, $6,000 of depreciation expense for the three months ended March 31, 2023. Excluding these non-cash items, our net loss increased by $555,000.

 

 26 

 

 

Financial Condition, Liquidity and Capital Resources

 

Cash, Cash Equivalents

 

As of March 31, 2024, we had cash and cash equivalents of $11,599,000, compared to cash and cash equivalents of $12,508,000 as of December 31, 2023. The $909,000 decrease in cash and cash equivalents during the three months ended March 31, 2024, was the result of cash used in operations. Our cash is held in bank depository accounts in a financial institution. During the three months ended March 31, 2024, we held deposits in this financial institution that exceeded the federally insured amount.

 

As of March 31, 2024, we had accounts receivable (net of allowance for doubtful accounts) of $20,000, contract assets (net of allowance for doubtful accounts) of $224,000, inventory (net of excess and obsolete allowance) of $246,000, and prepaid expenses and other assets of $228,000 (including $13,000 in advance payments on inventory purchases). While we typically require advance payment before we commence engineering services or ship equipment to our customers, we have made exceptions requiring us to record accounts receivable, which carry a risk of non-collectability especially since most of our customers are funded on an as-needed basis to complete facility construction.

 

As of March 31, 2024, we had total accounts payable and accrued expenses of $362,000, deferred revenue of $540,000, and the current portion of operating lease liability of $129,000. As of March 31, 2024, we had working capital of $11,286,000, compared to working capital of $12,110,000 as of December 31, 2023. The decrease in our working capital was primarily related to (i) a decrease in cash of $909,000, (ii) a decrease in prepaid and other expenses of $86,000, (iii) a decrease in inventory (net) of $51,000, (iv) a decrease in accounts payable and accrued liabilities of $263,000, offset by, (v) an increase in deferred revenue of $40,000.

 

We currently intend to retain all available funds and any future earnings for use in the operation of our business. We have never declared or paid any cash dividends on our common stock and do not anticipate paying any cash dividends in the foreseeable future.

 

Because of the challenges to the CEA industry economy and the specific challenges of our business, we cannot predict the continuing level of working capital that we will have in the future. As mentioned elsewhere, we have taken steps to conserve our cash resources by reducing staff and taking other cost-cutting measures and we will continue to evaluate further such measures in the future.

 

Summary of Cash Flows

 

The following summarizes our approximate cash flows for the three months ended March 31, 2024 and March 31, 2023:

 

  

For the Three Months Ended

March 31,

 
   2024   2023 
Net cash used in operating activities  $(909,000)  $(2,689,000)
Net cash provided by (used in) investing activities   -    - 
Net cash provided by (used in) financing activities   -    - 
Net decrease in cash  $(909,000)  $(2,689,000)

 

Operating Activities

 

We incurred a net loss for the three months ended March 31, 2024 of $917,000 and have an accumulated deficit of $38,107,000 as of March 31, 2024.

 

Cash used in operations for the three months ended March 31, 2024 was $909,000 compared to cash used in operating activities of $2,689,000 for the three months ended March 31, 2023, a decrease of $1,780,000.

 

The decrease in cash used in operating activities during the three months ended March 31, 2024 as compared to the three months ended March 31, 2023, was primarily attributable to: (i) a decrease in cash used to fund working capital of $2,350,000, (ii) an increase in net loss of $485,000, and (iii) a decrease in non-cash operating charges of $85,000.

 

 27 

 

 

The decrease in our working capital was primarily related to (i) a decrease in cash of $909,000, (ii) a decrease in prepaid and other expenses of $86,000, (iii) a decrease in inventory (net) of $51,000, (iv) a decrease in accounts payable and accrued liabilities of $263,000, offset by, (v) an increase in deferred revenue of $40,000.

 

The decrease in non-cash operating charges was primarily due to (i) a decrease of $70,000 for share-based compensation, (ii) a decrease in the provision for doubtful accounts of $33,000, and (iii) an increase in loss on asset disposal of $12,000.

 

Investing Activities

 

There were no cash flows from investing activities during the three months ended March 31, 2024. Cash provided by investing activities during the three months ended March 31, 2023 was less than $1,000.

 

Financing Activities

 

There were no cash flows from financing activities during the three months ended March 31, 2024 and March 31, 2023.

 

Inflation

 

Our operations are being influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build CEA facilities in which we operate. We believe that we will continue to face inflationary increases in the cost of products and our operations, which will adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment, delivery and transportation costs, and general operational expenses. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.

 

Contractual Payment Obligations

 

As of March 31, 2024, our contractual payment obligations consisted of a building lease. Refer to Note 2Leases of the notes to the condensed consolidated financial statements, included as part of this Quarterly Report for a discussion of our building lease.

 

Commitments and Contingencies

 

Refer to Note 6 – Commitments and Contingencies of the notes to the condensed consolidated financial statements, included as part of this Quarterly Report for a discussion of commitments and contingencies.

 

Off-Balance Sheet Arrangements

 

We are required to disclose any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that are material to investors. As of March 31, 2024, we had no off-balance sheet arrangements. During the three months ended March 31, 2024, we did not engage in any off-balance sheet financing activities other than those included in the “Contractual Payment Obligations” discussed above and those reflected in Note 6 of our condensed consolidated financial statements.

 

 28 

 

 

Critical Accounting Estimates

 

This discussion and analysis of our financial condition and results of operations is based upon our condensed consolidated financial statements, which have been prepared in conformity with accounting principles generally accepted in the United States of America. Certain accounting policies are particularly important to the understanding of our financial position and results of operations and require the application of significant judgment by our management or can be materially affected by changes from period to period in economic factors or conditions that are outside of our control. As a result, they are subject to an inherent degree of uncertainty. In applying these policies, management uses their judgment to determine the appropriate assumptions to be used in the determination of certain estimates. Those estimates are based on our historical operations, our future business plans and projected financial results, the terms of existing contracts, observance of trends in the industry, information provided by our customers, and information available from other outside sources, as appropriate. Actual results could materially differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company, as defined by Rule 12b-2 of the Exchange Act, therefore are not required to provide the information under this item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer and our Principal Financial and Accounting Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our Chief Executive Officer and Principal Financial and Accounting Officer concluded that as a result of material weaknesses in our internal control over financial reporting as described in Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC, our disclosure controls and procedures were not effective as of March 31, 2024.

 

We did not maintain effective controls over certain aspects of the financial reporting process because: (i) we lack a sufficient complement of personnel with a level of accounting expertise and an adequate supervisory review structure that is commensurate with our financial reporting requirements, (ii) there is inadequate segregation of duties due to our limited number of accounting personnel, and (iii) we have insufficient controls and processes in place to adequately verify the accuracy and completeness of spreadsheets that we use for a variety of purposes including revenue, taxes, stock-based compensation and other areas, and place significant reliance on, for our financial reporting.

 

We intend to take appropriate and reasonable steps to make the necessary improvements to remediate these deficiencies. We are committed to continuing to improve our financial organization including, without limitation, expanding our accounting staff and improving our systems and controls to reduce our reliance on the manual nature of our existing systems. However, due to our size and our financial resources, remediating the several identified weaknesses has not been possible and may not be economically feasible now or in the future.

 

Changes in Internal Control over Financial Reporting

 

There were no changes identified in connection with our internal control over financial reporting during the three months ended March 31, 2024, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 29 

 

 

PART II — OTHER INFORMATION

 

Item 1. Legal Proceedings

 

On October 20, 2023, Sweet Cut Grow, LLC and Green Ice, LLC (collectively, “Claimant”) a client of the Company with which it had an equipment contract and engineering contract, filed a demand for arbitration asserting claims for breach of contract, breach of warranty, and unjust enrichment, and demand for $1,049,280 in damages, plus interest (“Claims”). The Company continues to deny all the Claims and has asserted a counterclaim. The Company believes Claimant is owed nothing as the Company fulfilled all its obligations under the contracts to Claimant, and further, that the negligence of a third-party supplier is the basis of the Claims. We intend to generally defend the claims on the basis that we promptly addressed all problems, and that any issues with defective HVAC equipment are the responsibility of our third-party equipment manufacturer. The Company’s equipment contract with Claimant requires the parties to arbitrate their disputes under the rules of the American Arbitration Association (“AAA”). The arbitration will be heard in Denver, Colorado. The matter is in the preliminary phase. The parties will pay their own legal fees and expenses. The Company intends to defend itself vigorously, believing there are no merits to the claims as currently presented.

 

Given the current uncertainty around estimability and success of claims, we have not recorded an accrual for any potential loss related to this matter.

 

From time to time, we may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our customers. While the outcome of these legal proceedings cannot be predicted with certainty, we do not expect that these proceedings will have a material effect upon our financial condition or results of operations.

 

Item 1A. Risk Factors

 

In addition to the information set forth in this Form 10-Q, you should also carefully review and consider the risk factors contained in our other reports and periodic filings with the SEC, including, without limitation, the risk factors and uncertainties contained under the caption “Item 1A—Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023, that could materially and adversely affect our business, financial condition, and results of operations. The risk factors discussed in that Form 10-K do not identify all risks that we face because our business operations could also be affected by additional factors that are not known to us or that we currently consider to be immaterial to our operations.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

Nasdaq Notice Regarding Minimum Bid Price

 

As stated in Note 12 (Subsequent Events) above, on April 10, 2023 the Company received notice from The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between February 24, 2023, through April 6, 2023, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The notice indicated that the Company may submit an update to its existing plan to regain compliance with the Listing Rule no later than October 9, 2023, and, following receipt of the update, Nasdaq would consider granting an extension of 180 calendar days to regain compliance. On October 11, 2023, Nasdaq formally determined to grant the Company a second 180-day compliance period, which allowed the Company until April 7, 2024, to satisfy the Listing Rule 5550(a)(2) deficiency. During that time, the Company was unable to satisfy the Listing Rule 5550(a)(2) deficiency.

 

 30 

 

 

On April 9, 2024, the Company received a second notice from Nasdaq indicating that the Listings Qualifications Staff would be delisting the shares of common stock and common stock warrants from Nasdaq at the opening of business on April 18, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission, which would remove the Company’s securities from listing and registration on The Nasdaq Stock Market.

 

On April 16, 2024, the Company filed an appeal with Nasdaq’s Listing Committee, which temporarily stays the delisting of the Company’s securities and the filing of the Form 25-NSE, pending the decision of the Nasdaq’s Listing Committee. As part of this process the Company will be provided a hearing, at which it will be asked to provide a plan to regain compliance and a commitment to effect a reverse stock split, if necessary.

 

As a result, until further notice, the Company’s shares and common stock warrants continue to trade on the Nasdaq under the tickers “CEA” and “CEADW”.

 

Item 6. Exhibits

 

The documents listed in the Exhibit Index of this Form 10-Q are incorporated by reference or are filed with this Form 10-Q, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).

 

 31 

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  CEA INDUSTRIES INC.
  (the “Registrant”)
     
Dated: May 14, 2024 By: /s/ Anthony K. McDonald
    Anthony K. McDonald
    Chief Executive Officer and President
    (Principal Executive Officer)
     

 

 32 

 

 

EXHIBIT INDEX

 

Exhibit    
Number   Description of Exhibit
     
31.1 *   Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
31.2 *   Certification of Principal Financial and Accounting Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
32.1**   Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
32.2**   Certification of Principal Financial and Accounting, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
101.INS*   Inline XBRL Instance Document
     
101.SCH*   Inline XBRL Taxonomy Schema
     
101.CAL*   Inline XBRL Taxonomy Calculation Linkbase
     
101.DEF*   Inline XBRL Taxonomy Definition Linkbase
     
101.LAB*   Inline XBRL Taxonomy Label Linkbase
     
101.PRE*   Inline XBRL Taxonomy Presentation Linkbase
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

* Filed herewith.
** Furnished herewith.

 

 33 

 

EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION PURSUANT TO RULE 13a-14(a) and 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, Anthony K. McDonald, the Chief Executive Officer of CEA Industries Inc. certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of CEA Industries Inc. for the quarterly period ended March 31, 2024;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated May 14, 2024.

 

By: /s/ Anthony K. McDonald  
  Anthony K. McDonald  
  Chief Executive Officer  

 

 

 

EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION PURSUANT TO RULE 13a-14(a) and 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, Anthony K. McDonald, the Principal Financial and Accounting Officer of CEA Industries Inc. certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of CEA Industries Inc. for the quarterly period ended March 31, 2024;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated May 14, 2024.

 

By: /s/ Anthony K. McDonald  
 

Anthony K. McDonald

 
  Principal Financial and Accounting Officer  

 

 

 

EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the “Report”) of CEA Industries Inc. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, Anthony K. McDonald, the Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

    /s/ Anthony K. McDonald
  Name: Anthony K. McDonald,
    Chief Executive Officer
  Date: May 14, 2024

 

This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

 

 

EX-32.2 5 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the “Report”) of CEA Industries Inc. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, Anthony K. McDjonald, the Principal Financial and Accounting Officer of the Registrant, hereby certify, to the best of my knowledge, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

    /s/ Anthony K. McDonald
  Name:  Anthony K. McDonald,
    Principal Financial and Accounting Officer
  Date: May 14, 2024

 

This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

 

 

EX-101.SCH 6 cead-20240331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Nature of Operations and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Accounts Payable and Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Equity Incentive Plans link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Nature of Operations and Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Nature of Operations and Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Equity Incentive Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Schedule of Revenue by Source (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Schedule of Share-based Compensation Costs (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Nature of Operations and Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Schedule of Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Leases (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Schedule of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Inventory (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Schedule of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Property and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Stockholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Schedule of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Schedule of Restricted Units Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Equity Incentive Plans (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Schedule of Warrants Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 cead-20240331_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 cead-20240331_def.xml XBRL DEFINITION FILE EX-101.LAB 9 cead-20240331_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, $0.00001 par value Warrants to purchase common stock Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Series B Preferred Stock [Member] Title and Position [Axis] Director And Staff [Member] Statistical Measurement [Axis] Maximum [Member] Customer [Axis] One Customer [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Customer One [Member] Customer Two [Member] Customer Three [Member] Accounts Receivable [Member] Product and Service [Axis] Equipment And Systems Sales [Member] Engineering And Other Services [Member] Shipping and Handling [Member] Forfeited Non Refundable Customer Deposits [Member] Award Date [Axis] 2024 [Member] Statement of Income Location, Balance [Axis] Cost of Sales [Member] Advertising And Marketing Expenses [Member] Product Development Costs [Member] Selling, General and Administrative Expenses [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] New Facility Lease [Member] Long-Lived Tangible Asset [Axis] Furniture and Fixtures [Member] Vehicles [Member] Property, Plant and Equipment [Member] Inventory [Member] Award Type [Axis] Restricted Stock Units (RSUs) [Member] Plan Name [Axis] 2021 Equity Incentive Plan [Member] Directors [Member] 2021 Equity Plan [Member] Director [Member] 2017 Equity Incentive Plan [Member] Derivative Instrument [Axis] Non Qualified Stock Option [Member] Restricted Stock [Member] Incentive Stock Option [Member] 2017 Equity Plan and 2021 Equity Plan [Member] Related and Nonrelated Parties [Axis] Employees and Consultants [Member] Non-Qualified Stock Options [Member] 3 Directors [Member] Employees, Directors and Consultants [Member] 2017 and 2021 Equity Plan [Member] Exercise Price Range [Axis] Warrants Range One [Member] Warrants Range Two [Member] Warrants Range Three [Member] Warrants Range Four [Member] Investment, Name [Axis] Ownership [Member] Consulting Agreement [Member] Legal Entity [Axis] Lone Star Bioscience Inc [Member] Chief Executive Officer [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current Assets Cash and cash equivalents Accounts receivable, net Contract assets, net Inventory, net Prepaid expenses and other Total Current Assets Noncurrent Assets Property and equipment, net Intangible assets, net Deposits Operating lease right-of-use asset Total Noncurrent Assets TOTAL ASSETS LIABILITIES AND SHAREHOLDERS’ EQUITY LIABILITIES Current Liabilities Accounts payable and accrued liabilities Deferred revenue Current portion of operating lease liability Total Current Liabilities Noncurrent Liabilities Operating lease liability, net of current portion Total Noncurrent Liabilities TOTAL LIABILITIES Commitments and Contingencies (Note 6) SHAREHOLDERS’ EQUITY Preferred stock, $0.00001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding Common stock, $0.00001 par value; 200,000,000 authorized; 8,212,737 and 8,076,372 shares issued and outstanding, respectively Additional paid in capital Accumulated deficit Total Shareholders’ Equity TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue Cost of revenue Gross (loss) profit Operating expenses: Advertising and marketing expenses Product development costs Selling, general and administrative expenses Total operating expenses Operating loss Other income (expense): Other income (expense), net Interest income (expense), net Total other income (expense) Loss before provision for income taxes Income taxes Net loss Loss per common share - basic Loss per common share - diluted Weighted average number of common shares outstanding, basic Weighted average number of common shares outstanding, diluted Balance Balance, shares Fair value of vested stock options granted to employees Common shares issued in settlement of restricted stock units issued to directors Common shares issued in settlement of restricted stock units issued to directors, shares Fair value of restricted stock units issued to directors Net loss Balance Balance, shares Statement of Cash Flows [Abstract] Cash Flows From Operating Activities: Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and intangible asset amortization expense Share-based compensation Provision for doubtful accounts Provision for excess and obsolete inventory Loss on disposal of assets Operating lease expense Changes in operating assets and liabilities: Accounts receivable Inventory Prepaid expenses and other Accounts payable and accrued liabilities Deferred revenue Operating lease liability, net Net cash used in operating activities Cash Flows From Investing Activities Proceeds from the sale of property and equipment Net cash provided by investing activities Net change in cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Supplemental cash flow information: Interest paid Income taxes paid Non-cash investing and financing activities: Options issued for accrued equity compensation liability Accounting Policies [Abstract] Nature of Operations and Significant Accounting Policies Leases [Abstract] Leases Inventory Disclosure [Abstract] Inventory Property, Plant and Equipment [Abstract] Property and Equipment Payables and Accruals [Abstract] Accounts Payable and Accrued Liabilities Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Equity [Abstract] Stockholders’ Equity Share-Based Payment Arrangement [Abstract] Equity Incentive Plans Warrants Warrants Income Tax Disclosure [Abstract] Income Taxes Related Party Transactions [Abstract] Related Party Transactions Subsequent Events [Abstract] Subsequent Events Description of Business Impact of the COVID-19 Pandemic on Our Business Impact of Ukrainian Conflict Inflation Financial Statement Presentation Interim Financial Statements Liquidity Principles of Consolidation Use of Estimates Cash, Cash Equivalents, and Restricted Cash Accounts Receivable and Allowance for Accounts Receivable Income (Loss) Per Common Share Revenue Recognition Product Warranty Accounting for Share-Based Compensation Concentrations Recently Issued Accounting Pronouncements Schedule of Revenue by Source Schedule of Remaining Performance Obligations Expected to be Recognized Schedule of Share-based Compensation Costs Schedule of Lease Cost Schedule of Future Annual Minimum Lease Payments Schedule of Inventory Schedule of Property and Equipment Schedule of Accounts Payable and Accrued Liabilities Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Schedule of Stock Option Activity Summary of Non-vested Non-qualified Stock Option Activity Schedule of Restricted Units Activity Schedule of Outstanding Warrants to Purchase Common Stock Schedule of Warrants Outstanding Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Total revenue Remaining performance obligations related to partial equipment & engineering paid contracts Total remaining performance obligations Total share-based compensation expense included in consolidated statement of operations Proceeds from issuance of common stock FDIC insured amount Cash balance, amount FDIC uninsured amount Allowance for doubtful accounts Provision for doubtful accounts Potentially dilutive equity instruments that are convertible into common stock Contract assets Allowance for doubtful accounts Contract with customer liability current Revenue recognized Revenue remaining performance obligation Revenue remaining performance amount cancelled Product warranty description Product warranty accrual classified current Concentration risk percentage Operating lease liability, current Operating lease liability, long-term Remaining lease term Discount rate Cash paid for operating lease 2024 (excluding the three months ended March 31, 2024) 2025 2026 Thereafter Total minimum lease payments Less imputed interest Present value of minimum lease payments Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Area of land Operating lease term description Lease rental expense Increase in rent percent Security deposit Lease renew term Operating lease ROU Operating lease liability Finished goods Raw materials Allowance for excess & obsolete inventory Inventory, net Overhead expenses Prepaid inventory expenses Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment, gross Accumulated depreciation Property and equipment, net Depreciation expenses Accounts payable Sales commissions payable Accrued payroll liabilities Product warranty accrual Other accrued expenses Total Damages sought value Common stock par value Number of stock options issued Number of shares vested in period Share based compensation arrangement payment Vesting rights description Number of Options, Outstanding Beginning Weighted Average Exercise Price, Outstanding Beginning Weighted Average Remaining Contractual Term, Outstanding Ending Aggregate Intrinsic Value, Outstanding Beginning Number of Options, Granted Weighted Average Exercise Price, Granted Number of Options, Exercised Weighted Average Exercise Price, Exercised Number of Options, Forfeited/Cancelled Weighted Average Exercise Price, Forfeited/Cancelled Number of Options, Expired Weighted Average Exercise Price, Expired Number of Options, Outstanding Ending Weighted Average Exercise Price, Outstanding Ending Aggregate Intrinsic Value, Outstanding Ending Number of Options, Exercisable Weighted Average Exercise Price, Exercisable Ending Weighted Average Remaining Contractual Term, Exercisable Ending Aggregate Intrinsic Value, Exercisable Ending Number of Options, Expired Number of Options Nonvested, Beginning Weighted Average Grant-Date Fair Value, Nonvested, Beginning Aggregated Intrinsic Value, Nonvested Beginning Grant Date Fair Value Nonvested, Beginning Number of Options Nonvested, Granted Weighted Average Grant-Date Fair Value, Nonvested, Granted Grant Date Fair Value Nonvested, Granted Number of Options Nonvested, Vested Weighted Average Grant-Date Fair Value, Nonvested, Vested Grant Date Fair Value Nonvested, Vested Number of Options Nonvested, Forfeited Weighted Average Grant-Date Fair Value, Nonvested, Forfeited Grant Date Fair Value Nonvested, Forfeited Number of Options Nonvested, Expired Weighted Average Grant-Date Fair Value, Nonvested, Expired Grant Date Fair Value Nonvested, Expired Number of Options Nonvested, Ending Weighted Average Grant-Date Fair Value, Nonvested Ending Aggregated Intrinsic Value, Nonvested Ending Grant Date Fair Value Nonvested, Ending Number of Units Outstanding, beginning Weighted Average Grant-Date Fair Value Outstanding, Beginning Aggregate Intrinsic Value Outstanding, Beginning Number of Units, Granted Weighted Average Grant-Date Fair Value, Granted Aggregate Intrinsic Value Outstanding, Granted Number of Units, Vested and settled with share issuance Weighted Average Grant-Date Fair Value, Vested and settled with share issuance Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance Number of Units, Forfeited/canceled Weighted Average Grant-Date Fair Value, Forfeited/Canceled Aggregate Intrinsic Value Outstanding, Forfeited/canceled Number of Units Outstanding, ending Weighted Average Grant-Date Fair Value Outstanding,ending Aggregate Intrinsic Value Outstanding, ending Number of options to purchase shares Number of option remain forfeited Number of shares authorized Number of shares issued Number of option remain outstanding Shares available for future equity awards Number of shares grant in period Shares issued during the period Number of shares authorized Unrecognized compensation expense Weighted average remaining contractual term Share based compensation Schedule Of Outstanding Warrants To Purchase Common Stock Warrants Outstanding, Beginning Balance Warrants Exercisable, Beginning Balance Weighted Average Exercise Price, Beginning Balance Weighted Average Life of Outstanding Warrants in Months, Beginning Balance Aggregate Intrinsic Value, Beginning Balance Warrants Outstanding. Granted Warrants Exercisable, Granted Weighted Average Exercise Price, Granted Weighted Average Life of Outstanding Warrants in Months, Granted Aggregate Intrinsic Value, Granted Warrants Outstanding, Exercised Warrants Exercisable, Exercised Weighted Average Exercise Price, Exercised Weighted Average Life of Outstanding Warrants in Months, Exercised Aggregate Intrinsic Value, Exercised Warrants Outstanding, Expired Warrants Exercisable, Expired Weighted Average Exercise Price, Expired Weighted Average Life of Outstanding Warrants in Months, Expired Aggregate Intrinsic Value, Expired Warrants Outstanding, Ending Balance Warrants Exercisable, Ending Balance Weighted Average Exercise Price, Ending Balance Weighted Average Life of Outstanding Warrants in Months, Ending Balance Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] Exercise price Warrants Outstanding Warrants Exercisable Weighted Average Life of Outstanding Warrants in Months Operating loss carryforward Net operating loss carry forward expected to expire amount Net operating loss expiration term NOLs usage against taxable income, percentage Percentage of ownership change NOLs carryforwards term Payments for commissions Proceeds fom deposit Increased related party sales Proceeds from related party sales Payments for deposit Revenue Related party transaction Subsequent event description Options issued for accrued equity compensation liability. Description Of Business [Policy Text Block] Inflation [Policy Text Block] Interim Financial Statements [Policy Text Block] Director And Staff [Member] 2021 Equity Incentive Plan [Member] Directors [Member] 2021 Equity Plan [Member] Share based compensation arrangement by share based payment award value issued period. 2017 Equity Incentive Plan [Member] Non Qualified Stock Option [Member] Share-based compensation arrangement by share-based payment award, number of shares authorized. Incentive Stock Option [Member] Employees And Consultants [Member] Non-qualified Stock Options [Member] 2017 Equity Plan and 2021 Equity Plan [Member] Number of Options, Expired. One Customer [Member] Revenue remaining performance amount cancelled. Number of Options, price per share. Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested. 2024 [Member] Sharebased compensation arrangement by sharebased payment award options nonvested grant date fair values Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested. Remaining performance obligations related to partial equipment paid contracts. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited. Share based compensation arrangement by sharebased payment award options nonvested grant date fair value expired. Customer One [Member] Customer Two [Member] Customer Three [Member] New Facility Lease [Member] Increase in rent percent. 3 Directors [Member] Employees, Directors and Consultants [Member] Lessee operating lease liability payments due after year three. Lessee operating lease liability payments due after year two. Intrinsic value of granted under share-based payment arrangement. Excludes share and unit options. Intrinsic value of forfeited under share-based payment arrangement. Excludes share and unit options. Warrants Disclosure [Text Block] Schedule Of Outstanding Warrants To Purchase Common Stock [Table Text Block] Class of Warrant or Right Exercised Number of equity instruments other than options exercisable, including both vested and non-vested instruments. Net number of non-option equity instruments granted to participants. Number of non-option equity instruments exercised by participants. Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Warrants weighted average exercise price granted. Weighted average exercise price of warrants exercised. Weighted average exercise price of warrants expired. Weighted average life of outstanding warrants in months, beginning balance. Weighted average life of outstanding warrants in months, ending balance. Aggregate intrinsic value of outstanding warrants. Intrinsic value of exercised award under share-based payment arrangement. Excludes share and unit options. Intrinsic value of expirations award under share-based payment arrangement. Excludes share and unit options. Warrants weighted average remaining contractual terms. Weighted Average Remaining Life, Exercised Weighted Average Remaining Life, Expired Warrants Range One [Member] Prepaid inventory expenses Warrants Range Two [Member] Warrants Range Three [Member] Warrants Range Four [Member] Inventory [Member] Net operating loss carry forward expected to expire amount. Net operating loss expiration term. Nols usage against taxable income percentage. Ownership [Member]. Nols carryforwards term description. Consulting Agreement [Member] Lone Star Bioscience Inc [Member] Minimum bid price. 2017 and 2021 Equity Plan [Member] Proceeds from related party sales. Assets, Current Assets, Noncurrent Assets Liabilities, Current Liabilities, Noncurrent Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) Shares, Outstanding Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expenses, Other Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Contract with Customer, Liability Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Investing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Outstanding Warrants Allowance for Doubtful Accounts, Premiums and Other Receivables Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Inventory Valuation Reserves Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Aggregated Intrinsic Value, Nonvested Beginning Aggregated Intrinsic Value, Nonvested Beginning [Default Label] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Grant Date Fair Value Nonvested, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Grant Date Fair Value Nonvested, Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Number of shares authorized [Default Label] Aggregate intrinsic value of outstanding warrants ClassOfWarrantOrRightWeightedAverageExercisePriceGranted ClassOfWarrantOrRightExercised Weighted Average Exercise Price, Exercised [Default Label] Weighted Average Exercise Price, Expired [Default Label] Revenues EX-101.PRE 10 cead-20240331_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover - shares
3 Months Ended
Mar. 31, 2024
May 14, 2024
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2024  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --12-31  
Entity File Number 001-41266  
Entity Registrant Name CEA INDUSTRIES INC.  
Entity Central Index Key 0001482541  
Entity Tax Identification Number 27-3911608  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 385 South Pierce Avenue  
Entity Address, Address Line Two Suite C  
Entity Address, City or Town Louisville  
Entity Address, State or Province CO  
Entity Address, Postal Zip Code 80027  
City Area Code (303)  
Local Phone Number 993-5271  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   8,212,737
Common Stock, $0.00001 par value    
Title of 12(b) Security Common Stock, $0.00001 par value  
Trading Symbol CEAD  
Security Exchange Name NASDAQ  
Warrants to purchase common stock    
Title of 12(b) Security Warrants to purchase common stock  
Trading Symbol CEADW  
Security Exchange Name NASDAQ  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 11,598,836 $ 12,508,251
Accounts receivable, net 20,126 18,655
Contract assets, net 224,414 224,414
Inventory, net 245,894 296,404
Prepaid expenses and other 227,514 313,115
Total Current Assets 12,316,784 13,360,839
Noncurrent Assets    
Property and equipment, net 19,019 38,558
Intangible assets, net 1,830 1,830
Deposits 14,747 14,747
Operating lease right-of-use asset 328,792 356,109
Total Noncurrent Assets 364,388 411,244
TOTAL ASSETS 12,681,172 13,772,083
Current Liabilities    
Accounts payable and accrued liabilities 361,876 624,724
Deferred revenue 539,956 499,800
Current portion of operating lease liability 128,839 126,724
Total Current Liabilities 1,030,671 1,251,248
Noncurrent Liabilities    
Operating lease liability, net of current portion 228,927 259,627
Total Noncurrent Liabilities 228,927 259,627
TOTAL LIABILITIES 1,259,598 1,510,875
Commitments and Contingencies (Note 6)
SHAREHOLDERS’ EQUITY    
Preferred stock, $0.00001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding
Common stock, $0.00001 par value; 200,000,000 authorized; 8,212,737 and 8,076,372 shares issued and outstanding, respectively 82 81
Additional paid in capital 49,528,387 49,451,419
Accumulated deficit (38,106,895) (37,190,292)
Total Shareholders’ Equity 11,421,574 12,261,208
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 12,681,172 $ 13,772,083
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.00001 $ 0.00001
Preferred stock, shares authorized 25,000,000 25,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.00001 $ 0.00001
Common stock, shares authorized 200,000,000 200,000,000
Common stock, shares issued 8,212,737 8,076,372
Common stock, shares outstanding 8,212,737 8,076,372
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenue $ 234,506 $ 4,682,573
Cost of revenue 388,881 3,829,297
Gross (loss) profit (154,375) 853,276
Operating expenses:    
Advertising and marketing expenses 9,324 202,323
Product development costs 76,413
Selling, general and administrative expenses 760,110 1,020,702
Total operating expenses 769,434 1,299,438
Operating loss (923,809) (446,162)
Other income (expense):    
Other income (expense), net 5,704
Interest income (expense), net 7,206 9,020
Total other income (expense) 7,206 14,724
Loss before provision for income taxes (916,603) (431,438)
Income taxes
Net loss $ (916,603) $ (431,438)
Loss per common share - basic $ (0.11) $ (0.05)
Loss per common share - diluted $ (0.11) $ (0.05)
Weighted average number of common shares outstanding, basic 8,209,730 8,071,731
Weighted average number of common shares outstanding, diluted 8,209,730 8,071,731
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 $ 80 $ 49,173,836 $ (34,278,741) $ 14,895,175
Balance, shares at Dec. 31, 2022 7,953,974      
Fair value of vested stock options granted to employees 135,748 135,748
Common shares issued in settlement of restricted stock units issued to directors $ 1 (1)
Common shares issued in settlement of restricted stock units issued to directors, shares 123,398      
Fair value of restricted stock units issued to directors 101,316 101,316
Net loss (431,438) (431,438)
Balance at Mar. 31, 2023 $ 81 49,410,899 (34,710,179) 14,700,801
Balance, shares at Mar. 31, 2023 8,077,372      
Balance at Dec. 31, 2023 $ 81 49,451,419 (37,190,292) 12,261,208
Balance, shares at Dec. 31, 2023 8,076,372      
Fair value of vested stock options granted to employees 1,969 1,969
Common shares issued in settlement of restricted stock units issued to directors $ 1 (1)
Common shares issued in settlement of restricted stock units issued to directors, shares 136,365      
Fair value of restricted stock units issued to directors 75,000   75,000
Net loss (916,603) (916,603)
Balance at Mar. 31, 2024 $ 82 $ 49,528,387 $ (38,106,895) $ 11,421,574
Balance, shares at Mar. 31, 2024 8,212,737      
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows From Operating Activities:    
Net loss $ (916,603) $ (431,438)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and intangible asset amortization expense 6,914 7,500
Share-based compensation 76,969 147,094
Provision for doubtful accounts (34,566) (1,705)
Provision for excess and obsolete inventory 38,360 33,638
Loss on disposal of assets 12,625 100
Operating lease expense 27,317 26,325
Changes in operating assets and liabilities:    
Accounts receivable 33,096 (57,420)
Inventory 12,151 (126,360)
Prepaid expenses and other 85,600 1,018,785
Accounts payable and accrued liabilities (262,849) (43,124)
Deferred revenue 40,156 (3,235,970)
Operating lease liability, net (28,585) (26,662)
Net cash used in operating activities (909,415) (2,689,237)
Cash Flows From Investing Activities    
Proceeds from the sale of property and equipment 200
Net cash provided by investing activities 200
Net change in cash and cash equivalents (909,415) (2,689,037)
Cash and cash equivalents, beginning of period 12,508,251 18,637,114
Cash and cash equivalents, end of period 11,598,836 15,948,077
Supplemental cash flow information:    
Interest paid
Income taxes paid
Non-cash investing and financing activities:    
Options issued for accrued equity compensation liability $ 89,970
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Nature of Operations and Significant Accounting Policies
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Nature of Operations and Significant Accounting Policies

Note 1 – Nature of Operations and Significant Accounting Policies

 

Description of Business

 

CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the fastest-growing sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide CEA facilities with (i) air handling equipment and systems, (ii) air sanitation products, (iii) LED lighting, and (iv) benching and racking solutions for indoor cultivation. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.

 

We are evaluating merger and acquisition opportunities and other alternatives for our future. As part of that evaluative process, we are also considering the legal procedure and practical steps for dissolving ourselves, which would include a distribution of cash assets after creditors and other corporate obligations have been accounted for and satisfied. For any plan of dissolution, management and the board of directors will need to formulate and adopt a plan of dissolution. Certain transaction opportunities, depending on their structure, and any plan of dissolution will require shareholder approval through a proxy solicitation process.

 

Impact of the COVID-19 Pandemic on Our Business

 

The impact of the government and the business economic response to the COVID-19 pandemic affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. We believe we continue to see adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, costs, and working capital.

 

Due to this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the long-term impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2023, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.

 

Impact of Ukrainian Conflict

 

We believe that the conflicts involving Ukraine and Israel do not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflicts will have only a general impact on our operations in the same manner as it is having a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from countries involved in the conflicts, supply chain challenges, and the international and US domestic inflation resulting from the conflict and government spending in relation to the conflicts. As our operations are related only to the North American controlled agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to the conflicts. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflicts will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the conflicts.

 

Inflation

 

Our operations are being influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build CEA facilities in which we operate. We believe that we will continue to face inflationary increases in the cost of products and our operations, which will adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment, delivery and transportation costs, and general operational expenses. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

Financial Statement Presentation

 

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.

 

Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2024. The balance sheet information as of December 31, 2023 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2023.

 

Liquidity

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are available to be issued. The Company continues to experience recurring losses since its inception. As a result, in order to continue as a going concern, the Company has been reliant on the ability to obtain additional sources of financing to fund growth. On February 15, 2022, the Company received approximately $21,711,000 in net proceeds from completion of an equity offering. Based on management’s evaluation, the proceeds from the Offering will be more than sufficient to fund any deficiencies in working capital or cash flow from operations, and the Company is confident that it will be able to meet its obligations as they come due, and fund operations for at least 12 months after the issuance of these consolidated financial statements. Accordingly, the conditions around liquidity and limited working capital necessary to fund operations have been addressed.

 

However, we are continuing to evaluate merger and acquisition opportunities and other alternatives for our future. As part of that evaluative process, and as disclosed in the Form 8-K filed on April 10, 2024, we are also considering the legal procedure and practical steps for dissolving ourselves, which would include a distribution of cash assets after creditors and other corporate obligations have been accounted for and satisfied. For any plan of dissolution, management and the board of directors will need to formulate and adopt a plan of dissolution. Certain transaction opportunities, depending on their structure, and any plan of dissolution will require shareholder approval through a proxy solicitation process.

 

In the event our Board of Directors decides to implement a plan of dissolution, and such plan is approved by our shareholders, we then will not be continuing as a going concern. Accordingly, at such time, it would be management’s position that the Company would no longer be a going concern.

 

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.

 

Use of Estimates

 

Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets as it applies to impairment analysis, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, inventory allowances, and legal contingencies.

 

Cash, Cash Equivalents, and Restricted Cash

 

All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company maintains deposits in financial institutions that exceed the federally insured amount of $250,000. As of March 31, 2024, the balance in the Company’s accounts was approximately $11,599,000, consequently approximately $11,349,000 of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

Accounts Receivable and Allowance for Accounts Receivable.

 

Accounts receivables are recorded at the invoiced amount or based on revenue earned for items not yet invoiced, and generally do not bear interest. In accordance with ASU No. 2016-13 (as amended), Measurement of Credit Losses on Financial Instruments, which the Company adopted on a prospective basis effective January 1, 2023, an allowance for doubtful accounts is recorded against the Company’s receivables by applying an expected credit loss model. Each period, management assesses the appropriateness of the level of allowance for credit losses by considering credit risk inherent within its receivables as of the end of the period. The Company considers a receivable past due when a debtor has not paid us by the contractually specified payment due date. Account balances are written off against the allowance for credit losses if collection efforts are unsuccessful and the receivable balance is deemed uncollectible (debtor default), based on factors such as the debtor’s credit rating as well as the length of time the amounts are past due. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required.

 

As of March 31, 2024, and December 31, 2023, the allowance for doubtful accounts was $91,000 and $125,000, respectively. During the three months ended March 31, 2024, the Company received payment on certain accounts receivable which it had considered may have been uncollectible and had provided against in full. Accordingly, we wrote back $34,566 during the period in respect of these balances that no longer needed to be allowed against. Similarly, during the three months ended March 31, 2023, we wrote back $1,705 in respect payments received on accounts receivable balances that had previously been fully allowed against in prior periods.

 

Income (Loss) Per Common Share

 

Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.

 

As of March 31, 2024 and 2023, there were respectively, 7,942,220 and 8,010,956, potentially dilutive equity instruments outstanding in respect of warrants, options and restricted stock units that were convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, 7,623,772 related to warrants outstanding at both March 31, 2024 and 2023 issued in connection with the sale of our shares of series B Preferred stock and common stock. The remaining 318,448 and 387,184 potentially dilutive equity instruments outstanding as of March 31, 2024 and 2023, respectively, related to options that were convertible into shares of the Company’s common stock that had been issued to our directors and staff as compensation.

 

Revenue Recognition

 

On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) 2014-09 (Topic 606), Revenue from Contracts with Customers and all the related amendments (“ASC 606” or the “revenue standard”) to all contracts and elected the modified retrospective method.

 

Revenue Recognition Accounting Policy Summary

 

The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.

 

Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.

 

The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.

 

The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.

 

Disaggregation of Revenue

 

In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by equipment sales, engineering and other services, shipping and handling, and forfeited non-refundable customer deposits was required.

 

The following table sets forth the Company’s revenue by source:

 

   2024   2023 
  

For the Three Months Ended

March 31,

 
   2024   2023 
Equipment and systems sales  $113,172   $4,396,827 
Engineering and other services   88,165    124,410 
Shipping and handling   1,904    12,560 
Forfeited non-refundable customer deposits   31,265    148,776 
Total revenue  $234,506   $4,682,573 

 

Other Judgments and Assumptions

 

The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.

 

Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.

 

Contract Assets and Contract Liabilities

 

Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.

 

Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. Contract assets increased by $224,414 in 2023, due to revenue recognition related to the partial satisfaction of performance obligations, on three contracts with one customer, for which we have not yet billed out customer. In accordance with ASU No. 2016-13 (as amended), Measurement of Credit Losses on Financial Instruments, which the Company adopted on a prospective basis effective January 1, 2023, an allowance for doubtful accounts is recorded against the Company’s contract assets by applying an expected credit loss model. Each period, management assesses the appropriateness of the level of allowance for credit losses by considering credit risk inherent within its contract assets as of the end of the period. As of March 31, 2024, and December 31, 2023, the allowance for doubtful accounts was $1,436. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. We expect to complete our performance obligations and bill the customer for this contract asset during 2024. As of March 31, 2024, and December 31, 2023, the Company had contract assets of $224,414.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited and a period of three years has passed. As of March 31, 2024, and December 31, 2023, deferred revenue, which was classified as a current liability, was $539,956 and $499,800, respectively.

 

For the three months ended March 31, 2024, the Company recognized revenue of $47,440 related to the deferred revenue at January 1, 2024. For the three months ended March 31, 2023, the Company recognized revenue of $3,852,906 related to the deferred revenue at January 1, 2023.

 

Remaining Performance Obligations

 

Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.

 

Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, t and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.

 

As of March 31, 2024, the Company’s remaining performance obligations, or backlog, was approximately $535,000, a decrease of $1,334,000 from the March 31, 2023 backlog of $1,869,000. The decline was primarily the result of lower bookings. The Company has entered into fewer new contracts generally, and they have been for smaller amounts. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. Subsequent to March 31, 2024, a portion of one contract was cancelled. The amount cancelled was $170,000.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

The remaining performance obligations expected to be recognized through 2024 are as follows:

   

   2024   Total 
Remaining performance obligations related to partial equipment & engineering paid contracts   535,000    535,000 
Total remaining performance obligations  $535,000   $535,000 

 

Product Warranty

 

The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.

 

The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of March 31, 2024, and December 31, 2023, the Company had an accrued warranty reserve amount of $99,470 and $191,338, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.

 

Accounting for Share-Based Compensation

 

The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.

 

The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year.

 

The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.

 

The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2024 and March 31, 2023:

 

   2024   2023 
  

For the Three Months Ended

March 31,

 
   2024   2023 
Share-based compensation expense included in:          
Cost of revenue  $-   $4,898 
Advertising and marketing expenses   -    1,113 
Product development costs   -    3,570 
Selling, general and administrative expenses   76,969    137,513 
Total share-based compensation expense included in consolidated statement of operations  $76,969   $147,094 

 

Concentrations

 

Three customers accounted for 24%, 16%, and 13% of the Company’s revenue, respectively, for the three months ended March 31, 2024. Three customers accounted for 39%, 28%, and 17% of the Company’s revenue, respectively, for the three months ended March 31, 2023.

 

Three customers accounted for 60%, 29%, and 11% of the Company’s accounts receivable, respectively, as of March 31, 2024. Three customers accounted for 59%, 29%, and 12% of the Company’s accounts receivable, respectively, as of December 31, 2023.

 

Recently Issued Accounting Pronouncements

 

In March 2024, the Financial Accounting Standards Board (FASB) issued ASU 2024-01 to clarify how an entity should determine whether a profits interest or similar award should be accounted for as a share-based payment arrangement or similar to a cash bonus or profit-sharing arrangement. The amendments are effective in annual periods beginning after December 15, 2024, and interim periods within those annual periods, with early adoption permitted. The Company is currently evaluating the new guidance and the impact on its future consolidated statements.

 

In December 2023, FASB issued Accounting Standards Update 2023-09, Improvements to Income Tax Disclosures (ASU 2023-09). ASU 2023-09 includes requirements that an entity disclose specific categories in the rate reconciliation and provide additional information for reconciling items that are greater than five percent of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate. The standard also requires that entities disclose income (or loss) from continuing operations before income tax expense (or benefit) and income tax expense (or benefit) each disaggregated between domestic and foreign. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. The Company is currently assessing the impact of ASU 2023-09 on its disclosures.

 

In November 2023, the FASB issued Accounting Standards Update 2023-07, Improvements to Reportable Segment Disclosures (ASU 2023-07). ASU 2023-07 includes requirements that an entity disclose the title of the chief operating decision maker (CODM) and on an interim and annual basis, significant segment expenses and the composition of other segment items for each segment’s reported profit. The standard also permits disclosure of additional measures of segment profit. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company is currently assessing the impact of ASU 2023-07 on its disclosures.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

 

XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Leases
3 Months Ended
Mar. 31, 2024
Leases [Abstract]  
Leases

Note 2 – Leases

 

The Louisville Facility Lease

 

On July 28, 2021, the Company entered into an agreement to lease 11,491 square feet of office and manufacturing space (the “New Facility Lease”), in Louisville, CO. The New Facility lease commenced on November 1, 2021 and continues through January 31, 2027. From November 2021 through January 2022, the monthly rent was abated. Beginning February 2022, the monthly rent is $10,055 and will increase by 3% annually every November through the end of the New Facility Lease term. Pursuant to the New Facility Lease, the Company made a security deposit of $14,747. The Company has the option to renew the New Facility Lease for an additional five years. Additionally, the Company pays the actual amounts for property taxes, insurance, and common area maintenance. The New Facility Lease agreement contains customary events of default, representations, warranties, and covenants.

 

Upon commencement of the New Facility Lease, the Company recognized on the balance sheet an operating lease right-of-use asset and lease liability in the amount of $582,838. The lease liability was initially measured as the present value of the unpaid lease payments at commencement and the ROU asset was initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The renewal option to extend the New Facility Lease is not included in the right-of-use asset or lease liability, as the option is not reasonably certain to be exercised. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal period in its lease term.

 

The Company’s operating and finance right-of-use assets and lease liabilities are as follows:

  

  

As of

March 31, 2024

 
Operating lease right-of-use asset  $328,792 
Operating lease liability, current  $128,839 
Operating lease liability, long-term  $228,927 
      
Remaining lease term   2.8 years 
Discount rate   3.63%

 

  

For the

Three Months

Ended

March 31, 2024

 
Cash paid for operating lease  $32,001 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

Future annual minimum under non-cancellable operating leases as of March 31, 2024 were as follows:

  

As of March 31, 2024    
     
Years ended December 31,    
2024 (excluding the three months ended March 31, 2024)   96,643 
2025   132,503 
2026   136,473 
Thereafter   11,654 
Total minimum lease payments   377,273 
Less imputed interest   (19,507)
Present value of minimum lease payments  $357,766 

 

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Inventory
3 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
Inventory

Note 3 – Inventory

 

Inventory consisted of the following:

 

   March 31,   December 31, 
   2024   2023 
Finished goods  $355,138   $366,844 
Raw materials   121,814    122,258 
Allowance for excess & obsolete inventory   (231,058)   (192,698)
Inventory, net  $245,894   $296,404 

 

Overhead expenses of $11,475 and $13,679 were included in the inventory balance as of March 31, 2024, and December 31, 2023, respectively.

 

Advance payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses included approximately $13,000 and $6,000 in advance payments for inventory as of March 31, 2024, and December 31, 2023, respectively.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Property and Equipment
3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
Property and Equipment

Note 4 – Property and Equipment

 

Property and equipment consisted of the following:

 

   March 31,   December 31, 
   2024   2023 
Furniture and equipment  $249,511   $275,994 
Vehicles   15,000    15,000 
Property and equipment, gross    264,511    290,994 
Accumulated depreciation   (245,492)   (252,436)
Property and equipment, net  $19,019   $38,558 

 

Depreciation expense was $6,914 for the three months ended March 31, 2024. For the three months ended March 31, 2024, $535 was allocated to cost of sales, $134 was allocated to inventory with the remainder recorded as selling, general, and administrative expense.

 

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Accounts Payable and Accrued Liabilities
3 Months Ended
Mar. 31, 2024
Payables and Accruals [Abstract]  
Accounts Payable and Accrued Liabilities

Note 5 – Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities consisted of the following:

 

   March 31,   December 31, 
   2024   2023 
Accounts payable  $101,591   $183,359 
Sales commissions payable   1,706    1,710 
Accrued payroll liabilities   143,165    189,829 
Product warranty accrual   99,470    191,338 
Other accrued expenses   15,944    58,488 
Total  $361,876   $624,724 

 

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 6 – Commitments and Contingencies

 

Litigation

 

On October 20, 2023, Sweet Cut Grow, LLC and Green Ice, LLC (collectively, “Claimant”) a client of the Company with which it had an equipment contract and engineering contract, filed a demand for arbitration asserting claims for breach of contract, breach of warranty, and unjust enrichment, and a demand for $1,049,280 in damages, plus interest (“Claims”). The Company continues to deny all the Claims and has asserted a counterclaim. The Company believes Claimant is owed nothing as the Company fulfilled all its obligations under the contracts to Claimant, and further, that the negligence of a third-party supplier is the basis of the Claims. We intend to generally defend the claims on the basis that we promptly addressed all problems, and that any issues with defective HVAC equipment are the responsibility of our third-party equipment manufacturer. The Company’s equipment contract with Claimant requires the parties to arbitrate their disputes under the rules of the American Arbitration Association (“AAA”). The arbitration will be heard in Denver, Colorado. The matter is in the preliminary phase. The parties will pay their own legal fees and expenses. The Company intends to defend itself vigorously, believing there are no merits to the claims as currently presented.

 

Given the current uncertainty around estimability and success of claims, we have not recorded an accrual for any potential loss related to this matter.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

From time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.

 

Leases

 

The Company has a lease agreement for its manufacturing and office space. Refer to Note 2 Leases above.

 

Other Commitments

 

In the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.

 

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders’ Equity
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Stockholders’ Equity

Note 7 – Stockholders’ Equity

 

As of March 31, 2024, the Company had 200,000,000 shares of common stock and 25,000,000 shares of preferred stock authorized at a $0.00001 par value.

 

As of March 31, 2024, 8,212,737 shares of common stock were issued and outstanding and no shares of preferred stock were issued and outstanding.

 

Directors Remuneration

 

On January 3, 2023, the Company issued an RSU grant of 29,758 shares of common stock under the 2021 Equity Incentive Plan to each of its four independent directors. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors effective January 17, 2022 and vested immediately on the grant date. A total of 119,032 shares of the Company’s common stock were issued in settlement of the RSUs.

 

On January 2, 2024, the Company issued an RSU grant of 45,455 shares of common stock under the 2021 Equity Incentive Plan to three of its four independent directors. Mr. Shipley declined to receive the RSUs which he was entitled to receive. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors effective January 17, 2022 and vested immediately on the grant date. A total of 136,365 shares of the Company’s common stock were issued in settlement of the RSUs.

 

Revised Compensation Plan for Directors

 

On January 17, 2022, the Board of Directors revised the previously adopted compensation plan. This plan supersedes the plan adopted on August 20, 2021. The Plan is effective retroactively for the current independent directors and for independent directors elected or appointed after the Effective Date.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

At the time of initial election or appointment, each independent director received an equity retention award in the form of restricted stock units (“RSUs”). The aggregate value of the RSUs at the time of grant was to be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date.

 

In addition, on the first business day of January each year, each independent director will also receive an equity retention award in the form of RSUs. The aggregate value of the RSUs at the time of grant will be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. These RSUs will be fully vested at date of grant.

 

There is no additional compensation paid to members of any committee of the Board. Interested (i.e. Executive directors) serving on the Board do not receive compensation for their Board service.

 

All independent directors, Messrs. Shipley, Etten, Reisner, and Mariathasan are subject to the Plan.

 

Each independent director is responsible for the payment of any and all income taxes arising with respect to the issuance of any equity awarded under the plan, including the exercise of any non-qualified stock options.

 

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Equity Incentive Plans
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Equity Incentive Plans

Note 8 – Equity Incentive Plans

 

2017 Equity Incentive Plan

 

Under the Company’s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the “2017 Equity Plan”), the Board of Directors (the “Board”) (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates 333,333 shares of the Company’s common stock (“Plan Shares”) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.

 

During the three months ended March 31, 2024, no shares or options were issued and 6,134 options were forfeited under the 2017 Plan.

 

As of March 31, 2024, of the 333,333 shares authorized under the 2017 Plan for equity awards, 163,692 shares have been issued, awards relating to 139,378 options remain outstanding, and 30,263 shares remain available for future equity awards.

 

2021 Equity Incentive Plan

 

On March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the “2021 Equity Plan”), which was approved by the stockholders on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to 666,667 shares of common stock. The 2021 Equity Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), non-qualified stock options, stock appreciation rights (“SARs”), restricted stock awards and restricted stock unit awards and other equity linked awards to our employees, consultants, and directors. If an equity award (i) expires or otherwise terminates without having been exercised in full or (ii) is settled in cash (i.e., the holder of the award receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant to this Plan.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

During the three months ended March 31, 2024:

 

  - The Company issued 136,365 shares of its common stock in settlement of restricted stock units issued to three of its independent directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted on January 17, 2022.
     
  - 34,563 non-qualified stock options were forfeited that had previously been issued under the 2021 Equity Incentive Plan.

 

As of March 31, 2024, of the 666,667 shares authorized under the 2021 Equity Plan, 268,933 shares have been issued in settlement of restricted stock units, awards relating to 138,252 non-qualified stock options, and 40,816 incentive stock options remain outstanding, and 218,665 shares remain available for future equity awards.

 

There was $3,429 in unrecognized compensation expense for unvested non-qualified as of March 31, 2024 which will be recognized over approximately the next 12 months.

 

Non-Qualified and Incentive Stock Options

 

A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended March 31, 2024, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value

 
                 
Outstanding, December 31, 2023   302,022   $5.87    6.6   $       - 
Granted   -   $-    -   $- 
Exercised   -   $-    -   $- 
Forfeited   (40,697)  $3.36    -   $- 
Expired   -   $-    -   $- 
Outstanding, March 31, 2024   261,325   $6.26    7.2   $- 
Exercisable, March 31, 2024   256,325   $6.34    7.2   $- 

 

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the three months ended March 31, 2024, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

  

Grant-Date

Fair Value

 
                 
Nonvested, December 31, 2023   10,000   $2.18   $     -   $21,800 
Granted   -   $-   $-   $- 
Vested   (5,000)  $2.18   $-   $(10,900)
Forfeited   -   $-   $-   $- 
Expired   -   $-   $-   $- 
Nonvested, March 31, 2024   5,000   $2.18   $-   $10,900 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

For the three months ended March 31, 2024 and March 31, 2023, the Company recorded $1,969 and $45,778 as compensation expense related to vested options issued to employees and consultants, net of forfeitures, respectively.

 

A summary of the non-qualified stock options granted to directors under the 2017 and 2021 Equity Plans, during the three months ended March 31, 2024, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value ($000)

 
                 
Outstanding, December 31, 2023   57,122   $9.44    5.0   $     - 
Granted   -   $-    -   $- 
Exercised   -   $-    -   $- 
Forfeited/Cancelled   -   $-    -   $- 
Expired   -   $-    -   $- 
Outstanding, March 31, 2024   57,122   $9.44    4.7   $- 
Exercisable, March 31, 2024   57,122   $9.44    4.7   $- 

 

There were no non-vested, non-qualified stock options issued to directors under the 2017 Equity Plan and the 2021 Equity Plan, for the three months ended March 31, 2024.

 

During the three months ended March 31, 2024 and March 31, 2023, the Company incurred no compensation expense related to options issued to directors.

 

Restricted Stock Units

 

Effective January 2, 2024, the Company issued a total of 136,365 restricted stock units (RSUs) under the 2021 Equity Plan to three of its independent directors. These RSUs vested upon grant.

 

During the three months ended March 31, 2024 and March 31, 2023, the Company recorded $75,000 and $101,316, respectively, as compensation expense related to vested RSUs issued to directors.

 

 

Number of

Units

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

 
           
Outstanding, December 31, 2023   -   $-   $- 
Granted   136,365   $0.55   $27,274 
Vested and settled with share issuance   (136,365)  $0.55   $- 
Forfeited/canceled   -   $-   $- 
Outstanding, March 31, 2024   -   $-   $- 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Warrants
3 Months Ended
Mar. 31, 2024
Warrants  
Warrants

Note 9 - Warrants

 

The following table summarizes information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2024:

 

           Weighted   Weighted     
           Average   Average   Aggregate 
   Warrants   Exercise   Remaining Life   Intrinsic 
   Outstanding   Exercisable   Price   In Months   Value 
                     
Outstanding at December 31, 2023   7,623,772    7,623,772   $5.14    37       - 
                          
Granted   -    -    -    -    - 
                          
Exercised   -    -    -    -    - 
                          
Expired   -    -    -    -    - 
                          
Outstanding at March 31, 2024   7,623,772    7,623,772   $

 5.14

    34    - 

 

The following table summarizes information about warrants outstanding at March 31, 2024:

 

    Warrants   Weighted Average 
Exercise price   Outstanding   Exercisable   Months Outstanding 
              
$9.45    192,982    192,982    6 
                  
$10.40    34,737    34,737    7 
                  
$5.00    7,105,496    7,105,496    35 
                  
$5.16    290,557    290,557    35 
                  
      7,623,772    7,623,772    34 

 

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Income Taxes
3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes

Note 10 – Income Taxes

 

As of March 31, 2024, the Company has U.S. federal and state net operating losses (“NOLs”) of approximately $29,757,000, of which $11,196,000 will expire, if not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to 80%.

 

In addition, pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company’s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than 50% within a three-year period. In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), and corresponding provisions of state law, if a corporation undergoes an “ownership change,” which is generally defined as a greater than 50% change, by value, in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. Our sale of securities, both in September 2021 and February 2022, will need to be considered for determination of any “ownership change” that we have undergone during a determination period. If an ownership change occurs and our ability to use our net operating loss carryforwards is materially limited, it would harm our future bottom-line operating results by effectively increasing our future tax obligations.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

The Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes that recovery is not likely, the Company establishes a valuation allowance. Management’s judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against the net deferred tax assets. The Company recorded a full valuation allowance as of March 31, 2024 and December 31, 2023. Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions that are consistent with the Company’s plans. Should the actual amounts differ from the Company’s estimates, the carrying value of the Company’s deferred tax assets could be materially impacted.

 

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Related Party Transactions
3 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
Related Party Transactions

Note 11 – Related Party Transactions

 

Agreements and Transaction with a Company Director

 

The Company entered into a manufacturer representative agreement with RSX Enterprises (“RSX”) in March 2021 to become a non-exclusive representative for the Company to assist in marketing and soliciting orders. James R. Shipley, one of our independent directors, has a significant ownership interest in RSX.

 

Under the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada and Mexico and may receive a commission for qualified customer leads. The agreement had an initial term through December 31, 2021 with automatic one-year renewal terms unless notice is given 90 days prior to each annual expiration. During the three months ended March 31, 2024 and March 31, 2023, the Company paid $0 and $18,273, respectively, in commissions under this agreement.

 

On October 13, 2022, the Company entered into an agreement with Lone Star Bioscience, Inc. (Lone Star) to provide engineering design services. Nicholas Etten, one of our independent directors, is the Chief Executive Officer of Lone Star. The balance due under this agreement totaled $2,500 with $1,250 received as a deposit in 2022. Another agreement for engineering services was signed on December 20, 2022, in the amount of $10,900. We entered into positive change orders in March 2023 of $3,577 increasing the total of the second sales order to $14,477. During the three months ended March 31, 2023, the Company received $14,035 in cash payments for these contracts. Revenue of $16,977 was recorded in the three months ended March 31, 2023 in respect of these agreements. No transactions were recorded in the three months ended March 31, 2024 in respect of this agreement.

 

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Subsequent Events
3 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
Subsequent Events

Note 12 – Subsequent Events

 

In accordance with ASC 855, Subsequent Events, the Company has evaluated all subsequent events through the date the financial statements were available to be issued. No material subsequent events occurred after March 31, 2024, other than as set out below:

 

As previously disclosed, on April 10, 2023 the Company received notice from The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between February 24, 2023, through April 6, 2023, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The notice indicated that the Company may submit an update to its existing plan to regain compliance with the Listing Rule no later than October 9, 2023, and, following receipt of the update, Nasdaq would consider granting an extension of 180 calendar days to regain compliance. On October 11, 2023, Nasdaq formally determined to grant the Company a second 180-day compliance period, which allowed the Company until April 7, 2024, to satisfy the Listing Rule 5550(a)(2) deficiency. During that time, the Company was unable to satisfy the Listing Rule 5550(a)(2) deficiency.

 

On April 9, 2024, the Company received a second notice from Nasdaq indicating that the Listings Qualifications Staff would be delisting the shares of common stock and common stock warrants from Nasdaq at the opening of business on April 18, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission, which would remove the Company’s securities from listing and registration on The Nasdaq Stock Market.

 

On April 16, 2024, the Company filed an appeal with Nasdaq’s Listing Committee, which temporarily stays the delisting of the Company’s securities and the filing of the Form 25-NSE, pending the decision of the Nasdaq’s Listing Committee. As part of this process the Company will be provided a hearing, at which it will be asked to provide a plan to regain compliance and a commitment to effect a reverse stock split, if necessary.

 

As a result, until further notice, the Company’s shares and common stock warrants continue to trade on the Nasdaq under the tickers “CEA” and “CEADW”.

 

On May 2, 2024, the employment services of Mr. Ian Patel under his employment agreement were ended, with the effective date of contract termination being June 4, 2024. Mr. Patel had served as the Chief Financial Officer of the Company.

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Nature of Operations and Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Description of Business

Description of Business

 

CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the fastest-growing sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide CEA facilities with (i) air handling equipment and systems, (ii) air sanitation products, (iii) LED lighting, and (iv) benching and racking solutions for indoor cultivation. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.

 

We are evaluating merger and acquisition opportunities and other alternatives for our future. As part of that evaluative process, we are also considering the legal procedure and practical steps for dissolving ourselves, which would include a distribution of cash assets after creditors and other corporate obligations have been accounted for and satisfied. For any plan of dissolution, management and the board of directors will need to formulate and adopt a plan of dissolution. Certain transaction opportunities, depending on their structure, and any plan of dissolution will require shareholder approval through a proxy solicitation process.

 

Impact of the COVID-19 Pandemic on Our Business

Impact of the COVID-19 Pandemic on Our Business

 

The impact of the government and the business economic response to the COVID-19 pandemic affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. We believe we continue to see adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, costs, and working capital.

 

Due to this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the long-term impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2023, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.

 

Impact of Ukrainian Conflict

Impact of Ukrainian Conflict

 

We believe that the conflicts involving Ukraine and Israel do not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflicts will have only a general impact on our operations in the same manner as it is having a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from countries involved in the conflicts, supply chain challenges, and the international and US domestic inflation resulting from the conflict and government spending in relation to the conflicts. As our operations are related only to the North American controlled agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to the conflicts. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflicts will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the conflicts.

 

Inflation

Inflation

 

Our operations are being influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build CEA facilities in which we operate. We believe that we will continue to face inflationary increases in the cost of products and our operations, which will adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment, delivery and transportation costs, and general operational expenses. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

Financial Statement Presentation

Financial Statement Presentation

 

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.

 

Interim Financial Statements

Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2024. The balance sheet information as of December 31, 2023 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2023.

 

Liquidity

Liquidity

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are available to be issued. The Company continues to experience recurring losses since its inception. As a result, in order to continue as a going concern, the Company has been reliant on the ability to obtain additional sources of financing to fund growth. On February 15, 2022, the Company received approximately $21,711,000 in net proceeds from completion of an equity offering. Based on management’s evaluation, the proceeds from the Offering will be more than sufficient to fund any deficiencies in working capital or cash flow from operations, and the Company is confident that it will be able to meet its obligations as they come due, and fund operations for at least 12 months after the issuance of these consolidated financial statements. Accordingly, the conditions around liquidity and limited working capital necessary to fund operations have been addressed.

 

However, we are continuing to evaluate merger and acquisition opportunities and other alternatives for our future. As part of that evaluative process, and as disclosed in the Form 8-K filed on April 10, 2024, we are also considering the legal procedure and practical steps for dissolving ourselves, which would include a distribution of cash assets after creditors and other corporate obligations have been accounted for and satisfied. For any plan of dissolution, management and the board of directors will need to formulate and adopt a plan of dissolution. Certain transaction opportunities, depending on their structure, and any plan of dissolution will require shareholder approval through a proxy solicitation process.

 

In the event our Board of Directors decides to implement a plan of dissolution, and such plan is approved by our shareholders, we then will not be continuing as a going concern. Accordingly, at such time, it would be management’s position that the Company would no longer be a going concern.

 

Principles of Consolidation

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.

 

Use of Estimates

Use of Estimates

 

Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets as it applies to impairment analysis, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, inventory allowances, and legal contingencies.

 

Cash, Cash Equivalents, and Restricted Cash

Cash, Cash Equivalents, and Restricted Cash

 

All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company maintains deposits in financial institutions that exceed the federally insured amount of $250,000. As of March 31, 2024, the balance in the Company’s accounts was approximately $11,599,000, consequently approximately $11,349,000 of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

Accounts Receivable and Allowance for Accounts Receivable

Accounts Receivable and Allowance for Accounts Receivable.

 

Accounts receivables are recorded at the invoiced amount or based on revenue earned for items not yet invoiced, and generally do not bear interest. In accordance with ASU No. 2016-13 (as amended), Measurement of Credit Losses on Financial Instruments, which the Company adopted on a prospective basis effective January 1, 2023, an allowance for doubtful accounts is recorded against the Company’s receivables by applying an expected credit loss model. Each period, management assesses the appropriateness of the level of allowance for credit losses by considering credit risk inherent within its receivables as of the end of the period. The Company considers a receivable past due when a debtor has not paid us by the contractually specified payment due date. Account balances are written off against the allowance for credit losses if collection efforts are unsuccessful and the receivable balance is deemed uncollectible (debtor default), based on factors such as the debtor’s credit rating as well as the length of time the amounts are past due. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required.

 

As of March 31, 2024, and December 31, 2023, the allowance for doubtful accounts was $91,000 and $125,000, respectively. During the three months ended March 31, 2024, the Company received payment on certain accounts receivable which it had considered may have been uncollectible and had provided against in full. Accordingly, we wrote back $34,566 during the period in respect of these balances that no longer needed to be allowed against. Similarly, during the three months ended March 31, 2023, we wrote back $1,705 in respect payments received on accounts receivable balances that had previously been fully allowed against in prior periods.

 

Income (Loss) Per Common Share

Income (Loss) Per Common Share

 

Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.

 

As of March 31, 2024 and 2023, there were respectively, 7,942,220 and 8,010,956, potentially dilutive equity instruments outstanding in respect of warrants, options and restricted stock units that were convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, 7,623,772 related to warrants outstanding at both March 31, 2024 and 2023 issued in connection with the sale of our shares of series B Preferred stock and common stock. The remaining 318,448 and 387,184 potentially dilutive equity instruments outstanding as of March 31, 2024 and 2023, respectively, related to options that were convertible into shares of the Company’s common stock that had been issued to our directors and staff as compensation.

 

Revenue Recognition

Revenue Recognition

 

On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) 2014-09 (Topic 606), Revenue from Contracts with Customers and all the related amendments (“ASC 606” or the “revenue standard”) to all contracts and elected the modified retrospective method.

 

Revenue Recognition Accounting Policy Summary

 

The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.

 

Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.

 

The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.

 

The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.

 

Disaggregation of Revenue

 

In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by equipment sales, engineering and other services, shipping and handling, and forfeited non-refundable customer deposits was required.

 

The following table sets forth the Company’s revenue by source:

 

   2024   2023 
  

For the Three Months Ended

March 31,

 
   2024   2023 
Equipment and systems sales  $113,172   $4,396,827 
Engineering and other services   88,165    124,410 
Shipping and handling   1,904    12,560 
Forfeited non-refundable customer deposits   31,265    148,776 
Total revenue  $234,506   $4,682,573 

 

Other Judgments and Assumptions

 

The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.

 

Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.

 

Contract Assets and Contract Liabilities

 

Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.

 

Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. Contract assets increased by $224,414 in 2023, due to revenue recognition related to the partial satisfaction of performance obligations, on three contracts with one customer, for which we have not yet billed out customer. In accordance with ASU No. 2016-13 (as amended), Measurement of Credit Losses on Financial Instruments, which the Company adopted on a prospective basis effective January 1, 2023, an allowance for doubtful accounts is recorded against the Company’s contract assets by applying an expected credit loss model. Each period, management assesses the appropriateness of the level of allowance for credit losses by considering credit risk inherent within its contract assets as of the end of the period. As of March 31, 2024, and December 31, 2023, the allowance for doubtful accounts was $1,436. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. We expect to complete our performance obligations and bill the customer for this contract asset during 2024. As of March 31, 2024, and December 31, 2023, the Company had contract assets of $224,414.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited and a period of three years has passed. As of March 31, 2024, and December 31, 2023, deferred revenue, which was classified as a current liability, was $539,956 and $499,800, respectively.

 

For the three months ended March 31, 2024, the Company recognized revenue of $47,440 related to the deferred revenue at January 1, 2024. For the three months ended March 31, 2023, the Company recognized revenue of $3,852,906 related to the deferred revenue at January 1, 2023.

 

Remaining Performance Obligations

 

Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.

 

Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, t and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.

 

As of March 31, 2024, the Company’s remaining performance obligations, or backlog, was approximately $535,000, a decrease of $1,334,000 from the March 31, 2023 backlog of $1,869,000. The decline was primarily the result of lower bookings. The Company has entered into fewer new contracts generally, and they have been for smaller amounts. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. Subsequent to March 31, 2024, a portion of one contract was cancelled. The amount cancelled was $170,000.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

The remaining performance obligations expected to be recognized through 2024 are as follows:

   

   2024   Total 
Remaining performance obligations related to partial equipment & engineering paid contracts   535,000    535,000 
Total remaining performance obligations  $535,000   $535,000 

 

Product Warranty

Product Warranty

 

The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.

 

The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of March 31, 2024, and December 31, 2023, the Company had an accrued warranty reserve amount of $99,470 and $191,338, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.

 

Accounting for Share-Based Compensation

Accounting for Share-Based Compensation

 

The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.

 

The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year.

 

The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.

 

The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2024 and March 31, 2023:

 

   2024   2023 
  

For the Three Months Ended

March 31,

 
   2024   2023 
Share-based compensation expense included in:          
Cost of revenue  $-   $4,898 
Advertising and marketing expenses   -    1,113 
Product development costs   -    3,570 
Selling, general and administrative expenses   76,969    137,513 
Total share-based compensation expense included in consolidated statement of operations  $76,969   $147,094 

 

Concentrations

Concentrations

 

Three customers accounted for 24%, 16%, and 13% of the Company’s revenue, respectively, for the three months ended March 31, 2024. Three customers accounted for 39%, 28%, and 17% of the Company’s revenue, respectively, for the three months ended March 31, 2023.

 

Three customers accounted for 60%, 29%, and 11% of the Company’s accounts receivable, respectively, as of March 31, 2024. Three customers accounted for 59%, 29%, and 12% of the Company’s accounts receivable, respectively, as of December 31, 2023.

 

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

 

In March 2024, the Financial Accounting Standards Board (FASB) issued ASU 2024-01 to clarify how an entity should determine whether a profits interest or similar award should be accounted for as a share-based payment arrangement or similar to a cash bonus or profit-sharing arrangement. The amendments are effective in annual periods beginning after December 15, 2024, and interim periods within those annual periods, with early adoption permitted. The Company is currently evaluating the new guidance and the impact on its future consolidated statements.

 

In December 2023, FASB issued Accounting Standards Update 2023-09, Improvements to Income Tax Disclosures (ASU 2023-09). ASU 2023-09 includes requirements that an entity disclose specific categories in the rate reconciliation and provide additional information for reconciling items that are greater than five percent of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate. The standard also requires that entities disclose income (or loss) from continuing operations before income tax expense (or benefit) and income tax expense (or benefit) each disaggregated between domestic and foreign. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. The Company is currently assessing the impact of ASU 2023-09 on its disclosures.

 

In November 2023, the FASB issued Accounting Standards Update 2023-07, Improvements to Reportable Segment Disclosures (ASU 2023-07). ASU 2023-07 includes requirements that an entity disclose the title of the chief operating decision maker (CODM) and on an interim and annual basis, significant segment expenses and the composition of other segment items for each segment’s reported profit. The standard also permits disclosure of additional measures of segment profit. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company is currently assessing the impact of ASU 2023-07 on its disclosures.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2024

(in US Dollars except share numbers)

(Unaudited)

 

In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Nature of Operations and Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Schedule of Revenue by Source

The following table sets forth the Company’s revenue by source:

 

   2024   2023 
  

For the Three Months Ended

March 31,

 
   2024   2023 
Equipment and systems sales  $113,172   $4,396,827 
Engineering and other services   88,165    124,410 
Shipping and handling   1,904    12,560 
Forfeited non-refundable customer deposits   31,265    148,776 
Total revenue  $234,506   $4,682,573 
Schedule of Remaining Performance Obligations Expected to be Recognized

The remaining performance obligations expected to be recognized through 2024 are as follows:

   

   2024   Total 
Remaining performance obligations related to partial equipment & engineering paid contracts   535,000    535,000 
Total remaining performance obligations  $535,000   $535,000 
Schedule of Share-based Compensation Costs

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2024 and March 31, 2023:

 

   2024   2023 
  

For the Three Months Ended

March 31,

 
   2024   2023 
Share-based compensation expense included in:          
Cost of revenue  $-   $4,898 
Advertising and marketing expenses   -    1,113 
Product development costs   -    3,570 
Selling, general and administrative expenses   76,969    137,513 
Total share-based compensation expense included in consolidated statement of operations  $76,969   $147,094 
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Leases (Tables)
3 Months Ended
Mar. 31, 2024
Leases [Abstract]  
Schedule of Lease Cost

The Company’s operating and finance right-of-use assets and lease liabilities are as follows:

  

  

As of

March 31, 2024

 
Operating lease right-of-use asset  $328,792 
Operating lease liability, current  $128,839 
Operating lease liability, long-term  $228,927 
      
Remaining lease term   2.8 years 
Discount rate   3.63%

 

  

For the

Three Months

Ended

March 31, 2024

 
Cash paid for operating lease  $32,001 
Schedule of Future Annual Minimum Lease Payments

Future annual minimum under non-cancellable operating leases as of March 31, 2024 were as follows:

  

As of March 31, 2024    
     
Years ended December 31,    
2024 (excluding the three months ended March 31, 2024)   96,643 
2025   132,503 
2026   136,473 
Thereafter   11,654 
Total minimum lease payments   377,273 
Less imputed interest   (19,507)
Present value of minimum lease payments  $357,766 
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Inventory (Tables)
3 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
Schedule of Inventory

Inventory consisted of the following:

 

   March 31,   December 31, 
   2024   2023 
Finished goods  $355,138   $366,844 
Raw materials   121,814    122,258 
Allowance for excess & obsolete inventory   (231,058)   (192,698)
Inventory, net  $245,894   $296,404 
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Property and Equipment (Tables)
3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment

Property and equipment consisted of the following:

 

   March 31,   December 31, 
   2024   2023 
Furniture and equipment  $249,511   $275,994 
Vehicles   15,000    15,000 
Property and equipment, gross    264,511    290,994 
Accumulated depreciation   (245,492)   (252,436)
Property and equipment, net  $19,019   $38,558 
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Accounts Payable and Accrued Liabilities (Tables)
3 Months Ended
Mar. 31, 2024
Payables and Accruals [Abstract]  
Schedule of Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consisted of the following:

 

   March 31,   December 31, 
   2024   2023 
Accounts payable  $101,591   $183,359 
Sales commissions payable   1,706    1,710 
Accrued payroll liabilities   143,165    189,829 
Product warranty accrual   99,470    191,338 
Other accrued expenses   15,944    58,488 
Total  $361,876   $624,724 
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Equity Incentive Plans (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Restricted Units Activity

 

 

Number of

Units

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

 
           
Outstanding, December 31, 2023   -   $-   $- 
Granted   136,365   $0.55   $27,274 
Vested and settled with share issuance   (136,365)  $0.55   $- 
Forfeited/canceled   -   $-   $- 
Outstanding, March 31, 2024   -   $-   $- 
2017 and 2021 Equity Plan [Member] | Employees and Consultants [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended March 31, 2024, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value

 
                 
Outstanding, December 31, 2023   302,022   $5.87    6.6   $       - 
Granted   -   $-    -   $- 
Exercised   -   $-    -   $- 
Forfeited   (40,697)  $3.36    -   $- 
Expired   -   $-    -   $- 
Outstanding, March 31, 2024   261,325   $6.26    7.2   $- 
Exercisable, March 31, 2024   256,325   $6.34    7.2   $- 
Summary of Non-vested Non-qualified Stock Option Activity

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the three months ended March 31, 2024, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

  

Grant-Date

Fair Value

 
                 
Nonvested, December 31, 2023   10,000   $2.18   $     -   $21,800 
Granted   -   $-   $-   $- 
Vested   (5,000)  $2.18   $-   $(10,900)
Forfeited   -   $-   $-   $- 
Expired   -   $-   $-   $- 
Nonvested, March 31, 2024   5,000   $2.18   $-   $10,900 
2017 and 2021 Equity Plan [Member] | Directors [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

A summary of the non-qualified stock options granted to directors under the 2017 and 2021 Equity Plans, during the three months ended March 31, 2024, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value ($000)

 
                 
Outstanding, December 31, 2023   57,122   $9.44    5.0   $     - 
Granted   -   $-    -   $- 
Exercised   -   $-    -   $- 
Forfeited/Cancelled   -   $-    -   $- 
Expired   -   $-    -   $- 
Outstanding, March 31, 2024   57,122   $9.44    4.7   $- 
Exercisable, March 31, 2024   57,122   $9.44    4.7   $- 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Warrants (Tables)
3 Months Ended
Mar. 31, 2024
Warrants  
Schedule of Outstanding Warrants to Purchase Common Stock

The following table summarizes information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2024:

 

           Weighted   Weighted     
           Average   Average   Aggregate 
   Warrants   Exercise   Remaining Life   Intrinsic 
   Outstanding   Exercisable   Price   In Months   Value 
                     
Outstanding at December 31, 2023   7,623,772    7,623,772   $5.14    37       - 
                          
Granted   -    -    -    -    - 
                          
Exercised   -    -    -    -    - 
                          
Expired   -    -    -    -    - 
                          
Outstanding at March 31, 2024   7,623,772    7,623,772   $

 5.14

    34    - 
Schedule of Warrants Outstanding

The following table summarizes information about warrants outstanding at March 31, 2024:

 

    Warrants   Weighted Average 
Exercise price   Outstanding   Exercisable   Months Outstanding 
              
$9.45    192,982    192,982    6 
                  
$10.40    34,737    34,737    7 
                  
$5.00    7,105,496    7,105,496    35 
                  
$5.16    290,557    290,557    35 
                  
      7,623,772    7,623,772    34 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Revenue by Source (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Product Information [Line Items]    
Total revenue $ 234,506 $ 4,682,573
Equipment And Systems Sales [Member]    
Product Information [Line Items]    
Total revenue 113,172 4,396,827
Engineering And Other Services [Member]    
Product Information [Line Items]    
Total revenue 88,165 124,410
Shipping and Handling [Member]    
Product Information [Line Items]    
Total revenue 1,904 12,560
Forfeited Non Refundable Customer Deposits [Member]    
Product Information [Line Items]    
Total revenue $ 31,265 $ 148,776
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Remaining Performance Obligations Expected to be Recognized (Details) - USD ($)
Mar. 31, 2024
Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Remaining performance obligations related to partial equipment & engineering paid contracts $ 535,000  
Total remaining performance obligations 535,000 $ 1,869,000
2024 [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Remaining performance obligations related to partial equipment & engineering paid contracts 535,000  
Total remaining performance obligations $ 535,000  
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Share-based Compensation Costs (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Total share-based compensation expense included in consolidated statement of operations $ 76,969 $ 147,094
Cost of Sales [Member]    
Total share-based compensation expense included in consolidated statement of operations 4,898
Advertising And Marketing Expenses [Member]    
Total share-based compensation expense included in consolidated statement of operations 1,113
Product Development Costs [Member]    
Total share-based compensation expense included in consolidated statement of operations 3,570
Selling, General and Administrative Expenses [Member]    
Total share-based compensation expense included in consolidated statement of operations $ 76,969 $ 137,513
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Nature of Operations and Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Feb. 15, 2022
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Product Information [Line Items]        
Proceeds from issuance of common stock $ 21,711,000      
FDIC insured amount   $ 250,000    
Cash balance, amount   11,598,836   $ 12,508,251
FDIC uninsured amount   11,349,000    
Allowance for doubtful accounts   91,000   125,000
Provision for doubtful accounts   $ 34,566 $ 1,705  
Potentially dilutive equity instruments that are convertible into common stock   7,942,220 8,010,956  
Contract assets   $ 224,414   224,414
Allowance for doubtful accounts   1,436   1,436
Contract with customer liability current   539,956   499,800
Revenue recognized   47,440 $ 3,852,906  
Revenue remaining performance obligation   $ 535,000 $ 1,869,000  
Product warranty description   The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue.    
Product warranty accrual classified current   $ 99,470   191,338
One Customer [Member]        
Product Information [Line Items]        
Revenue remaining performance amount cancelled       $ 170,000
Customer One [Member] | Customer Concentration Risk [Member] | Revenue Benchmark [Member]        
Product Information [Line Items]        
Concentration risk percentage   24.00% 39.00%  
Customer One [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]        
Product Information [Line Items]        
Concentration risk percentage   60.00% 59.00%  
Customer Two [Member] | Customer Concentration Risk [Member] | Revenue Benchmark [Member]        
Product Information [Line Items]        
Concentration risk percentage   16.00% 28.00%  
Customer Two [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]        
Product Information [Line Items]        
Concentration risk percentage   29.00% 29.00%  
Customer Three [Member] | Customer Concentration Risk [Member] | Revenue Benchmark [Member]        
Product Information [Line Items]        
Concentration risk percentage   13.00% 17.00%  
Customer Three [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]        
Product Information [Line Items]        
Concentration risk percentage   11.00% 12.00%  
Maximum [Member]        
Product Information [Line Items]        
Revenue remaining performance obligation   $ 1,334,000    
Director And Staff [Member]        
Product Information [Line Items]        
Potentially dilutive equity instruments that are convertible into common stock   318,448 387,184  
Series B Preferred Stock [Member]        
Product Information [Line Items]        
Potentially dilutive equity instruments that are convertible into common stock   7,623,772 7,623,772  
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Lease Cost (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Leases [Abstract]    
Operating lease right-of-use asset $ 328,792 $ 356,109
Operating lease liability, current 128,839 126,724
Operating lease liability, long-term $ 228,927 $ 259,627
Remaining lease term 2 years 9 months 18 days  
Discount rate 3.63%  
Cash paid for operating lease $ 32,001  
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Future Annual Minimum Lease Payments (Details)
Mar. 31, 2024
USD ($)
Leases [Abstract]  
2024 (excluding the three months ended March 31, 2024) $ 96,643
2025 132,503
2026 136,473
Thereafter 11,654
Total minimum lease payments 377,273
Less imputed interest (19,507)
Present value of minimum lease payments $ 357,766
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Leases (Details Narrative)
Jul. 28, 2021
USD ($)
ft²
Mar. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Operating lease ROU   $ 328,792 $ 356,109
Operating lease liability   $ 357,766  
New Facility Lease [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Area of land | ft² 11,491    
Operating lease term description The New Facility lease commenced on November 1, 2021 and continues through January 31, 2027.    
Lease rental expense $ 10,055    
Increase in rent percent 3.00%    
Security deposit $ 14,747    
Lease renew term 5 years    
Operating lease ROU $ 582,838    
Operating lease liability $ 582,838    
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Inventory (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Finished goods $ 355,138 $ 366,844
Raw materials 121,814 122,258
Allowance for excess & obsolete inventory (231,058) (192,698)
Inventory, net $ 245,894 $ 296,404
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Inventory (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Overhead expenses $ 11,475 $ 13,679
Prepaid inventory expenses $ 13,000 $ 6,000
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Property and Equipment (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 264,511 $ 290,994
Accumulated depreciation (245,492) (252,436)
Property and equipment, net 19,019 38,558
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 249,511 275,994
Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 15,000 $ 15,000
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Property and Equipment (Details Narrative)
3 Months Ended
Mar. 31, 2024
USD ($)
Property, Plant and Equipment [Line Items]  
Depreciation expenses $ 6,914
Property, Plant and Equipment [Member] | Cost of Sales [Member]  
Property, Plant and Equipment [Line Items]  
Depreciation expenses 535
Property, Plant and Equipment [Member] | Inventory [Member]  
Property, Plant and Equipment [Line Items]  
Depreciation expenses $ 134
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Payables and Accruals [Abstract]    
Accounts payable $ 101,591 $ 183,359
Sales commissions payable 1,706 1,710
Accrued payroll liabilities 143,165 189,829
Product warranty accrual 99,470 191,338
Other accrued expenses 15,944 58,488
Total $ 361,876 $ 624,724
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies (Details Narrative)
Oct. 20, 2023
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Damages sought value $ 1,049,280
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders’ Equity (Details Narrative) - USD ($)
Jan. 02, 2024
Jan. 03, 2023
Jan. 17, 2022
Mar. 31, 2024
Dec. 31, 2023
Mar. 22, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Common stock, shares authorized       200,000,000 200,000,000  
Preferred stock, shares authorized       25,000,000 25,000,000  
Common stock par value       $ 0.00001 $ 0.00001  
Common stock, shares issued       8,212,737 8,076,372  
Common stock, shares outstanding       8,212,737 8,076,372  
Preferred stock, shares issued       0 0  
Preferred stock, shares outstanding       0 0  
2021 Equity Plan [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Number of stock options issued           666,667
Restricted Stock Units (RSUs) [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Vesting rights description     Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date.      
Restricted Stock Units (RSUs) [Member] | Director [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Share based compensation arrangement payment     $ 25,000      
Restricted Stock Units (RSUs) [Member] | 2021 Equity Incentive Plan [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Number of stock options issued 45,455 29,758        
Restricted Stock Units (RSUs) [Member] | 2021 Equity Plan [Member] | Directors [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Number of shares vested in period 136,365 119,032        
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Stock Option Activity (Details) - 2017 Equity Plan and 2021 Equity Plan [Member] - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Employees and Consultants [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Options, Granted  
Employees and Consultants [Member] | Non-Qualified Stock Options [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Options, Outstanding Beginning 302,022  
Weighted Average Exercise Price, Outstanding Beginning $ 5.87  
Weighted Average Remaining Contractual Term, Outstanding Ending 7 years 2 months 12 days 6 years 7 months 6 days
Aggregate Intrinsic Value, Outstanding Beginning  
Number of Options, Granted  
Weighted Average Exercise Price, Granted  
Number of Options, Exercised  
Weighted Average Exercise Price, Exercised  
Number of Options, Forfeited/Cancelled (40,697)  
Weighted Average Exercise Price, Forfeited/Cancelled $ 3.36  
Number of Options, Expired  
Weighted Average Exercise Price, Expired  
Number of Options, Outstanding Ending 261,325 302,022
Weighted Average Exercise Price, Outstanding Ending $ 6.26 $ 5.87
Aggregate Intrinsic Value, Outstanding Ending
Number of Options, Exercisable 256,325  
Weighted Average Exercise Price, Exercisable Ending $ 6.34  
Weighted Average Remaining Contractual Term, Exercisable Ending 7 years 2 months 12 days  
Aggregate Intrinsic Value, Exercisable Ending  
Number of Options, Expired  
Directors [Member] | Non-Qualified Stock Options [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Options, Outstanding Beginning 57,122  
Weighted Average Exercise Price, Outstanding Beginning $ 9.44  
Weighted Average Remaining Contractual Term, Outstanding Ending 4 years 8 months 12 days 5 years
Aggregate Intrinsic Value, Outstanding Beginning  
Number of Options, Granted  
Weighted Average Exercise Price, Granted  
Number of Options, Exercised  
Weighted Average Exercise Price, Exercised  
Number of Options, Forfeited/Cancelled  
Weighted Average Exercise Price, Forfeited/Cancelled  
Number of Options, Expired  
Weighted Average Exercise Price, Expired  
Number of Options, Outstanding Ending 57,122 57,122
Weighted Average Exercise Price, Outstanding Ending $ 9.44 $ 9.44
Aggregate Intrinsic Value, Outstanding Ending
Weighted Average Exercise Price, Exercisable Ending $ 9.44  
Weighted Average Remaining Contractual Term, Exercisable Ending 4 years 8 months 12 days  
Aggregate Intrinsic Value, Exercisable Ending  
Number of Options, Expired  
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Non-vested Non-qualified Stock Option Activity (Details) - Employees and Consultants [Member] - 2017 Equity Plan and 2021 Equity Plan [Member]
3 Months Ended
Mar. 31, 2024
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options Nonvested, Beginning | shares 10,000
Weighted Average Grant-Date Fair Value, Nonvested, Beginning | $ / shares $ 2.18
Aggregated Intrinsic Value, Nonvested Beginning
Grant Date Fair Value Nonvested, Beginning $ 21,800
Number of Options Nonvested, Granted | shares
Weighted Average Grant-Date Fair Value, Nonvested, Granted | $ / shares
Grant Date Fair Value Nonvested, Granted
Number of Options Nonvested, Vested | shares (5,000)
Weighted Average Grant-Date Fair Value, Nonvested, Vested | $ / shares $ 2.18
Grant Date Fair Value Nonvested, Vested $ (10,900)
Number of Options Nonvested, Forfeited | shares
Weighted Average Grant-Date Fair Value, Nonvested, Forfeited | $ / shares
Grant Date Fair Value Nonvested, Forfeited
Number of Options Nonvested, Expired | shares
Weighted Average Grant-Date Fair Value, Nonvested, Expired | $ / shares
Grant Date Fair Value Nonvested, Expired
Number of Options Nonvested, Ending | shares 5,000
Weighted Average Grant-Date Fair Value, Nonvested Ending | $ / shares $ 2.18
Aggregated Intrinsic Value, Nonvested Ending
Grant Date Fair Value Nonvested, Ending $ 10,900
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Restricted Units Activity (Details)
3 Months Ended
Mar. 31, 2024
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Aggregate Intrinsic Value Outstanding, Granted
Aggregate Intrinsic Value Outstanding, ending
2017 Equity Incentive Plan [Member] | Directors [Member] | Restricted Stock Units (RSUs) [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Units Outstanding, beginning | shares
Weighted Average Grant-Date Fair Value Outstanding, Beginning | $ / shares
Aggregate Intrinsic Value Outstanding, Beginning
Number of Units, Granted | shares 136,365
Weighted Average Grant-Date Fair Value, Granted | $ / shares $ 0.55
Aggregate Intrinsic Value Outstanding, Granted $ 27,274
Number of Units, Vested and settled with share issuance | shares (136,365)
Weighted Average Grant-Date Fair Value, Vested and settled with share issuance | $ / shares $ 0.55
Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance
Number of Units, Forfeited/canceled | shares
Weighted Average Grant-Date Fair Value, Forfeited/Canceled | $ / shares
Aggregate Intrinsic Value Outstanding, Forfeited/canceled
Number of Units Outstanding, ending | shares
Weighted Average Grant-Date Fair Value Outstanding,ending | $ / shares
Aggregate Intrinsic Value Outstanding, ending
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Equity Incentive Plans (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Jan. 02, 2024
Jan. 03, 2023
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Mar. 22, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Share based compensation     $ 76,969 $ 147,094    
Restricted Stock Units (RSUs) [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Shares issued during the period     136,365      
Restricted Stock Units (RSUs) [Member] | 3 Directors [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Number of shares vested in period 136,365          
Restricted Stock Units (RSUs) [Member] | Employees, Directors and Consultants [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Share based compensation     $ 75,000 101,316    
2017 Equity Incentive Plan [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Number of options to purchase shares     333,333      
Number of option remain forfeited     6,134      
Number of shares authorized     333,333      
Number of shares issued     163,692      
Number of option remain outstanding         139,378  
Shares available for future equity awards     30,263      
2017 Equity Incentive Plan [Member] | Director [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Share based compensation     $ 0 0    
2017 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Directors [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Number of shares vested in period     136,365      
2021 Equity Plan [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Shares available for future equity awards     218,665      
Number of shares grant in period           666,667
Number of shares authorized     666,667      
Unrecognized compensation expense     $ 3,429      
Weighted average remaining contractual term     12 months      
2021 Equity Plan [Member] | Non Qualified Stock Option [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Number of option remain forfeited     34,563      
Number of option remain outstanding     138,252      
2021 Equity Plan [Member] | Incentive Stock Option [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Number of option remain outstanding     40,816      
2021 Equity Plan [Member] | Restricted Stock Units (RSUs) [Member] | Directors [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Number of shares vested in period 136,365 119,032        
2021 Equity Plan [Member] | Restricted Stock [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Number of shares issued     268,933      
2021 Equity Plan [Member] | Non-Qualified Stock Options [Member] | Directors [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Number of shares issued     0      
2017 Equity Plan and 2021 Equity Plan [Member] | Employees and Consultants [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Share based compensation     $ 1,969 $ 45,778    
2017 Equity Plan and 2021 Equity Plan [Member] | Non-Qualified Stock Options [Member] | Directors [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Number of option remain forfeited          
Number of option remain outstanding     57,122   57,122  
Weighted average remaining contractual term     4 years 8 months 12 days   5 years  
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Outstanding Warrants to Purchase Common Stock (Details)
3 Months Ended
Mar. 31, 2024
USD ($)
$ / shares
shares
Warrants  
Warrants Outstanding, Beginning Balance 7,623,772
Warrants Exercisable, Beginning Balance 7,623,772
Weighted Average Exercise Price, Beginning Balance | $ / shares $ 5.14
Weighted Average Life of Outstanding Warrants in Months, Beginning Balance 37 months
Aggregate Intrinsic Value, Beginning Balance | $
Warrants Outstanding. Granted
Warrants Exercisable, Granted
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Life of Outstanding Warrants in Months, Granted
Aggregate Intrinsic Value, Granted | $
Warrants Outstanding, Exercised
Warrants Exercisable, Exercised
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Life of Outstanding Warrants in Months, Exercised
Aggregate Intrinsic Value, Exercised | $
Warrants Outstanding, Expired
Warrants Exercisable, Expired
Weighted Average Exercise Price, Expired | $ / shares
Weighted Average Life of Outstanding Warrants in Months, Expired
Aggregate Intrinsic Value, Expired | $
Warrants Outstanding, Ending Balance 7,623,772
Warrants Exercisable, Ending Balance 7,623,772
Weighted Average Exercise Price, Ending Balance | $ / shares $ 5.14
Weighted Average Life of Outstanding Warrants in Months, Ending Balance 34 months
Aggregate Intrinsic Value Outstanding, ending | $
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Warrants Outstanding (Details) - $ / shares
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 5.14 $ 5.14
Warrants Outstanding 7,623,772 7,623,772
Warrants Exercisable 7,623,772 7,623,772
Weighted Average Life of Outstanding Warrants in Months 34 months  
Warrants Range One [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 9.45  
Warrants Outstanding 192,982  
Warrants Exercisable 192,982  
Weighted Average Life of Outstanding Warrants in Months 6 months  
Warrants Range Two [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 10.40  
Warrants Outstanding 34,737  
Warrants Exercisable 34,737  
Weighted Average Life of Outstanding Warrants in Months 7 months  
Warrants Range Three [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 5.00  
Warrants Outstanding 7,105,496  
Warrants Exercisable 7,105,496  
Weighted Average Life of Outstanding Warrants in Months 35 months  
Warrants Range Four [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 5.16  
Warrants Outstanding 290,557  
Warrants Exercisable 290,557  
Weighted Average Life of Outstanding Warrants in Months 35 months  
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Income Taxes (Details Narrative)
3 Months Ended
Mar. 31, 2024
USD ($)
Operating loss carryforward $ 29,757,000
Net operating loss carry forward expected to expire amount $ 11,196,000
Net operating loss expiration term 2034 through 2037
NOLs usage against taxable income, percentage 80.00%
NOLs carryforwards term three-year period
Ownership [Member]  
Percentage of ownership change 50.00%
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Related Party Transactions (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2022
Dec. 20, 2022
Oct. 13, 2022
Payments for commissions   $ 0 $ 18,273      
Payments for deposit     14,035      
Consulting Agreement [Member]            
Proceeds fom deposit         $ 10,900  
Consulting Agreement [Member] | Lone Star Bioscience Inc [Member] | Chief Executive Officer [Member]            
Proceeds fom deposit       $ 1,250   $ 2,500
Increased related party sales $ 3,577          
Proceeds from related party sales $ 14,477          
Revenue     $ 16,977      
Related party transaction   $ 0        
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Subsequent Events (Details Narrative)
3 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
Subsequent event description April 10, 2023 the Company received notice from The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between February 24, 2023, through April 6, 2023, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2).
EXCEL 61 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 62 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 63 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 65 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 129 280 1 false 53 0 false 7 false false R1.htm 00000001 - Document - Cover Sheet http://ir.ceaindustries.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://ir.ceaindustries.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://ir.ceaindustries.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://ir.ceaindustries.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) Sheet http://ir.ceaindustries.com/role/StatementsOfChangesInShareholdersEquity Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://ir.ceaindustries.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Nature of Operations and Significant Accounting Policies Sheet http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies Nature of Operations and Significant Accounting Policies Notes 7 false false R8.htm 00000008 - Disclosure - Leases Sheet http://ir.ceaindustries.com/role/Leases Leases Notes 8 false false R9.htm 00000009 - Disclosure - Inventory Sheet http://ir.ceaindustries.com/role/Inventory Inventory Notes 9 false false R10.htm 00000010 - Disclosure - Property and Equipment Sheet http://ir.ceaindustries.com/role/PropertyAndEquipment Property and Equipment Notes 10 false false R11.htm 00000011 - Disclosure - Accounts Payable and Accrued Liabilities Sheet http://ir.ceaindustries.com/role/AccountsPayableAndAccruedLiabilities Accounts Payable and Accrued Liabilities Notes 11 false false R12.htm 00000012 - Disclosure - Commitments and Contingencies Sheet http://ir.ceaindustries.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 00000013 - Disclosure - Stockholders??? Equity Sheet http://ir.ceaindustries.com/role/StockholdersEquity Stockholders??? Equity Notes 13 false false R14.htm 00000014 - Disclosure - Equity Incentive Plans Sheet http://ir.ceaindustries.com/role/EquityIncentivePlans Equity Incentive Plans Notes 14 false false R15.htm 00000015 - Disclosure - Warrants Sheet http://ir.ceaindustries.com/role/Warrants Warrants Notes 15 false false R16.htm 00000016 - Disclosure - Income Taxes Sheet http://ir.ceaindustries.com/role/IncomeTaxes Income Taxes Notes 16 false false R17.htm 00000017 - Disclosure - Related Party Transactions Sheet http://ir.ceaindustries.com/role/RelatedPartyTransactions Related Party Transactions Notes 17 false false R18.htm 00000018 - Disclosure - Subsequent Events Sheet http://ir.ceaindustries.com/role/SubsequentEvents Subsequent Events Notes 18 false false R19.htm 00000019 - Disclosure - Nature of Operations and Significant Accounting Policies (Policies) Sheet http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies Nature of Operations and Significant Accounting Policies (Policies) Policies http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies 19 false false R20.htm 00000020 - Disclosure - Nature of Operations and Significant Accounting Policies (Tables) Sheet http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables Nature of Operations and Significant Accounting Policies (Tables) Tables http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies 20 false false R21.htm 00000021 - Disclosure - Leases (Tables) Sheet http://ir.ceaindustries.com/role/LeasesTables Leases (Tables) Tables http://ir.ceaindustries.com/role/Leases 21 false false R22.htm 00000022 - Disclosure - Inventory (Tables) Sheet http://ir.ceaindustries.com/role/InventoryTables Inventory (Tables) Tables http://ir.ceaindustries.com/role/Inventory 22 false false R23.htm 00000023 - Disclosure - Property and Equipment (Tables) Sheet http://ir.ceaindustries.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://ir.ceaindustries.com/role/PropertyAndEquipment 23 false false R24.htm 00000024 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) Sheet http://ir.ceaindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables Accounts Payable and Accrued Liabilities (Tables) Tables http://ir.ceaindustries.com/role/AccountsPayableAndAccruedLiabilities 24 false false R25.htm 00000025 - Disclosure - Equity Incentive Plans (Tables) Sheet http://ir.ceaindustries.com/role/EquityIncentivePlansTables Equity Incentive Plans (Tables) Tables http://ir.ceaindustries.com/role/EquityIncentivePlans 25 false false R26.htm 00000026 - Disclosure - Warrants (Tables) Sheet http://ir.ceaindustries.com/role/WarrantsTables Warrants (Tables) Tables http://ir.ceaindustries.com/role/Warrants 26 false false R27.htm 00000027 - Disclosure - Schedule of Revenue by Source (Details) Sheet http://ir.ceaindustries.com/role/ScheduleOfRevenueBySourceDetails Schedule of Revenue by Source (Details) Details 27 false false R28.htm 00000028 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details) Sheet http://ir.ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails Schedule of Remaining Performance Obligations Expected to be Recognized (Details) Details 28 false false R29.htm 00000029 - Disclosure - Schedule of Share-based Compensation Costs (Details) Sheet http://ir.ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails Schedule of Share-based Compensation Costs (Details) Details 29 false false R30.htm 00000030 - Disclosure - Nature of Operations and Significant Accounting Policies (Details Narrative) Sheet http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative Nature of Operations and Significant Accounting Policies (Details Narrative) Details http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables 30 false false R31.htm 00000031 - Disclosure - Schedule of Lease Cost (Details) Sheet http://ir.ceaindustries.com/role/ScheduleOfLeaseCostDetails Schedule of Lease Cost (Details) Details 31 false false R32.htm 00000032 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details) Sheet http://ir.ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails Schedule of Future Annual Minimum Lease Payments (Details) Details 32 false false R33.htm 00000033 - Disclosure - Leases (Details Narrative) Sheet http://ir.ceaindustries.com/role/LeasesDetailsNarrative Leases (Details Narrative) Details http://ir.ceaindustries.com/role/LeasesTables 33 false false R34.htm 00000034 - Disclosure - Schedule of Inventory (Details) Sheet http://ir.ceaindustries.com/role/ScheduleOfInventoryDetails Schedule of Inventory (Details) Details 34 false false R35.htm 00000035 - Disclosure - Inventory (Details Narrative) Sheet http://ir.ceaindustries.com/role/InventoryDetailsNarrative Inventory (Details Narrative) Details http://ir.ceaindustries.com/role/InventoryTables 35 false false R36.htm 00000036 - Disclosure - Schedule of Property and Equipment (Details) Sheet http://ir.ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails Schedule of Property and Equipment (Details) Details 36 false false R37.htm 00000037 - Disclosure - Property and Equipment (Details Narrative) Sheet http://ir.ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative Property and Equipment (Details Narrative) Details http://ir.ceaindustries.com/role/PropertyAndEquipmentTables 37 false false R38.htm 00000038 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details) Sheet http://ir.ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails Schedule of Accounts Payable and Accrued Liabilities (Details) Details 38 false false R39.htm 00000039 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://ir.ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://ir.ceaindustries.com/role/CommitmentsAndContingencies 39 false false R40.htm 00000040 - Disclosure - Stockholders??? Equity (Details Narrative) Sheet http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative Stockholders??? Equity (Details Narrative) Details http://ir.ceaindustries.com/role/StockholdersEquity 40 false false R41.htm 00000041 - Disclosure - Schedule of Stock Option Activity (Details) Sheet http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails Schedule of Stock Option Activity (Details) Details 41 false false R42.htm 00000042 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details) Sheet http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails Summary of Non-vested Non-qualified Stock Option Activity (Details) Details 42 false false R43.htm 00000043 - Disclosure - Schedule of Restricted Units Activity (Details) Sheet http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails Schedule of Restricted Units Activity (Details) Details 43 false false R44.htm 00000044 - Disclosure - Equity Incentive Plans (Details Narrative) Sheet http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative Equity Incentive Plans (Details Narrative) Details http://ir.ceaindustries.com/role/EquityIncentivePlansTables 44 false false R45.htm 00000045 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details) Sheet http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails Schedule of Outstanding Warrants to Purchase Common Stock (Details) Details 45 false false R46.htm 00000046 - Disclosure - Schedule of Warrants Outstanding (Details) Sheet http://ir.ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails Schedule of Warrants Outstanding (Details) Details 46 false false R47.htm 00000047 - Disclosure - Income Taxes (Details Narrative) Sheet http://ir.ceaindustries.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://ir.ceaindustries.com/role/IncomeTaxes 47 false false R48.htm 00000048 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://ir.ceaindustries.com/role/RelatedPartyTransactions 48 false false R49.htm 00000049 - Disclosure - Subsequent Events (Details Narrative) Sheet http://ir.ceaindustries.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://ir.ceaindustries.com/role/SubsequentEvents 49 false false All Reports Book All Reports cead-20240331.xsd cead-20240331_cal.xml cead-20240331_def.xml cead-20240331_lab.xml cead-20240331_pre.xml form10-q.htm http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 true true JSON 67 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-q.htm": { "nsprefix": "CEAD", "nsuri": "http://ir.ceaindustries.com/20240331", "dts": { "schema": { "local": [ "cead-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "cead-20240331_cal.xml" ] }, "definitionLink": { "local": [ "cead-20240331_def.xml" ] }, "labelLink": { "local": [ "cead-20240331_lab.xml" ] }, "presentationLink": { "local": [ "cead-20240331_pre.xml" ] }, "inline": { "local": [ "form10-q.htm" ] } }, "keyStandard": 233, "keyCustom": 47, "axisStandard": 19, "axisCustom": 0, "memberStandard": 18, "memberCustom": 34, "hidden": { "total": 97, "http://ir.ceaindustries.com/20240331": 23, "http://xbrl.sec.gov/dei/2024": 6, "http://fasb.org/us-gaap/2024": 68 }, "contextCount": 129, "entityCount": 1, "segmentCount": 53, "elementCount": 443, "unitCount": 7, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 494, "http://xbrl.sec.gov/dei/2024": 34 }, "report": { "R1": { "role": "http://ir.ceaindustries.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R2": { "role": "http://ir.ceaindustries.com/role/BalanceSheets", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R3": { "role": "http://ir.ceaindustries.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R4": { "role": "http://ir.ceaindustries.com/role/StatementsOfOperations", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CostOfRevenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R5": { "role": "http://ir.ceaindustries.com/role/StatementsOfChangesInShareholdersEquity", "longName": "00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited)", "shortName": "Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R6": { "role": "http://ir.ceaindustries.com/role/StatementsOfCashFlows", "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R7": { "role": "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies", "longName": "00000007 - Disclosure - Nature of Operations and Significant Accounting Policies", "shortName": "Nature of Operations and Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R8": { "role": "http://ir.ceaindustries.com/role/Leases", "longName": "00000008 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R9": { "role": "http://ir.ceaindustries.com/role/Inventory", "longName": "00000009 - Disclosure - Inventory", "shortName": "Inventory", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R10": { "role": "http://ir.ceaindustries.com/role/PropertyAndEquipment", "longName": "00000010 - Disclosure - Property and Equipment", "shortName": "Property and Equipment", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R11": { "role": "http://ir.ceaindustries.com/role/AccountsPayableAndAccruedLiabilities", "longName": "00000011 - Disclosure - Accounts Payable and Accrued Liabilities", "shortName": "Accounts Payable and Accrued Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R12": { "role": "http://ir.ceaindustries.com/role/CommitmentsAndContingencies", "longName": "00000012 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R13": { "role": "http://ir.ceaindustries.com/role/StockholdersEquity", "longName": "00000013 - Disclosure - Stockholders\u2019 Equity", "shortName": "Stockholders\u2019 Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R14": { "role": "http://ir.ceaindustries.com/role/EquityIncentivePlans", "longName": "00000014 - Disclosure - Equity Incentive Plans", "shortName": "Equity Incentive Plans", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R15": { "role": "http://ir.ceaindustries.com/role/Warrants", "longName": "00000015 - Disclosure - Warrants", "shortName": "Warrants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "CEAD:WarrantsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "CEAD:WarrantsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R16": { "role": "http://ir.ceaindustries.com/role/IncomeTaxes", "longName": "00000016 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R17": { "role": "http://ir.ceaindustries.com/role/RelatedPartyTransactions", "longName": "00000017 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R18": { "role": "http://ir.ceaindustries.com/role/SubsequentEvents", "longName": "00000018 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R19": { "role": "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies", "longName": "00000019 - Disclosure - Nature of Operations and Significant Accounting Policies (Policies)", "shortName": "Nature of Operations and Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "19", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "CEAD:DescriptionOfBusinessPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "CEAD:DescriptionOfBusinessPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R20": { "role": "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables", "longName": "00000020 - Disclosure - Nature of Operations and Significant Accounting Policies (Tables)", "shortName": "Nature of Operations and Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R21": { "role": "http://ir.ceaindustries.com/role/LeasesTables", "longName": "00000021 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R22": { "role": "http://ir.ceaindustries.com/role/InventoryTables", "longName": "00000022 - Disclosure - Inventory (Tables)", "shortName": "Inventory (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R23": { "role": "http://ir.ceaindustries.com/role/PropertyAndEquipmentTables", "longName": "00000023 - Disclosure - Property and Equipment (Tables)", "shortName": "Property and Equipment (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R24": { "role": "http://ir.ceaindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables", "longName": "00000024 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)", "shortName": "Accounts Payable and Accrued Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R25": { "role": "http://ir.ceaindustries.com/role/EquityIncentivePlansTables", "longName": "00000025 - Disclosure - Equity Incentive Plans (Tables)", "shortName": "Equity Incentive Plans (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R26": { "role": "http://ir.ceaindustries.com/role/WarrantsTables", "longName": "00000026 - Disclosure - Warrants (Tables)", "shortName": "Warrants (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R27": { "role": "http://ir.ceaindustries.com/role/ScheduleOfRevenueBySourceDetails", "longName": "00000027 - Disclosure - Schedule of Revenue by Source (Details)", "shortName": "Schedule of Revenue by Source (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_custom_EquipmentAndSystemsSalesMember", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R28": { "role": "http://ir.ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "longName": "00000028 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)", "shortName": "Schedule of Remaining Performance Obligations Expected to be Recognized (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "CEAD:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "CEAD:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R29": { "role": "http://ir.ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails", "longName": "00000029 - Disclosure - Schedule of Share-based Compensation Costs (Details)", "shortName": "Schedule of Share-based Compensation Costs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R30": { "role": "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "longName": "00000030 - Disclosure - Nature of Operations and Significant Accounting Policies (Details Narrative)", "shortName": "Nature of Operations and Significant Accounting Policies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "From2022-02-152022-02-15", "name": "us-gaap:ProceedsFromIssuanceOfCommonStock", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "CEAD:LiquidityPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-02-152022-02-15", "name": "us-gaap:ProceedsFromIssuanceOfCommonStock", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "CEAD:LiquidityPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R31": { "role": "http://ir.ceaindustries.com/role/ScheduleOfLeaseCostDetails", "longName": "00000031 - Disclosure - Schedule of Lease Cost (Details)", "shortName": "Schedule of Lease Cost (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R32": { "role": "http://ir.ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails", "longName": "00000032 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details)", "shortName": "Schedule of Future Annual Minimum Lease Payments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R33": { "role": "http://ir.ceaindustries.com/role/LeasesDetailsNarrative", "longName": "00000033 - Disclosure - Leases (Details Narrative)", "shortName": "Leases (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-07-28_custom_NewFacilityLeaseMember", "name": "us-gaap:AreaOfLand", "unitRef": "SquareFoot", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R34": { "role": "http://ir.ceaindustries.com/role/ScheduleOfInventoryDetails", "longName": "00000034 - Disclosure - Schedule of Inventory (Details)", "shortName": "Schedule of Inventory (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:InventoryFinishedGoods", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:InventoryFinishedGoods", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R35": { "role": "http://ir.ceaindustries.com/role/InventoryDetailsNarrative", "longName": "00000035 - Disclosure - Inventory (Details Narrative)", "shortName": "Inventory (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CostOfGoodsAndServicesSoldOverhead", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CostOfGoodsAndServicesSoldOverhead", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R36": { "role": "http://ir.ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails", "longName": "00000036 - Disclosure - Schedule of Property and Equipment (Details)", "shortName": "Schedule of Property and Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R37": { "role": "http://ir.ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "longName": "00000037 - Disclosure - Property and Equipment (Details Narrative)", "shortName": "Property and Equipment (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R38": { "role": "http://ir.ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails", "longName": "00000038 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details)", "shortName": "Schedule of Accounts Payable and Accrued Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R39": { "role": "http://ir.ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative", "longName": "00000039 - Disclosure - Commitments and Contingencies (Details Narrative)", "shortName": "Commitments and Contingencies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "From2023-10-202023-10-20", "name": "us-gaap:LossContingencyDamagesSoughtValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-10-202023-10-20", "name": "us-gaap:LossContingencyDamagesSoughtValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R40": { "role": "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative", "longName": "00000040 - Disclosure - Stockholders\u2019 Equity (Details Narrative)", "shortName": "Stockholders\u2019 Equity (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-122022-01-17_us-gaap_RestrictedStockUnitsRSUMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R41": { "role": "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "longName": "00000041 - Disclosure - Schedule of Stock Option Activity (Details)", "shortName": "Schedule of Stock Option Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R42": { "role": "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails", "longName": "00000042 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)", "shortName": "Summary of Non-vested Non-qualified Stock Option Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R43": { "role": "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "longName": "00000043 - Disclosure - Schedule of Restricted Units Activity (Details)", "shortName": "Schedule of Restricted Units Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "From2024-01-012024-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_us-gaap_RestrictedStockUnitsRSUMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_us-gaap_RestrictedStockUnitsRSUMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R44": { "role": "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "longName": "00000044 - Disclosure - Equity Incentive Plans (Details Narrative)", "shortName": "Equity Incentive Plans (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ShareBasedCompensation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_us-gaap_RestrictedStockUnitsRSUMember", "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R45": { "role": "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "longName": "00000045 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details)", "shortName": "Schedule of Outstanding Warrants to Purchase Common Stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "CEAD:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R46": { "role": "http://ir.ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails", "longName": "00000046 - Disclosure - Schedule of Warrants Outstanding (Details)", "shortName": "Schedule of Warrants Outstanding (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R47": { "role": "http://ir.ceaindustries.com/role/IncomeTaxesDetailsNarrative", "longName": "00000047 - Disclosure - Income Taxes (Details Narrative)", "shortName": "Income Taxes (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R48": { "role": "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "longName": "00000048 - Disclosure - Related Party Transactions (Details Narrative)", "shortName": "Related Party Transactions (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PaymentsForCommissions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PaymentsForCommissions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R49": { "role": "http://ir.ceaindustries.com/role/SubsequentEventsDetailsNarrative", "longName": "00000049 - Disclosure - Subsequent Events (Details Narrative)", "shortName": "Subsequent Events (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SubsequentEventDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SubsequentEventDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 }, "http://ir.ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets", "http://ir.ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued liabilities", "totalLabel": "Total", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r41", "r42" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/AccountsPayableAndAccruedLiabilities" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities", "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period." } } }, "auth_ref": [ "r40", "r42", "r45", "r675" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r40", "r552" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableMember", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r522" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts receivable, net", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r623" ] }, "us-gaap_AccruedSalesCommissionCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedSalesCommissionCurrent", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Sales commissions payable", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r42", "r531" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r23", "r118", "r400" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r50", "r552", "r738" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r435", "r612", "r613", "r614", "r615", "r680", "r739" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Fair value of restricted stock units issued to directors", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Fair value of vested stock options granted to employees", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "CEAD_AdvertisingAndMarketingExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "AdvertisingAndMarketingExpensesMember", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "lang": { "en-us": { "role": { "label": "Advertising And Marketing Expenses [Member]" } } }, "auth_ref": [] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "lang": { "en-us": { "role": { "label": "Total share-based compensation expense included in consolidated statement of operations", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r299", "r307" ] }, "us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Allowance for doubtful accounts", "label": "Allowance for Doubtful Accounts, Premiums and Other Receivables", "documentation": "The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet." } } }, "auth_ref": [ "r624" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Allowance for doubtful accounts", "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance." } } }, "auth_ref": [ "r196" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r584" ] }, "us-gaap_AreaOfLand": { "xbrltype": "areaItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AreaOfLand", "presentation": [ "http://ir.ceaindustries.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Area of land", "documentation": "Area of land held." } } }, "auth_ref": [] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://ir.ceaindustries.com/role/LeasesDetailsNarrative", "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r336" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL ASSETS", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r89", "r98", "r119", "r140", "r168", "r172", "r178", "r179", "r187", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r337", "r339", "r355", "r392", "r470", "r537", "r538", "r552", "r569", "r641", "r642", "r697" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r114", "r124", "r140", "r187", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r337", "r339", "r355", "r552", "r641", "r642", "r697" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "auth_ref": [] }, "us-gaap_AssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsNoncurrent", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Noncurrent Assets", "label": "Assets, Noncurrent", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r140", "r187", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r337", "r339", "r355", "r641", "r642", "r697" ] }, "us-gaap_AssetsNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsNoncurrentAbstract", "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Noncurrent Assets" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r584" ] }, "us-gaap_AwardDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardDateAxis", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "lang": { "en-us": { "role": { "label": "Award Date [Axis]", "documentation": "Information by date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672" ] }, "us-gaap_AwardDateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardDateDomain", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r270", "r271", "r272", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r294", "r295", "r296", "r297", "r298" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Financial Statement Presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets", "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "verboseLabel": "Cash balance, amount", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r12", "r116", "r529" ] }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, and Restricted Cash", "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits." } } }, "auth_ref": [ "r13", "r88" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents, beginning of period", "periodEndLabel": "Cash and cash equivalents, end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r12", "r66", "r138" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net change in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r0", "r66" ] }, "us-gaap_CashFDICInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFDICInsuredAmount", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "FDIC insured amount", "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Non-cash investing and financing activities:" } } }, "auth_ref": [] }, "us-gaap_CashUninsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashUninsuredAmount", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "FDIC uninsured amount", "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "srt_ChiefExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ChiefExecutiveOfficerMember", "presentation": [ "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "auth_ref": [ "r622" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://ir.ceaindustries.com/role/Cover", "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r111", "r120", "r121", "r122", "r140", "r158", "r159", "r163", "r165", "r170", "r171", "r187", "r223", "r225", "r226", "r227", "r230", "r231", "r233", "r234", "r236", "r239", "r245", "r355", "r426", "r427", "r428", "r429", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r458", "r479", "r499", "r516", "r517", "r518", "r519", "r520", "r590", "r610", "r616" ] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ir.ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Exercise Price, Beginning Balance", "periodEndLabel": "Weighted Average Exercise Price, Ending Balance", "label": "Exercise price", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r246" ] }, "CEAD_ClassOfWarrantOrRightExercised": { "xbrltype": "sharesItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ClassOfWarrantOrRightExercised", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Warrants Outstanding, Exercised", "documentation": "Class of Warrant or Right Exercised", "label": "ClassOfWarrantOrRightExercised" } } }, "auth_ref": [] }, "CEAD_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregate Intrinsic Value, Beginning Balance", "documentation": "Aggregate intrinsic value of outstanding warrants.", "label": "Aggregate intrinsic value of outstanding warrants" } } }, "auth_ref": [] }, "CEAD_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised": { "xbrltype": "perShareItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceExercised", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted Average Exercise Price, Exercised", "documentation": "Weighted average exercise price of warrants exercised.", "label": "Weighted Average Exercise Price, Exercised [Default Label]" } } }, "auth_ref": [] }, "CEAD_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired": { "xbrltype": "perShareItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceExpired", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted Average Exercise Price, Expired", "documentation": "Weighted average exercise price of warrants expired.", "label": "Weighted Average Exercise Price, Expired [Default Label]" } } }, "auth_ref": [] }, "CEAD_ClassOfWarrantOrRightWeightedAverageExercisePriceGranted": { "xbrltype": "perShareItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceGranted", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted Average Exercise Price, Granted", "documentation": "Warrants weighted average exercise price granted.", "label": "ClassOfWarrantOrRightWeightedAverageExercisePriceGranted" } } }, "auth_ref": [] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://ir.ceaindustries.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r336" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Note 6)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r46", "r91", "r394", "r457" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r77", "r217", "r218", "r523", "r630", "r632" ] }, "CEAD_CommonStock0.00001ParValueMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "CommonStock0.00001ParValueMember", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock, $0.00001 par value" } } }, "auth_ref": [] }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares available for future equity awards", "documentation": "Aggregate number of common shares reserved for future issuance." } } }, "auth_ref": [ "r49" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r560", "r561", "r562", "r564", "r565", "r566", "r567", "r612", "r613", "r615", "r680", "r736", "r739" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheetsParenthetical", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "verboseLabel": "Common stock par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r49" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheetsParenthetical", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r49", "r458" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheetsParenthetical", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r49" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheetsParenthetical", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r6", "r49", "r458", "r476", "r739", "r740" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock, $0.00001 par value; 200,000,000 authorized; 8,212,737 and 8,076,372 shares issued and outstanding, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r49", "r396", "r552" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r17", "r18", "r35", "r36", "r182", "r522" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r17", "r18", "r35", "r36", "r182", "r424", "r522" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r17", "r18", "r35", "r36", "r182", "r522", "r596" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentrations", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r39", "r102" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration risk percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r17", "r18", "r35", "r36", "r182" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r17", "r18", "r35", "r36", "r182", "r522" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Principles of Consolidation", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r31", "r533" ] }, "CEAD_ConsultingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ConsultingAgreementMember", "presentation": [ "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consulting Agreement [Member]", "documentation": "Consulting Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerAssetNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerAssetNetCurrent", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets", "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Contract assets, net", "verboseLabel": "Contract assets", "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current." } } }, "auth_ref": [ "r248", "r250", "r261" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets", "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deferred revenue", "verboseLabel": "Contract with customer liability current", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r248", "r249", "r261" ] }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerLiabilityRevenueRecognized", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue recognized", "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due." } } }, "auth_ref": [ "r262" ] }, "us-gaap_CostOfGoodsAndServicesSoldOverhead": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfGoodsAndServicesSoldOverhead", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/InventoryDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Overhead expenses", "documentation": "Indirect cost incurred related to good produced and service rendered." } } }, "auth_ref": [ "r605" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of revenue", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r60", "r140", "r187", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r355", "r537", "r641" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfSalesMember", "presentation": [ "http://ir.ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "lang": { "en-us": { "role": { "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditLossFinancialInstrumentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditLossFinancialInstrumentPolicyTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable and Allowance for Accounts Receivable", "documentation": "Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status." } } }, "auth_ref": [ "r190", "r191", "r192", "r193", "r194", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r72", "r182" ] }, "CEAD_CustomerOneMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "CustomerOneMember", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer One [Member]", "documentation": "Customer One [Member]" } } }, "auth_ref": [] }, "CEAD_CustomerThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "CustomerThreeMember", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Three [Member]", "documentation": "Customer Three [Member]" } } }, "auth_ref": [] }, "CEAD_CustomerTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "CustomerTwoMember", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Two [Member]", "documentation": "Customer Two [Member]" } } }, "auth_ref": [] }, "us-gaap_Deposits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Deposits", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds fom deposit", "documentation": "The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others." } } }, "auth_ref": [ "r90" ] }, "us-gaap_DepositsAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepositsAssetsNoncurrent", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deposits", "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r598" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciation expenses", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r4", "r22" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation and intangible asset amortization expense", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r4", "r168", "r175", "r179", "r537", "r538" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r447", "r449", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r471", "r472", "r473", "r474", "r487", "r488", "r489", "r490", "r493", "r494", "r495", "r496", "r511", "r512", "r513", "r514", "r560", "r562", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r32", "r33", "r34", "r87", "r447", "r449", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r471", "r472", "r473", "r474", "r487", "r488", "r489", "r490", "r493", "r494", "r495", "r496", "r511", "r512", "r513", "r514", "r532", "r560", "r562", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689" ] }, "CEAD_DescriptionOfBusinessPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "DescriptionOfBusinessPolicyTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Description of Business", "documentation": "Description Of Business [Policy Text Block]" } } }, "auth_ref": [] }, "CEAD_DirectorAndStaffMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "DirectorAndStaffMember", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Director And Staff [Member]", "documentation": "Director And Staff [Member]" } } }, "auth_ref": [] }, "srt_DirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "DirectorMember", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "auth_ref": [ "r622", "r737" ] }, "CEAD_DirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "DirectorsMember", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/EquityIncentivePlansTables", "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Directors [Member]", "documentation": "Directors [Member]" } } }, "auth_ref": [] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Revenue by Source", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r645" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlans" ], "lang": { "en-us": { "role": { "label": "Equity Incentive Plans", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r266", "r269", "r300", "r301", "r302", "r544" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "CEAD_DisclosureWarrantsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "DisclosureWarrantsAbstract", "lang": { "en-us": { "role": { "label": "Warrants", "verboseLabel": "Schedule Of Outstanding Warrants To Purchase Common Stock" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r583" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r581", "r583", "r584" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r582" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r570" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r583" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r583" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r585" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r573" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Loss per common share - basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r131", "r147", "r148", "r149", "r150", "r151", "r152", "r156", "r158", "r163", "r164", "r165", "r167", "r332", "r335", "r349", "r350", "r389", "r405", "r534" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Loss per common share - diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r131", "r147", "r148", "r149", "r150", "r151", "r152", "r158", "r163", "r164", "r165", "r167", "r332", "r335", "r349", "r350", "r389", "r405", "r534" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income (Loss) Per Common Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r15", "r16", "r166" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued payroll liabilities", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r42" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized compensation expense", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r673" ] }, "CEAD_EmployeesAndConsultantsMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "EmployeesAndConsultantsMember", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/EquityIncentivePlansTables", "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Employees and Consultants [Member]", "documentation": "Employees And Consultants [Member]" } } }, "auth_ref": [] }, "CEAD_EmployeesDirectorsandConsultantsMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "EmployeesDirectorsandConsultantsMember", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Employees, Directors and Consultants [Member]", "documentation": "Employees, Directors and Consultants [Member]" } } }, "auth_ref": [] }, "CEAD_EngineeringAndOtherServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "EngineeringAndOtherServicesMember", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "lang": { "en-us": { "role": { "label": "Engineering And Other Services [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r576" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r572" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityDomain", "presentation": [ "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r572" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r589" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r572" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r586" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r584" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r572" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r572" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r572" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r572" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r587" ] }, "CEAD_EquipmentAndSystemsSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "EquipmentAndSystemsSalesMember", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "lang": { "en-us": { "role": { "label": "Equipment And Systems Sales [Member]" } } }, "auth_ref": [] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r6", "r112", "r127", "r128", "r129", "r142", "r143", "r144", "r146", "r151", "r153", "r155", "r169", "r188", "r189", "r213", "r247", "r321", "r322", "r329", "r330", "r331", "r333", "r334", "r335", "r341", "r342", "r343", "r344", "r345", "r346", "r348", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r364", "r374", "r404", "r418", "r419", "r420", "r435", "r499" ] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://ir.ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "auth_ref": [ "r184", "r185", "r186", "r328", "r591", "r592", "r593", "r676", "r677", "r678", "r679" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://ir.ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of ownership change", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r184" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "CEAD_ForfeitedNonRefundableCustomerDepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ForfeitedNonRefundableCustomerDepositsMember", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "lang": { "en-us": { "role": { "label": "Forfeited Non Refundable Customer Deposits [Member]" } } }, "auth_ref": [] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "us-gaap_GainLossOnDispositionOfAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainLossOnDispositionOfAssets", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss on disposal of assets", "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property", "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property." } } }, "auth_ref": [ "r609", "r628", "r629" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Gross (loss) profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r58", "r60", "r97", "r140", "r187", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r355", "r536", "r537", "r617", "r618", "r619", "r620", "r621", "r641" ] }, "CEAD_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impact of the COVID-19 Pandemic on Our Business" } } }, "auth_ref": [] }, "CEAD_ImpactofUkrainianConflictPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ImpactofUkrainianConflictPolicyTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impact of Ukrainian Conflict" } } }, "auth_ref": [] }, "CEAD_IncentiveStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "IncentiveStockOptionMember", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Incentive Stock Option [Member]", "documentation": "Incentive Stock Option [Member]" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Loss before provision for income taxes", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r59", "r93", "r97", "r390", "r402", "r536", "r537", "r617", "r618", "r619", "r620", "r621" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://ir.ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "lang": { "en-us": { "role": { "label": "Statement of Income Location, Balance [Axis]", "documentation": "Information by location in statement of income where disaggregated amount has been reported." } } }, "auth_ref": [ "r214", "r215", "r216", "r352", "r353", "r354", "r415", "r417", "r484", "r526", "r546", "r707" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://ir.ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "lang": { "en-us": { "role": { "documentation": "Location in statement of income where disaggregated amount has been reported." } } }, "auth_ref": [ "r215", "r216", "r352", "r353", "r354", "r415", "r417", "r484", "r526", "r546", "r707" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Income Taxes", "documentation": "The entire disclosure for income tax." } } }, "auth_ref": [ "r141", "r310", "r312", "r313", "r314", "r315", "r316", "r317", "r323", "r325", "r326", "r327", "r431", "r545" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income taxes", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r99", "r109", "r154", "r155", "r168", "r176", "r179", "r311", "r312", "r324", "r406", "r545" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest paid", "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax." } } }, "auth_ref": [ "r14", "r137", "r318", "r319" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable and accrued liabilities", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred revenue", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r386", "r608" ] }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInDueToRelatedParties", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Increased related party sales", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Operating lease liability, net", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r597", "r608" ] }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInPrepaidExpensesOther", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other", "label": "Increase (Decrease) in Prepaid Expenses, Other", "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods." } } }, "auth_ref": [ "r3" ] }, "CEAD_IncreaseInRentPercent": { "xbrltype": "percentItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "IncreaseInRentPercent", "presentation": [ "http://ir.ceaindustries.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Increase in rent percent", "documentation": "Increase in rent percent." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Potentially dilutive equity instruments that are convertible into common stock", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method." } } }, "auth_ref": [ "r160", "r161", "r165" ] }, "CEAD_InflationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "InflationPolicyTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Inflation", "documentation": "Inflation [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Intangible assets, net", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r212", "r626", "r627" ] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest income (expense), net", "documentation": "Amount of interest income (expense) classified as operating." } } }, "auth_ref": [ "r388", "r618" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income taxes paid", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r133", "r135", "r136" ] }, "CEAD_InterimFinancialStatementsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "InterimFinancialStatementsPolicyTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Interim Financial Statements", "documentation": "Interim Financial Statements [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/Inventory" ], "lang": { "en-us": { "role": { "label": "Inventory", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r210" ] }, "us-gaap_InventoryFinishedGoods": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryFinishedGoods", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/ScheduleOfInventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfInventoryDetails" ], "lang": { "en-us": { "role": { "label": "Finished goods", "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer." } } }, "auth_ref": [ "r601" ] }, "CEAD_InventoryMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "InventoryMember", "presentation": [ "http://ir.ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Inventory [Member]", "documentation": "Inventory [Member]" } } }, "auth_ref": [] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 }, "http://ir.ceaindustries.com/role/ScheduleOfInventoryDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets", "http://ir.ceaindustries.com/role/ScheduleOfInventoryDetails" ], "lang": { "en-us": { "role": { "label": "Inventory, net", "totalLabel": "Inventory, net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r123", "r530", "r552" ] }, "us-gaap_InventoryRawMaterials": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryRawMaterials", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/ScheduleOfInventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfInventoryDetails" ], "lang": { "en-us": { "role": { "label": "Raw materials", "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r602" ] }, "us-gaap_InventoryValuationReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryValuationReserves", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/ScheduleOfInventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfInventoryDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Allowance for excess & obsolete inventory", "label": "Inventory Valuation Reserves", "documentation": "Amount of valuation reserve for inventory." } } }, "auth_ref": [ "r74", "r603" ] }, "us-gaap_InventoryWriteDown": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryWriteDown", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Provision for excess and obsolete inventory", "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels." } } }, "auth_ref": [ "r211" ] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Lease Cost", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r693" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LegalEntityAxis", "presentation": [ "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseDescription", "presentation": [ "http://ir.ceaindustries.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating lease term description", "documentation": "Description of lessee's operating lease." } } }, "auth_ref": [ "r368" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Future Annual Minimum Lease Payments", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r694" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total minimum lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r372" ] }, "CEAD_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearTwo", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Thereafter", "documentation": "Lessee operating lease liability payments due after year two." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "2025", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r372" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "2026", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r372" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "2024 (excluding the three months ended March 31, 2024)", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year." } } }, "auth_ref": [ "r694" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r372" ] }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseRenewalTerm", "presentation": [ "http://ir.ceaindustries.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease renew term", "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r692" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/Leases" ], "lang": { "en-us": { "role": { "label": "Leases", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r363" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r10", "r41", "r42", "r43", "r44", "r45", "r46", "r47", "r140", "r187", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r338", "r339", "r340", "r355", "r456", "r535", "r569", "r641", "r697", "r698" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAbstract", "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r54", "r92", "r398", "r552", "r611", "r625", "r690" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r43", "r115", "r140", "r187", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r338", "r339", "r340", "r355", "r552", "r641", "r697", "r698" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Noncurrent Liabilities", "label": "Liabilities, Noncurrent", "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r10", "r44", "r45", "r46", "r47", "r140", "r187", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r338", "r339", "r340", "r355", "r641", "r697", "r698" ] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Noncurrent Liabilities" } } }, "auth_ref": [] }, "CEAD_LiquidityPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "LiquidityPolicyTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Liquidity" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "CEAD_LoneStarBioscienceIncMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "LoneStarBioscienceIncMember", "presentation": [ "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lone Star Bioscience Inc [Member]", "documentation": "Lone Star Bioscience Inc [Member]" } } }, "auth_ref": [] }, "us-gaap_LossContingencyDamagesSoughtValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingencyDamagesSoughtValue", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Damages sought value", "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter." } } }, "auth_ref": [ "r633", "r634", "r635" ] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MajorCustomersAxis", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r182", "r542", "r554", "r557", "r645", "r706", "r708", "r709", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735" ] }, "us-gaap_MarketingAndAdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MarketingAndAdvertisingExpense", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Advertising and marketing expenses", "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising." } } }, "auth_ref": [ "r62" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MaximumMember", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r219", "r220", "r221", "r222", "r265", "r308", "r351", "r385", "r414", "r416", "r423", "r448", "r449", "r507", "r508", "r509", "r510", "r515", "r524", "r525", "r539", "r540", "r543", "r547", "r548", "r549", "r550", "r555", "r643", "r699", "r700", "r701", "r702", "r703", "r704" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r182", "r542", "r554", "r557", "r645", "r706", "r708", "r709", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r134" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Flows From Investing Activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r66", "r67", "r68" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Flows From Operating Activities:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://ir.ceaindustries.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows", "http://ir.ceaindustries.com/role/StatementsOfChangesInShareholdersEquity", "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "label": "Net loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r61", "r68", "r94", "r113", "r125", "r126", "r129", "r140", "r145", "r147", "r148", "r149", "r150", "r151", "r154", "r155", "r162", "r187", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r332", "r335", "r350", "r355", "r403", "r478", "r497", "r498", "r568", "r641" ] }, "CEAD_NetOperatingLossCarryForwardExpectedToExpireAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "NetOperatingLossCarryForwardExpectedToExpireAmount", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net operating loss carry forward expected to expire amount", "documentation": "Net operating loss carry forward expected to expire amount." } } }, "auth_ref": [] }, "CEAD_NetOperatingLossExpirationTerm": { "xbrltype": "stringItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "NetOperatingLossExpirationTerm", "presentation": [ "http://ir.ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net operating loss expiration term", "documentation": "Net operating loss expiration term." } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recently Issued Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "CEAD_NewFacilityLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "NewFacilityLeaseMember", "presentation": [ "http://ir.ceaindustries.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "New Facility Lease [Member]", "documentation": "New Facility Lease [Member]" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "CEAD_NolsCarryforwardsTermDescription": { "xbrltype": "stringItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "NolsCarryforwardsTermDescription", "presentation": [ "http://ir.ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "NOLs carryforwards term", "documentation": "Nols carryforwards term description." } } }, "auth_ref": [] }, "CEAD_NolsUsageAgainstTaxableIncomePercentage": { "xbrltype": "percentItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "NolsUsageAgainstTaxableIncomePercentage", "presentation": [ "http://ir.ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "NOLs usage against taxable income, percentage", "documentation": "Nols usage against taxable income percentage." } } }, "auth_ref": [] }, "CEAD_NonQualifiedStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "NonQualifiedStockOptionMember", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non Qualified Stock Option [Member]", "documentation": "Non Qualified Stock Option [Member]" } } }, "auth_ref": [] }, "CEAD_NonQualifiedStockOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "NonQualifiedStockOptionsMember", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Non-Qualified Stock Options [Member]", "documentation": "Non-qualified Stock Options [Member]" } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income (expense)", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r63" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other income (expense):" } } }, "auth_ref": [] }, "CEAD_OneCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "OneCustomerMember", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "One Customer [Member]", "documentation": "One Customer [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpensesAbstract", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Operating loss", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r97", "r536", "r617", "r618", "r619", "r620", "r621" ] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseExpense", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Operating lease expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r691" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiability", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/LeasesDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Present value of minimum lease payments", "label": "Operating lease liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r366" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets", "http://ir.ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Current portion of operating lease liability", "verboseLabel": "Operating lease liability, current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r366" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets", "http://ir.ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease liability, net of current portion", "verboseLabel": "Operating lease liability, long-term", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r366" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Cash paid for operating lease", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r367", "r369" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets", "http://ir.ceaindustries.com/role/LeasesDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease right-of-use asset", "verboseLabel": "Operating lease ROU", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r365" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Discount rate", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r371", "r551" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "lang": { "en-us": { "role": { "label": "Remaining lease term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r370", "r551" ] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating loss carryforward", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r320" ] }, "CEAD_OptionsIssuedForAccruedEquityCompensationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "OptionsIssuedForAccruedEquityCompensationLiability", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Options issued for accrued equity compensation liability", "documentation": "Options issued for accrued equity compensation liability." } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Nature of Operations and Significant Accounting Policies", "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles." } } }, "auth_ref": [ "r69", "r70", "r71", "r86" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other accrued expenses", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r42" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other income (expense), net", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r64" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r583" ] }, "CEAD_OwnershipMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "OwnershipMember", "presentation": [ "http://ir.ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ownership [Member]", "documentation": "Ownership [Member]." } } }, "auth_ref": [] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsForCommissions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForCommissions", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments for commissions", "documentation": "The amount of cash paid for commissions during the current period." } } }, "auth_ref": [ "r2" ] }, "us-gaap_PaymentsForDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForDeposits", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments for deposit", "documentation": "The amount of cash paid for deposits on goods and services during the period; excludes time deposits and deposits with other institutions, which pertain to financial service entities." } } }, "auth_ref": [ "r606", "r607" ] }, "us-gaap_PaymentsForRent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForRent", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease rental expense", "documentation": "Cash payments to lessor's for use of assets under operating leases." } } }, "auth_ref": [ "r2" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameAxis", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/EquityIncentivePlansTables", "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative", "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameDomain", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/EquityIncentivePlansTables", "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative", "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r577" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r579" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r48", "r233" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheetsParenthetical", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r48", "r458" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesIssued", "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheetsParenthetical", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares issued", "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt." } } }, "auth_ref": [ "r48", "r233" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheetsParenthetical", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r48", "r458", "r476", "r739", "r740" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred stock, $0.00001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r48", "r395", "r552" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses and other", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r604" ] }, "CEAD_PrepaidInventoryExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "PrepaidInventoryExpenses", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/InventoryDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Prepaid inventory expenses", "documentation": "Prepaid inventory expenses" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of common stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r1" ] }, "CEAD_ProceedsFromRelatedPartySales": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ProceedsFromRelatedPartySales", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from related party sales", "documentation": "Proceeds from related party sales." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from the sale of property and equipment", "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r65" ] }, "CEAD_ProductDevelopmentCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ProductDevelopmentCostsMember", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "lang": { "en-us": { "role": { "label": "Product Development Costs [Member]" } } }, "auth_ref": [] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductInformationLineItems", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "lang": { "en-us": { "role": { "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductOrServiceAxis", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r180", "r387", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r528", "r541", "r553", "r555", "r556", "r558", "r559", "r636", "r637", "r645", "r706", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735" ] }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductWarrantyAccrualClassifiedCurrent", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Product warranty accrual classified current", "verboseLabel": "Product warranty accrual", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r42", "r639", "r640" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductsAndServicesDomain", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "auth_ref": [ "r180", "r387", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r528", "r541", "r553", "r555", "r556", "r558", "r559", "r636", "r637", "r645", "r706", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://ir.ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r5", "r373" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/PropertyAndEquipment" ], "lang": { "en-us": { "role": { "label": "Property and Equipment", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r75", "r103", "r107", "r108" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r76", "r117", "r401" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://ir.ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r373" ] }, "us-gaap_PropertyPlantAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentMember", "presentation": [ "http://ir.ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Member]", "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 1.0 }, "http://ir.ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets", "http://ir.ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net", "totalLabel": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r5", "r373", "r391", "r401", "r552" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/PropertyAndEquipmentTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Property and Equipment", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r5" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://ir.ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r76", "r373" ] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Provision for doubtful accounts", "negatedLabel": "Provision for doubtful accounts", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r132", "r195" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeAxis", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r219", "r220", "r221", "r222", "r263", "r265", "r295", "r296", "r297", "r308", "r351", "r383", "r384", "r385", "r414", "r416", "r423", "r448", "r449", "r507", "r508", "r509", "r510", "r515", "r524", "r525", "r539", "r540", "r543", "r547", "r548", "r549", "r550", "r555", "r562", "r631", "r643", "r681", "r700", "r701", "r702", "r703", "r704" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeMember", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r219", "r220", "r221", "r222", "r263", "r265", "r295", "r296", "r297", "r308", "r351", "r383", "r384", "r385", "r414", "r416", "r423", "r448", "r449", "r507", "r508", "r509", "r510", "r515", "r524", "r525", "r539", "r540", "r543", "r547", "r548", "r549", "r550", "r555", "r562", "r631", "r643", "r681", "r700", "r701", "r702", "r703", "r704" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyDomain", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r183", "r264", "r378", "r379", "r393", "r399", "r451", "r452", "r453", "r454", "r455", "r475", "r477", "r506" ] }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionAmountsOfTransaction", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related party transaction", "documentation": "Amount of transactions with related party during the financial reporting period." } } }, "auth_ref": [ "r37", "r378" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Parties [Axis]", "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r183", "r264", "r378", "r379", "r393", "r399", "r451", "r452", "r453", "r454", "r455", "r475", "r477", "r506", "r696" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r375", "r376", "r377", "r379", "r380", "r432", "r433", "r434", "r482", "r483", "r484", "r503", "r505" ] }, "CEAD_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "lang": { "en-us": { "role": { "label": "Remaining performance obligations related to partial equipment & engineering paid contracts", "documentation": "Remaining performance obligations related to partial equipment paid contracts." } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Product development costs", "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity." } } }, "auth_ref": [ "r309", "r526", "r537", "r705" ] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedStockMember", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock [Member]", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r15" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r51", "r79", "r397", "r421", "r422", "r430", "r459", "r552" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r112", "r142", "r143", "r144", "r146", "r151", "r153", "r155", "r188", "r189", "r213", "r321", "r322", "r329", "r330", "r331", "r333", "r334", "r335", "r341", "r343", "r344", "r346", "r348", "r362", "r364", "r418", "r420", "r435", "r739" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRevenueBySourceDetails", "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenue", "verboseLabel": "Total revenue", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r95", "r96", "r168", "r173", "r174", "r177", "r179", "r180", "r181", "r182", "r259", "r260", "r387" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r110", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r527" ] }, "CEAD_RevenueRemainingPerformanceAmountCancelled": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "RevenueRemainingPerformanceAmountCancelled", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue remaining performance amount cancelled", "documentation": "Revenue remaining performance amount cancelled." } } }, "auth_ref": [] }, "us-gaap_RevenueRemainingPerformanceObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueRemainingPerformanceObligation", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "lang": { "en-us": { "role": { "label": "Total remaining performance obligations", "verboseLabel": "Revenue remaining performance obligation", "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue." } } }, "auth_ref": [ "r106" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Remaining Performance Obligations Expected to be Recognized", "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation." } } }, "auth_ref": [ "r594" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Revenues", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Revenue", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r95", "r96", "r130", "r140", "r168", "r173", "r174", "r177", "r179", "r180", "r181", "r182", "r187", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r355", "r390", "r537", "r641" ] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SalesRevenueNetMember", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r182", "r595" ] }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Accounts Payable and Accrued Liabilities", "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "presentation": [ "http://ir.ceaindustries.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r336" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://ir.ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "auth_ref": [ "r184", "r185", "r186", "r328", "r591", "r592", "r593", "r676", "r677", "r678", "r679" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/InventoryTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Inventory", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r11", "r55", "r56", "r57" ] }, "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfNonvestedShareActivityTableTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansTables" ], "lang": { "en-us": { "role": { "label": "Summary of Non-vested Non-qualified Stock Option Activity", "documentation": "Tabular disclosure of the changes in outstanding nonvested shares." } } }, "auth_ref": [ "r84" ] }, "CEAD_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/WarrantsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Outstanding Warrants to Purchase Common Stock", "documentation": "Schedule Of Outstanding Warrants To Purchase Common Stock [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "lang": { "en-us": { "role": { "label": "Nature of Operation, Product Information, Concentration of Risk [Table]", "documentation": "Disclosure of information about concentration risk of product within nature of operation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://ir.ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r5", "r373" ] }, "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-based Compensation Costs", "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value." } } }, "auth_ref": [ "r8", "r9", "r84" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/EquityIncentivePlansTables", "http://ir.ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative", "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r267", "r268", "r270", "r271", "r272", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r294", "r295", "r296", "r297", "r298" ] }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Restricted Units Activity", "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [ "r80" ] }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]", "documentation": "Disclosure of information about share-based payment arrangement by range of exercise prices." } } }, "auth_ref": [ "r27" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Stock Option Activity", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r8", "r9", "r80" ] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/WarrantsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Warrants Outstanding", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r26" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r571" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r575" ] }, "us-gaap_SecurityDeposit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SecurityDeposit", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Security deposit", "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease." } } }, "auth_ref": [ "r598" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r574" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r580" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Selling, general and administrative expenses", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r62" ] }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingGeneralAndAdministrativeExpensesMember", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "lang": { "en-us": { "role": { "label": "Selling, General and Administrative Expenses [Member]", "documentation": "Primary financial statement caption encompassing selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_SeriesBPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SeriesBPreferredStockMember", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series B Preferred Stock [Member]", "documentation": "Series B preferred stock." } } }, "auth_ref": [ "r599", "r600", "r644" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://ir.ceaindustries.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Share-based compensation", "verboseLabel": "Share based compensation", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r3" ] }, "CEAD_ShareBasedCompensationArrangemenByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ShareBasedCompensationArrangemenByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Number of shares authorized", "documentation": "Share-based compensation arrangement by share-based payment award, number of shares authorized.", "label": "Number of shares authorized [Default Label]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights", "presentation": [ "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Vesting rights description", "documentation": "Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r28" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Number of Units, Forfeited/canceled", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r287" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant-Date Fair Value, Forfeited/Canceled", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r287" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Number of Units, Granted", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r285" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant-Date Fair Value, Granted", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r285" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of Units Outstanding, beginning", "periodEndLabel": "Number of Units Outstanding, ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r282", "r283" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Grant-Date Fair Value Outstanding, Beginning", "periodEndLabel": "Weighted Average Grant-Date Fair Value Outstanding,ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r282", "r283" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Life of Outstanding Warrants in Months", "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r85" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares vested in period", "negatedLabel": "Number of Units, Vested and settled with share issuance", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r286" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant-Date Fair Value, Vested and settled with share issuance", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r286" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/EquityIncentivePlansTables", "http://ir.ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative", "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r267", "r268", "r270", "r271", "r272", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r294", "r295", "r296", "r297", "r298" ] }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised": { "xbrltype": "sharesItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Exercisable, Exercised", "documentation": "Number of non-option equity instruments exercised by participants." } } }, "auth_ref": [] }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations": { "xbrltype": "sharesItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Exercisable, Expired", "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed." } } }, "auth_ref": [] }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted": { "xbrltype": "sharesItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Exercisable, Granted", "documentation": "Net number of non-option equity instruments granted to participants." } } }, "auth_ref": [] }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ir.ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warrants Exercisable, Beginning Balance", "periodEndLabel": "Warrants Exercisable, Ending Balance", "label": "Warrants Exercisable", "documentation": "Number of equity instruments other than options exercisable, including both vested and non-vested instruments." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Outstanding, Expired", "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed." } } }, "auth_ref": [ "r83" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Outstanding. Granted", "documentation": "Net number of non-option equity instruments granted to participants." } } }, "auth_ref": [ "r7" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ir.ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warrants Outstanding, Beginning Balance", "periodEndLabel": "Warrants Outstanding, Ending Balance", "label": "Warrants Outstanding", "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments." } } }, "auth_ref": [ "r81", "r82" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares authorized", "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of stock options issued", "verboseLabel": "Number of shares grant in period", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r27" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Number of Options, Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r276" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted Average Exercise Price, Exercisable Ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r276" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Options, Expired", "label": "Number of Options, Expired", "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements." } } }, "auth_ref": [ "r281" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Options, Forfeited/Cancelled", "label": "Number of option remain forfeited", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r280" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Number of Options, Granted", "verboseLabel": "Number of Options Nonvested, Granted", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r278" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant-Date Fair Value, Nonvested, Granted", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r288" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregate Intrinsic Value, Outstanding Beginning", "periodEndLabel": "Aggregate Intrinsic Value, Outstanding Ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r27" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of Options, Outstanding Beginning", "periodEndLabel": "Number of Options, Outstanding Ending", "label": "Number of option remain outstanding", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r274", "r275" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Exercise Price, Outstanding Beginning", "periodEndLabel": "Weighted Average Exercise Price, Outstanding Ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r274", "r275" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares issued", "documentation": "Number of shares issued under share-based payment arrangement." } } }, "auth_ref": [ "r27" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of options to purchase shares", "documentation": "Number of shares purchased for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r674" ] }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedPeriod", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share based compensation arrangement payment", "documentation": "Share based compensation arrangement by share based payment award value issued period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r270", "r271", "r272", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r294", "r295", "r296", "r297", "r298" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Exercised", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r279" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Expired", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired." } } }, "auth_ref": [ "r281" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Forfeited/Cancelled", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r280" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Granted", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r278" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounting for Share-Based Compensation", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r266", "r273", "r292", "r293", "r294", "r295", "r298", "r303", "r304", "r305", "r306" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise Price Range [Axis]", "documentation": "Information by range of option prices pertaining to options granted." } } }, "auth_ref": [ "r29" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "auth_ref": [ "r30" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value, Exercised", "documentation": "Intrinsic value of exercised award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value, Expired", "documentation": "Intrinsic value of expirations award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value Outstanding, Forfeited/canceled", "documentation": "Intrinsic value of forfeited under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value Outstanding, Granted", "verboseLabel": "Aggregate Intrinsic Value, Granted", "documentation": "Intrinsic value of granted under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregate Intrinsic Value Outstanding, Beginning", "periodEndLabel": "Aggregate Intrinsic Value Outstanding, ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding", "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance", "documentation": "Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms": { "xbrltype": "durationItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Life of Outstanding Warrants in Months, Exercised", "documentation": "Weighted Average Remaining Life, Exercised" } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExpiredWeightedAverageRemainingContractualTerms": { "xbrltype": "durationItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExpiredWeightedAverageRemainingContractualTerms", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Life of Outstanding Warrants in Months, Expired", "documentation": "Weighted Average Remaining Life, Expired" } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms": { "xbrltype": "durationItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Life of Outstanding Warrants in Months, Granted", "documentation": "Warrants weighted average remaining contractual terms." } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Life of Outstanding Warrants in Months, Ending Balance", "documentation": "Weighted average life of outstanding warrants in months, ending balance." } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms": { "xbrltype": "durationItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Life of Outstanding Warrants in Months, Beginning Balance", "documentation": "Weighted average life of outstanding warrants in months, beginning balance." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Aggregate Intrinsic Value, Exercisable Ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r27" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Term, Exercisable Ending", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r27" ] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Grant Date Fair Value Nonvested, Forfeited", "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited.", "label": "Grant Date Fair Value Nonvested, Forfeited" } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregated Intrinsic Value, Nonvested Beginning", "periodEndLabel": "Aggregated Intrinsic Value, Nonvested Ending", "documentation": "Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Aggregated Intrinsic Value, Nonvested Beginning" } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Grant Date Fair Value Nonvested, Beginning", "periodEndLabel": "Grant Date Fair Value Nonvested, Ending", "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested.", "label": "Aggregated Intrinsic Value, Nonvested Beginning [Default Label]" } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Grant Date Fair Value Nonvested, Expired", "documentation": "Share based compensation arrangement by sharebased payment award options nonvested grant date fair value expired.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired" } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Grant Date Fair Value Nonvested, Vested", "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested.", "label": "Grant Date Fair Value Nonvested, Vested" } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValues": { "xbrltype": "monetaryItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValues", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Grant Date Fair Value Nonvested, Granted", "documentation": "Sharebased compensation arrangement by sharebased payment award options nonvested grant date fair values" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "presentation": [ "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of Options Nonvested, Beginning", "periodEndLabel": "Number of Options Nonvested, Ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "documentation": "Number of non-vested options outstanding." } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue", "presentation": [ "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant-Date Fair Value, Nonvested, Expired", "documentation": "Number of Options, price per share." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "presentation": [ "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Options Nonvested, Forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares", "documentation": "Number of non-vested options forfeited." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "presentation": [ "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant-Date Fair Value, Nonvested, Forfeited", "documentation": "Weighted average grant-date fair value of non-vested options forfeited." } } }, "auth_ref": [] }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired": { "xbrltype": "sharesItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired", "presentation": [ "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Number of Options Nonvested, Expired", "documentation": "Number of Options, Expired." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Grant-Date Fair Value, Nonvested, Beginning", "periodEndLabel": "Weighted Average Grant-Date Fair Value, Nonvested Ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "documentation": "Weighted average grant-date fair value of non-vested options outstanding." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Term, Outstanding Ending", "verboseLabel": "Weighted average remaining contractual term", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r85" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "presentation": [ "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Options Nonvested, Vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares", "documentation": "Number of options vested." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "presentation": [ "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Grant-Date Fair Value, Nonvested, Vested", "documentation": "Weighted average grant-date fair value of options vested." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesOutstanding", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "periodEndLabel": "Balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_ShippingAndHandlingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShippingAndHandlingMember", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "lang": { "en-us": { "role": { "label": "Shipping and Handling [Member]", "documentation": "Packing and transport of product." } } }, "auth_ref": [ "r646" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r578" ] }, "us-gaap_StandardProductWarrantyDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StandardProductWarrantyDescription", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Product warranty description", "documentation": "Describes the nature of the product warranty, including the approximate term of the product warranty, how the product warranty arose, and the events or circumstances that would require the warrantor to perform under the product warranty." } } }, "auth_ref": [ "r24", "r25" ] }, "us-gaap_StandardProductWarrantyPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StandardProductWarrantyPolicy", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Product Warranty", "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability." } } }, "auth_ref": [ "r638" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://ir.ceaindustries.com/role/Cover", "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r111", "r120", "r121", "r122", "r140", "r158", "r159", "r163", "r165", "r170", "r171", "r187", "r223", "r225", "r226", "r227", "r230", "r231", "r233", "r234", "r236", "r239", "r245", "r355", "r426", "r427", "r428", "r429", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r458", "r479", "r499", "r516", "r517", "r518", "r519", "r520", "r590", "r610", "r616" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r6", "r49", "r52", "r53", "r112", "r127", "r128", "r129", "r142", "r143", "r144", "r146", "r151", "r153", "r155", "r169", "r188", "r189", "r213", "r247", "r321", "r322", "r329", "r330", "r331", "r333", "r334", "r335", "r341", "r342", "r343", "r344", "r345", "r346", "r348", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r364", "r374", "r404", "r418", "r419", "r420", "r435", "r499" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://ir.ceaindustries.com/role/Cover", "http://ir.ceaindustries.com/role/IncomeTaxesDetailsNarrative", "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails", "http://ir.ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r142", "r143", "r144", "r169", "r364", "r387", "r425", "r446", "r450", "r451", "r452", "r453", "r454", "r455", "r458", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r471", "r472", "r473", "r474", "r475", "r477", "r480", "r481", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r499", "r563" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://ir.ceaindustries.com/role/Cover", "http://ir.ceaindustries.com/role/IncomeTaxesDetailsNarrative", "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails", "http://ir.ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r142", "r143", "r144", "r169", "r183", "r364", "r387", "r425", "r446", "r450", "r451", "r452", "r453", "r454", "r455", "r458", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r471", "r472", "r473", "r474", "r475", "r477", "r480", "r481", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r499", "r563" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares issued during the period", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r6", "r48", "r49", "r79", "r426", "r499", "r517" ] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common shares issued in settlement of restricted stock units issued to directors, shares", "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards." } } }, "auth_ref": [ "r6", "r79" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Number of Options, Exercised", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r6", "r48", "r49", "r79", "r279" ] }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "crdr": "credit", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common shares issued in settlement of restricted stock units issued to directors", "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period." } } }, "auth_ref": [ "r6", "r48", "r49", "r79" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://ir.ceaindustries.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets", "http://ir.ceaindustries.com/role/StatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total Shareholders\u2019 Equity", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r49", "r52", "r53", "r73", "r460", "r476", "r500", "r501", "r552", "r569", "r611", "r625", "r690", "r739" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityAbstract", "presentation": [ "http://ir.ceaindustries.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "SHAREHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/StockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r78", "r139", "r232", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r247", "r347", "r502", "r504", "r521" ] }, "us-gaap_SubsequentEventDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventDescription", "presentation": [ "http://ir.ceaindustries.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent event description", "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued." } } }, "auth_ref": [ "r38" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r381", "r382" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental cash flow information:" } } }, "auth_ref": [] }, "CEAD_ThreeDirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "ThreeDirectorsMember", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "3 Directors [Member]", "documentation": "3 Directors [Member]" } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "TitleOfIndividualAxis", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/EquityIncentivePlansTables", "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative", "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Title and Position [Axis]" } } }, "auth_ref": [ "r622", "r695" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/EquityIncentivePlansTables", "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails", "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative", "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "CEAD_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ir.ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "2017 Equity Plan and 2021 Equity Plan [Member]", "documentation": "2017 Equity Plan and 2021 Equity Plan [Member]" } } }, "auth_ref": [] }, "CEAD_TwoThousandAndSeventeenEquityPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "TwoThousandAndSeventeenEquityPlanMember", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/ScheduleOfRestrictedUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "2017 Equity Incentive Plan [Member]", "documentation": "2017 Equity Incentive Plan [Member]" } } }, "auth_ref": [] }, "CEAD_TwoThousandAndTwentyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "TwoThousandAndTwentyFourMember", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "lang": { "en-us": { "role": { "label": "2024 [Member]", "documentation": "2024 [Member]" } } }, "auth_ref": [] }, "CEAD_TwoThousandSeventeenAndTwoThousandTwentyOneEquityPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "TwoThousandSeventeenAndTwoThousandTwentyOneEquityPlanMember", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansTables" ], "lang": { "en-us": { "role": { "label": "2017 and 2021 Equity Plan [Member]", "documentation": "2017 and 2021 Equity Plan [Member]" } } }, "auth_ref": [] }, "CEAD_TwoThousandTwentyOneEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "TwoThousandTwentyOneEquityIncentivePlanMember", "presentation": [ "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2021 Equity Incentive Plan [Member]", "documentation": "2021 Equity Incentive Plan [Member]" } } }, "auth_ref": [] }, "CEAD_TwoThousandTwentyOneEquityPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "TwoThousandTwentyOneEquityPlanMember", "presentation": [ "http://ir.ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ir.ceaindustries.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2021 Equity Plan [Member]", "documentation": "2021 Equity Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TypeOfArrangementAxis", "presentation": [ "http://ir.ceaindustries.com/role/LeasesDetailsNarrative", "http://ir.ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r336" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UseOfEstimates", "presentation": [ "http://ir.ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r19", "r20", "r21", "r100", "r101", "r104", "r105" ] }, "us-gaap_VehiclesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "VehiclesMember", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Vehicles [Member]", "documentation": "Equipment used primarily for road transportation." } } }, "auth_ref": [] }, "CEAD_WarrantsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "WarrantsDisclosureTextBlock", "presentation": [ "http://ir.ceaindustries.com/role/Warrants" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrants", "documentation": "Warrants Disclosure [Text Block]", "label": "Outstanding Warrants" } } }, "auth_ref": [] }, "CEAD_WarrantsRangeFourMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "WarrantsRangeFourMember", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Range Four [Member]", "documentation": "Warrants Range Four [Member]" } } }, "auth_ref": [] }, "CEAD_WarrantsRangeOneMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "WarrantsRangeOneMember", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Range One [Member]", "documentation": "Warrants Range One [Member]" } } }, "auth_ref": [] }, "CEAD_WarrantsRangeThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "WarrantsRangeThreeMember", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Range Three [Member]", "documentation": "Warrants Range Three [Member]" } } }, "auth_ref": [] }, "CEAD_WarrantsRangeTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "WarrantsRangeTwoMember", "presentation": [ "http://ir.ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Range Two [Member]", "documentation": "Warrants Range Two [Member]" } } }, "auth_ref": [] }, "CEAD_WarrantsToPurchaseCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://ir.ceaindustries.com/20240331", "localname": "WarrantsToPurchaseCommonStockMember", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Warrants to purchase common stock" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares outstanding, diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r157", "r165" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://ir.ceaindustries.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares outstanding, basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r156", "r165" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://ir.ceaindustries.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r588" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "460", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-4" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "460", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "855", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "250", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/250/tableOfContent" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/275/tableOfContent" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/360/tableOfContent" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/810/tableOfContent" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org/606/tableOfContent" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-42" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479391/326-20-30-4A" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479391/326-20-30-5A" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "8A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479366/326-20-35-8A" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-5" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-17" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-21" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3C" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3D" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.M.2.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483530/326-20-S99-1" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479175/326-30-30-1B" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "13A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479148/326-30-35-13A" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "7A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479148/326-30-35-7A" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-3A" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-3C" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-3D" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/330/tableOfContent" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-2" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-3" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/740/tableOfContent" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/842-20/tableOfContent" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/850/tableOfContent" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r527": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r528": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r529": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8" }, "r532": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22" }, "r533": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r534": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r535": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r536": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r537": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r538": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r539": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r540": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r541": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r542": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r543": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r544": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r545": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r546": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "102", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102" }, "r547": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r548": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r549": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r550": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r551": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53" }, "r552": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r553": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2" }, "r554": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r555": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r556": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r557": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r558": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E" }, "r559": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18" }, "r560": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r562": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r566": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r567": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r568": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r569": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r570": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r571": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r572": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r573": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r574": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r576": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r577": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r578": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r579": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r580": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r581": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r582": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r583": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r584": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r585": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r587": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r588": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r589": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r590": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r591": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r592": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r593": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r594": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(1)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13" }, "r595": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r596": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r597": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r598": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r599": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r600": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r601": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r602": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r603": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r604": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r605": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r606": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r607": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r608": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r609": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r610": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r611": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r612": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r613": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r614": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r615": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r616": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55" }, "r617": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r618": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r619": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r620": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r621": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r622": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r623": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r624": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4" }, "r625": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r626": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r627": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r628": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-5" }, "r629": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r630": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r631": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r632": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r633": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r634": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r635": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r636": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r637": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r638": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8" }, "r639": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8" }, "r640": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8" }, "r641": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r642": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r643": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r644": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r645": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r646": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r647": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r648": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r649": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r650": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r651": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r652": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r653": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r654": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r655": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r656": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r657": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r658": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r659": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r660": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r661": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r662": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r663": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r664": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r665": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r666": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r667": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r668": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r669": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r670": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r671": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r672": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r673": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r674": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r675": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "720", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1" }, "r676": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r677": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r678": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r679": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r680": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r681": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r682": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r683": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r684": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r685": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r686": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r687": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r688": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r689": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r690": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r691": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4" }, "r692": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3" }, "r693": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r694": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6" }, "r695": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r696": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r697": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r698": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r699": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r700": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r701": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r702": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r703": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r704": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r705": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1" }, "r706": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r707": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r708": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r709": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r710": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r711": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r712": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r713": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r714": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r715": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r716": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r717": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r718": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r719": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r720": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r721": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r722": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r723": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r724": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r725": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r726": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r727": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r728": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r729": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r730": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r731": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r732": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r733": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r734": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r735": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r736": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r737": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r738": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r739": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r740": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" } } } ZIP 68 0001493152-24-019229-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-019229-xbrl.zip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

J!_'(E##_G(OI*1GAP -3?@NP M1T>4N!WD8S$FO@I3.<,.L>0:QSQFC$-J0'Y&=]2]V8Q"["7[YEY?E]<+<:*DGB>N82!NJK*\D]ZD*;BR+.*&3=0E,!FFLL MP/8)\2F8DH/3& Y<"30MA!0A/)IB-B;Q@MQ-(@PGW7)BEGOT64']N8EI& M; 7RFSH@1U(192@M]Y\HE-PB7Q-Y+"?G'G_(R=U%DQ6J;VNA"C*0%M(": _@ M%:S>!$F/KGWFWM(Q@TFP@YG?=QP>,!]6L-?@=P?ZANC6Z&<%_3LU0X4UH<M*_]7NYWZ\%AV'#G\/HI)[N,_6X""'(;;%!8V\WBT;, M2H]+";,6FG)HHD$;%F9S//0(X !W1$#<2XJ'U .5XO')BM(*NKTL=#%K%/'6 M$$;<48I]"^:J>M1T2GT]&0-X8)JF'L:$+28,9016T.UGH4MQU*@M\6SQ6C5Q MY\[WW-69<=\*G8,L.FE&__C[^_V]=S]$ZZL6FG)H0B]=, >,IO?DVL-Q.22W MQ0J>UUEXHJ5NP@MI9BTTY=!\PT+ >B."(_G+"H(W60CB[JW35TV=X9+7ZM^;T67% FD7K_G+WWQ!/55NN,4QP[R!@)792%=K"5BM@C-5^Q YI M?BC-L(5IQ0,]&$KR6P FGZFE85R$R]ZU@L58XR_8H)!/B\:FRVKKEMA5?M:76C],*":,XD7!IP5BC4IO&I:3="B*C0I%?M6WQVF#Y-HU? M!7HK/(V2AFTIMT5XC4)4&M&2=BL$C8I(?E&JQ:MB=2J-4>:>%2Y&N21FTB)A MNQAW)L0-/)BNWQ"8!P3D>'[+ ^&04^)CZL6+\U545F@9-928K9J\1XS1<(Y" MUNA5Q+S%L *&4Z!0*RLB1EQ,U6;/P="CXW!9=/8X(XY/W#M^3&Z(PV%]]#MQ M"Y%>@Y=5/)C%FZ5XB,2CE'R44@#%&B"?HR%!"R7:R*D>.7I[85=]"^*JSW8( MD]J2$RY]61 @-EVLXL H\:3C("4%I<4@+:>%>GLUGE,UZSU.G=9G=UP,X#E29] MQ@+L?09EIL%4.Q26FGH#2@&.MMVLX#5J3&EX0TDH%(4B61'HL;06^&K%V?RA MNJ#-"D*C!A47;-O!M'YN)J76@B0TVJV@,LI+Z6Q+57?;E*I8:\_/JN)F*[2, M4I*)4)M;-7(KK^A>D&9EI%88&F6G=,85%>O;]*O_=B4_$ZTHK0 U*E,K0&PS MM$:&VKQ6*NT]]_FI7:6#%>!&C:ET3WZ;Z)O8IY\/ MK06=#:*OC0)1\3[^%LZU2L/*KX.9TJ'O@.\6B!D5X6)**TA+RT*:.0JYHYA] M.P3;[[J=3K&8#T97G'7OB?2)JZZ24X16HER_OQ7V9LTH%*B@7XA$2S+;F-A4 MCM\0U:;>IGT!3>2*/%]!;86W^1G6TLN_6 #2$EIL-[(E)O^!;$5IA:GEMUOM MXWB=5!T$OCJ$3QW5F&R9X=>!<";Z3%@MRMVIW*^"-HE8ZF5,2%_MS M?(YBH2B4&@WF;8)7CHC8J2E'%X!?0FF%R=QZD7DR@) M)><;:^RSGHH$QRRP< PNQOG+P$2_0("@ZL7*QPQ\ZJONURDQ2,F!IW5O@Y9[ M>%C5DL6GRRD;,-NR*ZJ=B\GY);,/DV$F%9_ M["T?+@U_9P^@_@B&<^$C9IQH778D>7B8^B5W-*N2+NJO;MROJVYU]_:[!WL[ MC])=:%I%B84;JBD1]ZNA1,'!Z'GR91&YNM#!9"NTX(#U4J&Y?7K$\V5\I[8* MZ>/8U]!!LZFDQ.HSWHO46=53_RUK!8%^:2GF50(AW27^HQX:BX/T[8"(Z4,0 MU-GZ=<76B )3>&$(1"?OAR\ES_JGOZ9*)+L[^H0"F''K7X7X3*9#==*]4C=\ M@[F"CGJ>>KU\U/%%H$90]>,+AS"R4N[>Z0> &X3[G#LH?" D/S9PZ'+U=<2% M3Z:*$NR&*2.,O8&B_B1X,#OJA.PHD)294UH#6K;(CK0)1IU201R?"[4SW<>C MT;(=A:U-4'W R FL1F!=+I:USFMH@L*Q4J!?)@%R&IJD\-T#SU^62@H;FZ"\H,'1H2PA1SV81RDB88$V-L< 'F=-SRF#LI=A;_')MH4GV M'1IBXR6%!Y6KUBWY)I6T-\2"ZI_SZ.-P#4LWP* M/%]CJH\74(]P&;ME4\Q6^B;WZ:Z M8B0IEPP6Y4 MW!*A"N2IKUBK.O^DR!"Q;:>HYIN$%S;\F/6Q/1U+%A U:'AS5LT(T)PQ?OM$]J[G4* M\XLD5N3&_9@OH[$%FBW:_74[@5HBZ,5ZV;0YV3.X*?^6BWBQGDW"*OX[4%5D M=02[_A-F.%1L(8A72:M;Z%3"90/=&EGVC=#Q!.[V[V&N/R9FS&W+T17DKS<3 MUUHU"0#3QFW%=)FDES=^Q'L<)5BD%ZAZ3_K=!+/(+_WQ6) QN.."J=T]/.N4"& H#>/$B*.S1R(<*I55H=UKER.JR6J"1^LD9&)E^EBFS"P@ M*;S&Y>4 >W=$3-=?&ZXKO>8L,+Z[B=TD'I8R.=MJ(&Z4[BEC"L:S9*])[>XO MK9YHE6YY[ X3ACZ<3]]R.K3RBV,6.+8<7,RHE1CW#N%1']O./3$^^ M],S/\N?2X(^Z^%UWZ)O1Z%X4>E3W@F>;3G$%H7 M7T/;DE^D@E;=4*NN?&Z5IPAQ!7G@L^31]AKL_I M6FRZ+"=JZD!>?5>O^FJU_I[@J'=3-[%%/\9]3%T]!8WM-&^OE6/59Z0?>^&Y MGG#Y?U!+ P04 " "U@*Y8+^"GLT@0 "^R@ %0 &-E860M,C R-# S M,S%?8V%L+GAM;.U=ZV_<-A+_?L#]#SP7*-(/Z_4C:1(WN<+/P(#C-?QH[SX5 M6HGK%:(5-WK8WO[U-Z2DM1X4']J5R !7%*WC<(8S\QMR1N20_/3[RR) 3SB* M?1)^WMG?W=M!.'2)YX>/GW<>[D;'=Z>7ESLH3IS0" M?S[]:S1"%SX.O"-T1MS193@COZ%K9X&/T!<V/__/UZLZ=XX4S\D-J-Q?O%%24"X]N_^/'CV/VMT731LN7 M:104?1R."W'6G.%O?4'[DB2Q?Q0S\:Z(ZR0,=FDWJ+4%_=.H:#:BOQKM'XP. M]W=?8F^G,#ZS8$0"?(MGB/X?T%OWZD>[+G;\T$OC)/(Q VY,&XU/"3@F2,S( MYQ&>?=Z!EA[T-?>I?.VB\8?\G3D!M=C?'.(EE=0$LX+N5V):5#"B^@EW@RFRSI- !^)C6AF*H_"4_G3OB( MX\OP;@ZFF9/ @VGI_'OJ)RL=D178]*B#$\\O O*L9>0&T7;ENX9Y-<)E+(]# M[\Y_#/T9N%Z8'+LN2<,$0LT-"7P7:&7"=^>X7,F(H!%L@(ZW!]@RELYTP!#A_";*,7>E>], M_$G;*Q"KZ>$.39D9PI"*Y!N>RXB[C?-J;.-8KN29;PO M(?R!$9[P#41"J?E$--N5[D\GBF#BDDI4;[?MV01^Q/?.B]RS.$VW*\LM#B!" M>9"E)*M[T#EV7*7L04:W97]/IS'^GH)_G-/Y51YV6]J;CKC]1=Y^(["^//=T M]NY!SRK?/O(,-?_ZA)IZ<64_417 M->GXK;<<-]PY]M( 9IA;#,,CQ2>K.Y)&+C[#B>,'\CBB2-^?U MH0:<_',U( MM*#+"I-IX#]FD^7YRQ*[$(7OR0ETX1*8-__&7@?=-N^E+PNPK_L17>[RZ$(F MAD2#"G5*XB365E2#F>GXF8MS30<)';S;CZ1M/?2%)(N8U-3:L+51]B7I14IM M>1R&J1-\A8&Q2!=,!(@ [!M/6P%-AGUD-;K^)*;JR_+K)$;;Q&V4/>5DNN:4 M$O9E45[>I6U?IW-)5^"'UP^*Y8J?'I_RM4=Z3H\.@+@TF:L.H*F&;6'Z#D!C[I MYBS'7"Q(R!Q$&Y2.C/O2LY"A)):V2G(>O:V+Z^=74M)AULUU!=?ET^^ZNG;L M4Z072>TZ@9L&[)OU"OYI6*9 <@SKI<@(D&_80Q]NA/,7RT>]114,X)Y:QRP0O1 ^)6Q UH MU1&IE?44%5RLMFCFQ%-68)3&HT?'68XIP&,<)''Q&P8Y@SO_Q5_'<0Q]GZ91 M5-I+#IPI#EB/?^7M:LW&1F2E51>8MQ3+,9RF;D@V<4]+.(+$2FSLU* MNJA2A@2DV$'/V'^<)TQZ,Q 6'SRWV,4@-GSS7.-$[GU"*C7 #HP"IJ*W33C1 MS[<(XM>??C(_A2D0(G+$]%2!2XE8#;5#L\-,W0HV@;=>H0(QVU&JME*#XZU1 M.'AZV63WFP@O'=^CFRP0[&%^GB3SW&'D$5:)6 VE=T91TK""3>!E EZ3T%7+ MAQ(?IHH-'Q,KKI-SG49PD?WHT^7>#,%<7+^ MX@8I_0[_0HCW[ >!:*96H;8C#9)"IV,*FR \PTL2TR4ZY7FBG<*.W$<*E4QE MF^#)-\O#1[;;>4NEF

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ȩ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end XML 70 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001482541 2024-01-01 2024-03-31 0001482541 CEAD:CommonStock0.00001ParValueMember 2024-01-01 2024-03-31 0001482541 CEAD:WarrantsToPurchaseCommonStockMember 2024-01-01 2024-03-31 0001482541 2024-05-14 0001482541 2024-03-31 0001482541 2023-12-31 0001482541 2023-01-01 2023-03-31 0001482541 us-gaap:CommonStockMember 2023-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001482541 us-gaap:RetainedEarningsMember 2023-12-31 0001482541 us-gaap:CommonStockMember 2022-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001482541 us-gaap:RetainedEarningsMember 2022-12-31 0001482541 2022-12-31 0001482541 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001482541 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001482541 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001482541 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001482541 us-gaap:CommonStockMember 2024-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001482541 us-gaap:RetainedEarningsMember 2024-03-31 0001482541 us-gaap:CommonStockMember 2023-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001482541 us-gaap:RetainedEarningsMember 2023-03-31 0001482541 2023-03-31 0001482541 2022-02-15 2022-02-15 0001482541 2023-01-01 2023-12-31 0001482541 us-gaap:SeriesBPreferredStockMember 2024-01-01 2024-03-31 0001482541 us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-03-31 0001482541 CEAD:DirectorAndStaffMember 2024-01-01 2024-03-31 0001482541 CEAD:DirectorAndStaffMember 2023-01-01 2023-03-31 0001482541 srt:MaximumMember 2024-03-31 0001482541 CEAD:OneCustomerMember 2023-12-31 0001482541 CEAD:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001482541 CEAD:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001482541 CEAD:CustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001482541 CEAD:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001482541 CEAD:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001482541 CEAD:CustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001482541 CEAD:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001482541 CEAD:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001482541 CEAD:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001482541 CEAD:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001482541 CEAD:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001482541 CEAD:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001482541 CEAD:EquipmentAndSystemsSalesMember 2024-01-01 2024-03-31 0001482541 CEAD:EquipmentAndSystemsSalesMember 2023-01-01 2023-03-31 0001482541 CEAD:EngineeringAndOtherServicesMember 2024-01-01 2024-03-31 0001482541 CEAD:EngineeringAndOtherServicesMember 2023-01-01 2023-03-31 0001482541 us-gaap:ShippingAndHandlingMember 2024-01-01 2024-03-31 0001482541 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-03-31 0001482541 CEAD:ForfeitedNonRefundableCustomerDepositsMember 2024-01-01 2024-03-31 0001482541 CEAD:ForfeitedNonRefundableCustomerDepositsMember 2023-01-01 2023-03-31 0001482541 CEAD:TwoThousandAndTwentyFourMember 2024-03-31 0001482541 us-gaap:CostOfSalesMember 2024-01-01 2024-03-31 0001482541 us-gaap:CostOfSalesMember 2023-01-01 2023-03-31 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2024-01-01 2024-03-31 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2023-01-01 2023-03-31 0001482541 CEAD:ProductDevelopmentCostsMember 2024-01-01 2024-03-31 0001482541 CEAD:ProductDevelopmentCostsMember 2023-01-01 2023-03-31 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-01-01 2024-03-31 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-03-31 0001482541 CEAD:NewFacilityLeaseMember 2021-07-28 0001482541 CEAD:NewFacilityLeaseMember 2021-07-26 2021-07-28 0001482541 us-gaap:FurnitureAndFixturesMember 2024-03-31 0001482541 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001482541 us-gaap:VehiclesMember 2024-03-31 0001482541 us-gaap:VehiclesMember 2023-12-31 0001482541 us-gaap:CostOfSalesMember us-gaap:PropertyPlantAndEquipmentMember 2024-01-01 2024-03-31 0001482541 CEAD:InventoryMember us-gaap:PropertyPlantAndEquipmentMember 2024-01-01 2024-03-31 0001482541 2023-10-20 2023-10-20 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2023-01-03 0001482541 CEAD:DirectorsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityPlanMember 2023-01-03 2023-01-03 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2024-01-02 0001482541 CEAD:DirectorsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityPlanMember 2024-01-02 2024-01-02 0001482541 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-12 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember 2022-01-12 2022-01-17 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember 2024-01-01 2024-03-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-12-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember 2024-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2021-03-22 0001482541 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-03-31 0001482541 CEAD:NonQualifiedStockOptionMember CEAD:TwoThousandTwentyOneEquityPlanMember 2024-01-01 2024-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2024-03-31 0001482541 us-gaap:RestrictedStockMember CEAD:TwoThousandTwentyOneEquityPlanMember 2024-01-01 2024-03-31 0001482541 CEAD:NonQualifiedStockOptionMember CEAD:TwoThousandTwentyOneEquityPlanMember 2024-03-31 0001482541 CEAD:IncentiveStockOptionMember CEAD:TwoThousandTwentyOneEquityPlanMember 2024-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2024-01-01 2024-03-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2024-01-01 2024-03-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2023-01-01 2023-03-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandTwentyOneEquityPlanMember 2024-01-01 2024-03-31 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2024-01-01 2024-03-31 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-03-31 0001482541 CEAD:ThreeDirectorsMember us-gaap:RestrictedStockUnitsRSUMember 2024-01-02 2024-01-02 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-03-31 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandSeventeenAndTwoThousandTwentyOneEquityPlanMember 2024-01-01 2024-03-31 0001482541 CEAD:DirectorsMember CEAD:TwoThousandSeventeenAndTwoThousandTwentyOneEquityPlanMember 2024-01-01 2024-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-12-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-12-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2024-01-01 2024-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2024-03-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-12-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-12-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2024-01-01 2024-03-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2024-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-12-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2024-01-01 2024-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2024-03-31 0001482541 CEAD:DirectorsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-12-31 0001482541 CEAD:DirectorsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2024-01-01 2024-03-31 0001482541 CEAD:DirectorsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2024-03-31 0001482541 CEAD:WarrantsRangeOneMember 2024-03-31 0001482541 CEAD:WarrantsRangeOneMember 2024-01-01 2024-03-31 0001482541 CEAD:WarrantsRangeTwoMember 2024-03-31 0001482541 CEAD:WarrantsRangeTwoMember 2024-01-01 2024-03-31 0001482541 CEAD:WarrantsRangeThreeMember 2024-03-31 0001482541 CEAD:WarrantsRangeThreeMember 2024-01-01 2024-03-31 0001482541 CEAD:WarrantsRangeFourMember 2024-03-31 0001482541 CEAD:WarrantsRangeFourMember 2024-01-01 2024-03-31 0001482541 CEAD:OwnershipMember 2024-03-31 0001482541 srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember 2022-10-13 0001482541 srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember 2022-12-31 0001482541 CEAD:ConsultingAgreementMember 2022-12-20 0001482541 srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember 2023-03-01 2023-03-31 0001482541 srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember 2023-01-01 2023-03-31 0001482541 srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember 2024-01-01 2024-03-31 iso4217:USD shares iso4217:USD shares utr:sqft CEAD:integer CEAD:Segment pure false --12-31 Q1 0001482541 Yes Yes 10-Q true 2024-03-31 2024 false 001-41266 CEA INDUSTRIES INC. NV 27-3911608 385 South Pierce Avenue Suite C Louisville CO 80027 80027 (303) 993-5271 Common Stock, $0.00001 par value CEAD NASDAQ Warrants to purchase common stock CEADW NASDAQ Non-accelerated Filer true false false 8212737 11598836 12508251 20126 18655 224414 224414 245894 296404 227514 313115 12316784 13360839 19019 38558 1830 1830 14747 14747 328792 356109 364388 411244 12681172 13772083 361876 624724 539956 499800 128839 126724 1030671 1251248 228927 259627 228927 259627 1259598 1510875 0.00001 0.00001 25000000 25000000 0 0 0 0 0.00001 0.00001 200000000 200000000 8212737 8212737 8076372 8076372 82 81 49528387 49451419 -38106895 -37190292 11421574 12261208 12681172 13772083 234506 4682573 388881 3829297 -154375 853276 9324 202323 76413 760110 1020702 769434 1299438 -923809 -446162 5704 7206 9020 7206 14724 -916603 -431438 -916603 -431438 -0.11 -0.11 -0.05 -0.05 8209730 8209730 8071731 8071731 8076372 81 49451419 -37190292 12261208 1969 1969 136365 1 -1 75000 75000 -916603 -916603 8212737 82 49528387 -38106895 11421574 7953974 80 49173836 -34278741 14895175 7953974 80 49173836 -34278741 14895175 135748 135748 123398 1 -1 101316 101316 -431438 -431438 8077372 81 49410899 -34710179 14700801 8077372 81 49410899 -34710179 14700801 -916603 -431438 6914 7500 76969 147094 -34566 -1705 38360 33638 -12625 -100 27317 26325 -33096 57420 -12151 126360 -85600 -1018785 -262849 -43124 40156 -3235970 -28585 -26662 -909415 -2689237 200 200 -909415 -2689037 12508251 18637114 11598836 15948077 89970 <p id="xdx_800_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zxWBr5W2SLef" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 – <span id="xdx_82D_zv2AZV7uO6Nh">Nature of Operations and Significant Accounting Policies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--DescriptionOfBusinessPolicyTextBlock_zeJfUGUyGEC2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span><span id="xdx_86E_z2pN0OuqEZXg">Description of Business</span></span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the fastest-growing sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide CEA facilities with (i) air handling equipment and systems, (ii) air sanitation products, (iii) LED lighting, and (iv) benching and racking solutions for indoor cultivation. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="background-color: white">We are evaluating merger and acquisition opportunities and other alternatives for our future. As part of that evaluative process, we are also considering the legal procedure and practical steps for dissolving ourselves, which would include a distribution of cash assets after creditors and other corporate obligations have been accounted for and satisfied. For any plan of dissolution, management and the board of directors will need to formulate and adopt a plan of dissolution. Certain transaction opportunities, depending on their structure, and any plan of dissolution will require shareholder approval through a proxy solicitation process.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_zlzPOYJqlXei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zm2R3h6h9pEe">Impact of the COVID-19 Pandemic on Our Business</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The impact of the government and the business economic response to the COVID-19 pandemic affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. We believe we continue to see adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, costs, and working capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the long-term impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2023, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--ImpactofUkrainianConflictPolicyTextBlock_z5KMkPZadoAl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_z3Xp6tCjnL0i">Impact of Ukrainian Conflict</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We believe that the conflicts involving Ukraine and Israel do not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflicts will have only a general impact on our operations in the same manner as it is having a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from countries involved in the conflicts, supply chain challenges, and the international and US domestic inflation resulting from the conflict and government spending in relation to the conflicts. As our operations are related only to the North American controlled agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to the conflicts. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflicts will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the conflicts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_843_ecustom--InflationPolicyTextBlock_z5cHbf0amb8e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zOjMBQ5O3ay1">Inflation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our operations are being influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build CEA facilities in which we operate. We believe that we will continue to face inflationary increases in the cost of products and our operations, which will adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment, delivery and transportation costs, and general operational expenses. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zT5GLKZERPTd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zzvcQJaMrJB6">Financial Statement Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--InterimFinancialStatementsPolicyTextBlock_zJqbvuCqPWR1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zNjPZVTyjzqc">Interim Financial Statements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2024. The balance sheet information as of December 31, 2023 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--LiquidityPolicyTextBlock_zPcuK9R5f0oc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zdPnqtXrCiWd">Liquidity</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 30.25pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are available to be issued. The Company continues to experience recurring losses since its inception. As a result, in order to continue as a going concern, the Company has been reliant on the ability to obtain additional sources of financing to fund growth. On February 15, 2022, the Company received approximately $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220215__20220215_zlg8slndTkgi" title="Proceeds from issuance of common stock">21,711,000</span> in net proceeds from completion of an equity offering. Based on management’s evaluation, the proceeds from the Offering will be more than sufficient to fund any deficiencies in working capital or cash flow from operations, and the Company is confident that it will be able to meet its obligations as they come due, and fund operations for at least 12 months after the issuance of these consolidated financial statements. Accordingly, the conditions around liquidity and limited working capital necessary to fund operations have been addressed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">However, we are continuing to evaluate merger and acquisition opportunities and other alternatives for our future. As part of that evaluative process, <span style="background-color: white">and as disclosed in the Form 8-K filed on April 10, 2024, </span> we are also considering the legal procedure and practical steps for dissolving ourselves, which would include a distribution of cash assets after creditors and other corporate obligations have been accounted for and satisfied. For any plan of dissolution, management and the board of directors will need to formulate and adopt a plan of dissolution. Certain transaction opportunities, depending on their structure, and any plan of dissolution will require shareholder approval through a proxy solicitation process.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event our Board of Directors decides to implement a plan of dissolution, and such plan is approved by our shareholders, we then will not be continuing as a going concern. Accordingly, at such time, it would be management’s position that the Company would no longer be a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"> </p> <p id="xdx_84D_eus-gaap--ConsolidationPolicyTextBlock_zbeVnHh2Qzc7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_ztGiDxpacq0i">Principles of Consolidation </span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--UseOfEstimates_zKo2SG375nFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zKObAja6ogph">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets as it applies to impairment analysis, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, inventory allowances, and legal contingencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zreVDXWYjE35" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zZzaO1fjbdj5">Cash, Cash Equivalents, and Restricted Cash</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company maintains deposits in financial institutions that exceed the federally insured amount of $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_c20240331_zhBcpBlhTz77" title="FDIC insured amount">250,000</span>. As of March 31, 2024, the balance in the Company’s accounts was approximately $<span id="xdx_90D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3d_c20240331_z24JnSi6lvD7" title="Cash balance, amount">11,599,000</span>, consequently approximately $<span id="xdx_900_eus-gaap--CashUninsuredAmount_iI_c20240331_znmle6ZfJXDj" title="FDIC uninsured amount">11,349,000</span> of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_847_eus-gaap--CreditLossFinancialInstrumentPolicyTextBlock_zj8NXaLNOO07" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zKL1G592MQki">Accounts Receivable and Allowance for Accounts Receivable</span>. </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Accounts receivables are recorded at the invoiced amount or based on revenue earned for items not yet invoiced, and generally do not bear interest. In accordance with ASU No. 2016-13 (as amended), <i>Measurement of Credit Losses on Financial Instruments, </i>which the Company adopted on a prospective basis effective January 1, 2023, an allowance for doubtful accounts is recorded against the Company’s receivables by applying an expected credit loss model. Each period, management assesses the appropriateness of the level of allowance for credit losses by considering credit risk inherent within its receivables as of the end of the period. The Company considers a receivable past due when a debtor has not paid us by the contractually specified payment due date. Account balances are written off against the allowance for credit losses if collection efforts are unsuccessful and the receivable balance is deemed uncollectible (debtor default), based on factors such as the debtor’s credit rating as well as the length of time the amounts are past due. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As of March 31, 2024, and December 31, 2023, the allowance for doubtful accounts was $<span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_c20240101__20240331_zMM9tErYpEU5" title="Allowance for doubtful accounts">91,000</span> and $<span id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_c20230101__20231231_z0F0ehlSi1n2" title="Allowance for doubtful accounts">125,000</span>, respectively. During the three months ended March 31, 2024, the Company received payment on certain accounts receivable which it had considered may have been uncollectible and had provided against in full. Accordingly, we wrote back $<span id="xdx_908_eus-gaap--ProvisionForDoubtfulAccounts_iN_di_c20240101__20240331_z0CS2ZxkoHWe" title="Provision for doubtful accounts">34,566</span> during the period in respect of these balances that no longer needed to be <span style="background-color: white">allowed</span> against. Similarly, during the three months ended March 31, 2023, we wrote back $<span id="xdx_90E_eus-gaap--ProvisionForDoubtfulAccounts_iN_di_c20230101__20230331_zQXf3SpIWuRk" title="Provision for doubtful accounts">1,705</span> in respect payments received on accounts receivable balances that had previously been fully allowed against in prior periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zRSJPFfRLFY8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zRatercp45lf">Income (Loss) Per Common Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As of March 31, 2024 and 2023, there were respectively,</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20240101__20240331_z9nDJANit37i" title="Potentially dilutive equity instruments that are convertible into common stock">7,942,220</span> and <span id="xdx_90B_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230331_zJUmnxRxe0gb" title="Potentially dilutive equity instruments that are convertible into common stock">8,010,956</span>, potentially dilutive equity instruments outstanding in respect of warrants, options and restricted stock units that were convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, <span id="xdx_90A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20240101__20240331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zJKk1WS34loa" title="Potentially dilutive equity instruments that are convertible into common stock"><span id="xdx_90B_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zVDXmS2xyoKg" title="Potentially dilutive equity instruments that are convertible into common stock">7,623,772</span></span> related to warrants outstanding at both March 31, 2024 and 2023 issued in connection with the sale of our shares of series B Preferred stock and common stock. The remaining <span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorAndStaffMember_zwNfZYTj3xh7" title="Potentially dilutive equity instruments that are convertible into common stock">318,448</span> and <span id="xdx_90A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorAndStaffMember_zrmsg81DbWve" title="Potentially dilutive equity instruments that are convertible into common stock">387,184</span> potentially dilutive equity instruments outstanding as of March 31, 2024 and 2023, respectively, related to options that were convertible into shares of the Company’s common stock that had been issued to our directors and staff as compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zoZBijJ2EOVd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zCWPfJWkmAVj">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) 2014-09 (Topic 606), <i>Revenue from Contracts with Customers</i> and all the related amendments (“ASC 606” or the “revenue standard”) to all contracts and elected the modified retrospective method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue Recognition Accounting Policy Summary</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Disaggregation of Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by equipment sales, engineering and other services, shipping and handling, and forfeited non-refundable customer deposits was required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_zfhgkp4NlcD3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the Company’s revenue by source:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_z1sHswWIFaa" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Revenue by Source</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20240101__20240331_zEdeecnCGpHa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230101__20230331_zPKth88doWO7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_z2Rq6uUROo2b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Equipment and systems sales</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">113,172</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,396,827</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zVkVlUK1IFg2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Engineering and other services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">88,165</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">124,410</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zi35HmWy8aw3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Shipping and handling</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,904</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,560</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ForfeitedNonRefundableCustomerDepositsMember_z4v9XRu6sdFi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Forfeited non-refundable customer deposits</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,265</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">148,776</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zM3xh80bLotc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">234,506</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,682,573</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_z9PRvV0EJQHk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Other Judgments and Assumptions</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Contract Assets and Contract Liabilities</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. Contract assets increased by $<span id="xdx_90A_eus-gaap--ContractWithCustomerAssetNetCurrent_iI_c20240331_zSPrggLkOYS2" title="Contract assets">224,414</span> in 2023, due to revenue recognition related to the partial satisfaction of performance obligations, on three contracts with one customer, for which we have not yet billed out customer. In accordance with ASU No. 2016-13 (as amended), <i>Measurement of Credit Losses on Financial Instruments, </i>which the Company adopted on a prospective basis effective January 1, 2023, <span style="background-color: white">an allowance for doubtful accounts is recorded against the Company’s contract assets </span>by applying an expected credit loss model. Each period, management assesses the appropriateness of the level of allowance for credit losses by considering credit risk inherent within its contract assets as of the end of the period. As of March 31, 2024, and December 31, 2023, the allowance for doubtful accounts was $<span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20240331_z67RyNybnmEf" title="Allowance for doubtful accounts"><span id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20231231_zQrwNjcx2HD9" title="Allowance for doubtful accounts">1,436</span></span>. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. We expect to complete our performance obligations and bill the customer for this contract asset during 2024. As of March 31, 2024, and December 31, 2023, the Company had contract assets of $<span id="xdx_90F_eus-gaap--ContractWithCustomerAssetNetCurrent_iI_c20240331_zBNcysrgauwk" title="Contract assets"><span id="xdx_90D_eus-gaap--ContractWithCustomerAssetNetCurrent_iI_c20231231_zcUmxREyNeh9" title="Contract assets">224,414</span></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited and a period of three years has passed. As of March 31, 2024, and December 31, 2023, deferred revenue, which was classified as a current liability, was $<span id="xdx_909_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240331_zcHiP6fLNB95" title="Contract with customer liability current">539,956</span> and $<span id="xdx_90F_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20231231_zKDPc1dQX5w3" title="Contract with customer liability current">499,800</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three months ended March 31, 2024, the Company recognized revenue of $<span id="xdx_908_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20240101__20240331_z047QkSDKal6" title="Revenue recognized">47,440</span> related to the deferred revenue at January 1, 2024. For the three months ended March 31, 2023, the Company recognized revenue of $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230101__20230331_zagZ9FJ6PJcd" title="Revenue recognized">3,852,906</span> related to the deferred revenue at January 1, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Remaining Performance Obligations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, t and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, the Company’s remaining performance obligations, or backlog, was approximately $<span id="xdx_903_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20240331_zyK1sDQ9Apj" title="Revenue remaining performance obligation">535,000</span>, a decrease of $<span id="xdx_90F_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20240331__srt--RangeAxis__srt--MaximumMember_zS6TA3FmRmtk" title="Revenue remaining performance obligation">1,334,000</span> from the March 31, 2023 backlog of $<span id="xdx_907_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230331_zhnudmRs8lm5" title="Revenue remaining performance obligation">1,869,000</span>. The decline was primarily the result of lower bookings. The Company has entered into fewer new contracts generally, and they have been for smaller amounts. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. Subsequent to March 31, 2024, a portion of one contract was cancelled. The amount cancelled was $<span id="xdx_900_ecustom--RevenueRemainingPerformanceAmountCancelled_iI_c20231231__srt--MajorCustomersAxis__custom--OneCustomerMember_zgiCugAyh3Ke" title="Revenue remaining performance amount cancelled">170,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zm06cmASNlXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations expected to be recognized through 2024 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_z1JQ9obvL183" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Remaining Performance Obligations Expected to be Recognized</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20240331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyFourMember_zTcjSXk0Ozhf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20240331_zbmbksoZaW0c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_znTUlDGPV7i8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1.5pt">Remaining performance obligations related to partial equipment &amp; engineering paid contracts</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">535,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">535,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueRemainingPerformanceObligation_iI_zOJCMiWnnMd9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total remaining performance obligations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">535,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">535,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zdYDzKTITWae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--StandardProductWarrantyPolicy_zDfa0LxmcBEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zMfYk54NSCIh">Product Warranty</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--StandardProductWarrantyDescription_c20240101__20240331_zpmh5gBuGd1j" title="Product warranty description">The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue.</span> The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of March 31, 2024, and December 31, 2023, the Company had an accrued warranty reserve amount of $<span id="xdx_90D_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20240331_zdr3QcQdaVIe" title="Product warranty accrual classified current">99,470</span> and $<span id="xdx_903_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20231231_zceE8N422Jl7" title="Product warranty accrual classified current">191,338</span>, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zq5Aqs2Pzlul" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zJdFQgbyadv7">Accounting for Share-Based Compensation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zyj1qT3zQwZb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2024 and March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zEh4VAdnJT7h" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Share-based Compensation Costs</span> </span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20240101__20240331_zkjCsAz3humk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230101__20230331_zuQCQbSQAnR6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Share-based compensation expense included in:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zFZoyuR6Fatb" style="vertical-align: bottom; background-color: White"> <td style="width: 60%">Cost of revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0534">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,898</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_z4REYqgeHFD2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Advertising and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0537">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,113</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zamDmSVayu26" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product development costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0540">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,570</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_ztNPLWX6JiOl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">76,969</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">137,513</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_ziuBYkoOzkp3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total share-based compensation expense included in consolidated statement of operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">76,969</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">147,094</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zUfyabltAqz2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"> </p> <p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zB3hvBnAdNbh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zuPQcADrLoa3">Concentrations</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for<span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zmKrzf4HhQT4" title="Concentration risk percentage"> 24</span>%, <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zl9QLympP1Af" title="Concentration risk percentage">16</span>%, and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zgin678gufxl" title="Concentration risk percentage">13</span>% of the Company’s revenue, respectively, for the three months ended March 31, 2024. Three customers accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zMcBjIvXAFQa" title="Concentration risk percentage">39</span>%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zFia1EQssYih" title="Concentration risk percentage">28</span>%, and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zz7SFs4G4ZZd" title="Concentration risk percentage">17</span>% of the Company’s revenue, respectively, for the three months ended March 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zMQFRRtlIaQ" title="Concentration risk percentage">60</span>%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zuroVGILqQy4" title="Concentration risk percentage">29</span>%, and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zN9kEeQeI8U3" title="Concentration risk percentage">11</span>% of the Company’s accounts receivable, respectively, as of March 31, 2024. Three customers accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zkHUIPcSQTgc" title="Concentration risk percentage">59</span>%, <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zU1LxG6LsKX5" title="Concentration risk percentage">29</span>%, and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zFqpckwyaEW" title="Concentration risk percentage">12</span>% of the Company’s accounts receivable, respectively, as of December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zAok0gZbRdmb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_z9BYXGYEYof">Recently Issued Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In March 2024, </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Financial Accounting Standards Board (FASB) <span style="background-color: white">issued ASU 2024-01 to clarify how an entity should determine whether a profits interest or similar award should be accounted for as a share-based payment arrangement or similar to a cash bonus or profit-sharing arrangement. The amendments are effective in annual periods beginning after December 15, 2024, and interim periods within those annual periods, with early adoption permitted. The Company is currently evaluating the new guidance and the impact on its future consolidated statements.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2023, FASB issued Accounting Standards Update 2023-09, Improvements to Income Tax Disclosures (ASU 2023-09). ASU 2023-09 includes requirements that an entity disclose specific categories in the rate reconciliation and provide additional information for reconciling items that are greater than five percent of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate. The standard also requires that entities disclose income (or loss) from continuing operations before income tax expense (or benefit) and income tax expense (or benefit) each disaggregated between domestic and foreign. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. The Company is currently assessing the impact of ASU 2023-09 on its disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2023, the FASB issued Accounting Standards Update 2023-07, Improvements to Reportable Segment Disclosures (ASU 2023-07). ASU 2023-07 includes requirements that an entity disclose the title of the chief operating decision maker (CODM) and on an interim and annual basis, significant segment expenses and the composition of other segment items for each segment’s reported profit. The standard also permits disclosure of additional measures of segment profit. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company is currently assessing the impact of ASU 2023-07 on its disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of <i>Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</i> (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p> <p id="xdx_850_zh7mtZdXYpfb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--DescriptionOfBusinessPolicyTextBlock_zeJfUGUyGEC2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span><span id="xdx_86E_z2pN0OuqEZXg">Description of Business</span></span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the fastest-growing sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide CEA facilities with (i) air handling equipment and systems, (ii) air sanitation products, (iii) LED lighting, and (iv) benching and racking solutions for indoor cultivation. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="background-color: white">We are evaluating merger and acquisition opportunities and other alternatives for our future. As part of that evaluative process, we are also considering the legal procedure and practical steps for dissolving ourselves, which would include a distribution of cash assets after creditors and other corporate obligations have been accounted for and satisfied. For any plan of dissolution, management and the board of directors will need to formulate and adopt a plan of dissolution. Certain transaction opportunities, depending on their structure, and any plan of dissolution will require shareholder approval through a proxy solicitation process.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_zlzPOYJqlXei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zm2R3h6h9pEe">Impact of the COVID-19 Pandemic on Our Business</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The impact of the government and the business economic response to the COVID-19 pandemic affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. We believe we continue to see adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, costs, and working capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the long-term impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2023, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--ImpactofUkrainianConflictPolicyTextBlock_z5KMkPZadoAl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_z3Xp6tCjnL0i">Impact of Ukrainian Conflict</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We believe that the conflicts involving Ukraine and Israel do not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflicts will have only a general impact on our operations in the same manner as it is having a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from countries involved in the conflicts, supply chain challenges, and the international and US domestic inflation resulting from the conflict and government spending in relation to the conflicts. As our operations are related only to the North American controlled agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to the conflicts. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflicts will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the conflicts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_843_ecustom--InflationPolicyTextBlock_z5cHbf0amb8e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zOjMBQ5O3ay1">Inflation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our operations are being influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build CEA facilities in which we operate. We believe that we will continue to face inflationary increases in the cost of products and our operations, which will adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment, delivery and transportation costs, and general operational expenses. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zT5GLKZERPTd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zzvcQJaMrJB6">Financial Statement Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--InterimFinancialStatementsPolicyTextBlock_zJqbvuCqPWR1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zNjPZVTyjzqc">Interim Financial Statements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2024. The balance sheet information as of December 31, 2023 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--LiquidityPolicyTextBlock_zPcuK9R5f0oc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zdPnqtXrCiWd">Liquidity</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 30.25pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are available to be issued. The Company continues to experience recurring losses since its inception. As a result, in order to continue as a going concern, the Company has been reliant on the ability to obtain additional sources of financing to fund growth. On February 15, 2022, the Company received approximately $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220215__20220215_zlg8slndTkgi" title="Proceeds from issuance of common stock">21,711,000</span> in net proceeds from completion of an equity offering. Based on management’s evaluation, the proceeds from the Offering will be more than sufficient to fund any deficiencies in working capital or cash flow from operations, and the Company is confident that it will be able to meet its obligations as they come due, and fund operations for at least 12 months after the issuance of these consolidated financial statements. Accordingly, the conditions around liquidity and limited working capital necessary to fund operations have been addressed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">However, we are continuing to evaluate merger and acquisition opportunities and other alternatives for our future. As part of that evaluative process, <span style="background-color: white">and as disclosed in the Form 8-K filed on April 10, 2024, </span> we are also considering the legal procedure and practical steps for dissolving ourselves, which would include a distribution of cash assets after creditors and other corporate obligations have been accounted for and satisfied. For any plan of dissolution, management and the board of directors will need to formulate and adopt a plan of dissolution. Certain transaction opportunities, depending on their structure, and any plan of dissolution will require shareholder approval through a proxy solicitation process.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event our Board of Directors decides to implement a plan of dissolution, and such plan is approved by our shareholders, we then will not be continuing as a going concern. Accordingly, at such time, it would be management’s position that the Company would no longer be a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"> </p> 21711000 <p id="xdx_84D_eus-gaap--ConsolidationPolicyTextBlock_zbeVnHh2Qzc7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_ztGiDxpacq0i">Principles of Consolidation </span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--UseOfEstimates_zKo2SG375nFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zKObAja6ogph">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets as it applies to impairment analysis, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, inventory allowances, and legal contingencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zreVDXWYjE35" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zZzaO1fjbdj5">Cash, Cash Equivalents, and Restricted Cash</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company maintains deposits in financial institutions that exceed the federally insured amount of $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_c20240331_zhBcpBlhTz77" title="FDIC insured amount">250,000</span>. As of March 31, 2024, the balance in the Company’s accounts was approximately $<span id="xdx_90D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3d_c20240331_z24JnSi6lvD7" title="Cash balance, amount">11,599,000</span>, consequently approximately $<span id="xdx_900_eus-gaap--CashUninsuredAmount_iI_c20240331_znmle6ZfJXDj" title="FDIC uninsured amount">11,349,000</span> of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> 250000 11599000 11349000 <p id="xdx_847_eus-gaap--CreditLossFinancialInstrumentPolicyTextBlock_zj8NXaLNOO07" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zKL1G592MQki">Accounts Receivable and Allowance for Accounts Receivable</span>. </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Accounts receivables are recorded at the invoiced amount or based on revenue earned for items not yet invoiced, and generally do not bear interest. In accordance with ASU No. 2016-13 (as amended), <i>Measurement of Credit Losses on Financial Instruments, </i>which the Company adopted on a prospective basis effective January 1, 2023, an allowance for doubtful accounts is recorded against the Company’s receivables by applying an expected credit loss model. Each period, management assesses the appropriateness of the level of allowance for credit losses by considering credit risk inherent within its receivables as of the end of the period. The Company considers a receivable past due when a debtor has not paid us by the contractually specified payment due date. Account balances are written off against the allowance for credit losses if collection efforts are unsuccessful and the receivable balance is deemed uncollectible (debtor default), based on factors such as the debtor’s credit rating as well as the length of time the amounts are past due. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As of March 31, 2024, and December 31, 2023, the allowance for doubtful accounts was $<span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_c20240101__20240331_zMM9tErYpEU5" title="Allowance for doubtful accounts">91,000</span> and $<span id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_c20230101__20231231_z0F0ehlSi1n2" title="Allowance for doubtful accounts">125,000</span>, respectively. During the three months ended March 31, 2024, the Company received payment on certain accounts receivable which it had considered may have been uncollectible and had provided against in full. Accordingly, we wrote back $<span id="xdx_908_eus-gaap--ProvisionForDoubtfulAccounts_iN_di_c20240101__20240331_z0CS2ZxkoHWe" title="Provision for doubtful accounts">34,566</span> during the period in respect of these balances that no longer needed to be <span style="background-color: white">allowed</span> against. Similarly, during the three months ended March 31, 2023, we wrote back $<span id="xdx_90E_eus-gaap--ProvisionForDoubtfulAccounts_iN_di_c20230101__20230331_zQXf3SpIWuRk" title="Provision for doubtful accounts">1,705</span> in respect payments received on accounts receivable balances that had previously been fully allowed against in prior periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> 91000 125000 -34566 -1705 <p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zRSJPFfRLFY8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zRatercp45lf">Income (Loss) Per Common Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As of March 31, 2024 and 2023, there were respectively,</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20240101__20240331_z9nDJANit37i" title="Potentially dilutive equity instruments that are convertible into common stock">7,942,220</span> and <span id="xdx_90B_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230331_zJUmnxRxe0gb" title="Potentially dilutive equity instruments that are convertible into common stock">8,010,956</span>, potentially dilutive equity instruments outstanding in respect of warrants, options and restricted stock units that were convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, <span id="xdx_90A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20240101__20240331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zJKk1WS34loa" title="Potentially dilutive equity instruments that are convertible into common stock"><span id="xdx_90B_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zVDXmS2xyoKg" title="Potentially dilutive equity instruments that are convertible into common stock">7,623,772</span></span> related to warrants outstanding at both March 31, 2024 and 2023 issued in connection with the sale of our shares of series B Preferred stock and common stock. The remaining <span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorAndStaffMember_zwNfZYTj3xh7" title="Potentially dilutive equity instruments that are convertible into common stock">318,448</span> and <span id="xdx_90A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorAndStaffMember_zrmsg81DbWve" title="Potentially dilutive equity instruments that are convertible into common stock">387,184</span> potentially dilutive equity instruments outstanding as of March 31, 2024 and 2023, respectively, related to options that were convertible into shares of the Company’s common stock that had been issued to our directors and staff as compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 7942220 8010956 7623772 7623772 318448 387184 <p id="xdx_845_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zoZBijJ2EOVd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zCWPfJWkmAVj">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) 2014-09 (Topic 606), <i>Revenue from Contracts with Customers</i> and all the related amendments (“ASC 606” or the “revenue standard”) to all contracts and elected the modified retrospective method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue Recognition Accounting Policy Summary</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Disaggregation of Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by equipment sales, engineering and other services, shipping and handling, and forfeited non-refundable customer deposits was required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_zfhgkp4NlcD3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the Company’s revenue by source:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_z1sHswWIFaa" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Revenue by Source</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20240101__20240331_zEdeecnCGpHa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230101__20230331_zPKth88doWO7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_z2Rq6uUROo2b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Equipment and systems sales</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">113,172</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,396,827</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zVkVlUK1IFg2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Engineering and other services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">88,165</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">124,410</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zi35HmWy8aw3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Shipping and handling</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,904</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,560</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ForfeitedNonRefundableCustomerDepositsMember_z4v9XRu6sdFi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Forfeited non-refundable customer deposits</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,265</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">148,776</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zM3xh80bLotc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">234,506</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,682,573</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_z9PRvV0EJQHk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Other Judgments and Assumptions</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Contract Assets and Contract Liabilities</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. Contract assets increased by $<span id="xdx_90A_eus-gaap--ContractWithCustomerAssetNetCurrent_iI_c20240331_zSPrggLkOYS2" title="Contract assets">224,414</span> in 2023, due to revenue recognition related to the partial satisfaction of performance obligations, on three contracts with one customer, for which we have not yet billed out customer. In accordance with ASU No. 2016-13 (as amended), <i>Measurement of Credit Losses on Financial Instruments, </i>which the Company adopted on a prospective basis effective January 1, 2023, <span style="background-color: white">an allowance for doubtful accounts is recorded against the Company’s contract assets </span>by applying an expected credit loss model. Each period, management assesses the appropriateness of the level of allowance for credit losses by considering credit risk inherent within its contract assets as of the end of the period. As of March 31, 2024, and December 31, 2023, the allowance for doubtful accounts was $<span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20240331_z67RyNybnmEf" title="Allowance for doubtful accounts"><span id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20231231_zQrwNjcx2HD9" title="Allowance for doubtful accounts">1,436</span></span>. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. We expect to complete our performance obligations and bill the customer for this contract asset during 2024. As of March 31, 2024, and December 31, 2023, the Company had contract assets of $<span id="xdx_90F_eus-gaap--ContractWithCustomerAssetNetCurrent_iI_c20240331_zBNcysrgauwk" title="Contract assets"><span id="xdx_90D_eus-gaap--ContractWithCustomerAssetNetCurrent_iI_c20231231_zcUmxREyNeh9" title="Contract assets">224,414</span></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited and a period of three years has passed. As of March 31, 2024, and December 31, 2023, deferred revenue, which was classified as a current liability, was $<span id="xdx_909_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20240331_zcHiP6fLNB95" title="Contract with customer liability current">539,956</span> and $<span id="xdx_90F_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20231231_zKDPc1dQX5w3" title="Contract with customer liability current">499,800</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three months ended March 31, 2024, the Company recognized revenue of $<span id="xdx_908_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20240101__20240331_z047QkSDKal6" title="Revenue recognized">47,440</span> related to the deferred revenue at January 1, 2024. For the three months ended March 31, 2023, the Company recognized revenue of $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230101__20230331_zagZ9FJ6PJcd" title="Revenue recognized">3,852,906</span> related to the deferred revenue at January 1, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Remaining Performance Obligations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, t and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, the Company’s remaining performance obligations, or backlog, was approximately $<span id="xdx_903_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20240331_zyK1sDQ9Apj" title="Revenue remaining performance obligation">535,000</span>, a decrease of $<span id="xdx_90F_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20240331__srt--RangeAxis__srt--MaximumMember_zS6TA3FmRmtk" title="Revenue remaining performance obligation">1,334,000</span> from the March 31, 2023 backlog of $<span id="xdx_907_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230331_zhnudmRs8lm5" title="Revenue remaining performance obligation">1,869,000</span>. The decline was primarily the result of lower bookings. The Company has entered into fewer new contracts generally, and they have been for smaller amounts. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. Subsequent to March 31, 2024, a portion of one contract was cancelled. The amount cancelled was $<span id="xdx_900_ecustom--RevenueRemainingPerformanceAmountCancelled_iI_c20231231__srt--MajorCustomersAxis__custom--OneCustomerMember_zgiCugAyh3Ke" title="Revenue remaining performance amount cancelled">170,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zm06cmASNlXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations expected to be recognized through 2024 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_z1JQ9obvL183" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Remaining Performance Obligations Expected to be Recognized</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20240331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyFourMember_zTcjSXk0Ozhf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20240331_zbmbksoZaW0c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_znTUlDGPV7i8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1.5pt">Remaining performance obligations related to partial equipment &amp; engineering paid contracts</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">535,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">535,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueRemainingPerformanceObligation_iI_zOJCMiWnnMd9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total remaining performance obligations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">535,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">535,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zdYDzKTITWae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_zfhgkp4NlcD3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the Company’s revenue by source:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_z1sHswWIFaa" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Revenue by Source</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20240101__20240331_zEdeecnCGpHa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230101__20230331_zPKth88doWO7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_z2Rq6uUROo2b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Equipment and systems sales</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">113,172</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,396,827</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zVkVlUK1IFg2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Engineering and other services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">88,165</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">124,410</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zi35HmWy8aw3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Shipping and handling</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,904</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,560</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ForfeitedNonRefundableCustomerDepositsMember_z4v9XRu6sdFi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Forfeited non-refundable customer deposits</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,265</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">148,776</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zM3xh80bLotc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">234,506</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,682,573</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 113172 4396827 88165 124410 1904 12560 31265 148776 234506 4682573 224414 1436 1436 224414 224414 539956 499800 47440 3852906 535000 1334000 1869000 170000 <p id="xdx_89C_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zm06cmASNlXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations expected to be recognized through 2024 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_z1JQ9obvL183" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Remaining Performance Obligations Expected to be Recognized</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20240331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyFourMember_zTcjSXk0Ozhf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20240331_zbmbksoZaW0c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_znTUlDGPV7i8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1.5pt">Remaining performance obligations related to partial equipment &amp; engineering paid contracts</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">535,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">535,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueRemainingPerformanceObligation_iI_zOJCMiWnnMd9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total remaining performance obligations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">535,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">535,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 535000 535000 535000 535000 <p id="xdx_847_eus-gaap--StandardProductWarrantyPolicy_zDfa0LxmcBEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zMfYk54NSCIh">Product Warranty</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--StandardProductWarrantyDescription_c20240101__20240331_zpmh5gBuGd1j" title="Product warranty description">The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue.</span> The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of March 31, 2024, and December 31, 2023, the Company had an accrued warranty reserve amount of $<span id="xdx_90D_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20240331_zdr3QcQdaVIe" title="Product warranty accrual classified current">99,470</span> and $<span id="xdx_903_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20231231_zceE8N422Jl7" title="Product warranty accrual classified current">191,338</span>, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. 99470 191338 <p id="xdx_849_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zq5Aqs2Pzlul" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zJdFQgbyadv7">Accounting for Share-Based Compensation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zyj1qT3zQwZb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2024 and March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zEh4VAdnJT7h" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Share-based Compensation Costs</span> </span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20240101__20240331_zkjCsAz3humk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230101__20230331_zuQCQbSQAnR6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Share-based compensation expense included in:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zFZoyuR6Fatb" style="vertical-align: bottom; background-color: White"> <td style="width: 60%">Cost of revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0534">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,898</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_z4REYqgeHFD2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Advertising and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0537">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,113</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zamDmSVayu26" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product development costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0540">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,570</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_ztNPLWX6JiOl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">76,969</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">137,513</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_ziuBYkoOzkp3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total share-based compensation expense included in consolidated statement of operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">76,969</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">147,094</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zUfyabltAqz2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"> </p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zyj1qT3zQwZb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2024 and March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zEh4VAdnJT7h" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Share-based Compensation Costs</span> </span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20240101__20240331_zkjCsAz3humk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230101__20230331_zuQCQbSQAnR6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Share-based compensation expense included in:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zFZoyuR6Fatb" style="vertical-align: bottom; background-color: White"> <td style="width: 60%">Cost of revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0534">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,898</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_z4REYqgeHFD2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Advertising and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0537">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,113</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zamDmSVayu26" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product development costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0540">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,570</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_ztNPLWX6JiOl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">76,969</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">137,513</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_ziuBYkoOzkp3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total share-based compensation expense included in consolidated statement of operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">76,969</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">147,094</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 4898 1113 3570 76969 137513 76969 147094 <p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zB3hvBnAdNbh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zuPQcADrLoa3">Concentrations</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for<span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zmKrzf4HhQT4" title="Concentration risk percentage"> 24</span>%, <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zl9QLympP1Af" title="Concentration risk percentage">16</span>%, and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zgin678gufxl" title="Concentration risk percentage">13</span>% of the Company’s revenue, respectively, for the three months ended March 31, 2024. Three customers accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zMcBjIvXAFQa" title="Concentration risk percentage">39</span>%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zFia1EQssYih" title="Concentration risk percentage">28</span>%, and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zz7SFs4G4ZZd" title="Concentration risk percentage">17</span>% of the Company’s revenue, respectively, for the three months ended March 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zMQFRRtlIaQ" title="Concentration risk percentage">60</span>%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zuroVGILqQy4" title="Concentration risk percentage">29</span>%, and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zN9kEeQeI8U3" title="Concentration risk percentage">11</span>% of the Company’s accounts receivable, respectively, as of March 31, 2024. Three customers accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zkHUIPcSQTgc" title="Concentration risk percentage">59</span>%, <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zU1LxG6LsKX5" title="Concentration risk percentage">29</span>%, and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zFqpckwyaEW" title="Concentration risk percentage">12</span>% of the Company’s accounts receivable, respectively, as of December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.24 0.16 0.13 0.39 0.28 0.17 0.60 0.29 0.11 0.59 0.29 0.12 <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zAok0gZbRdmb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_z9BYXGYEYof">Recently Issued Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In March 2024, </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Financial Accounting Standards Board (FASB) <span style="background-color: white">issued ASU 2024-01 to clarify how an entity should determine whether a profits interest or similar award should be accounted for as a share-based payment arrangement or similar to a cash bonus or profit-sharing arrangement. The amendments are effective in annual periods beginning after December 15, 2024, and interim periods within those annual periods, with early adoption permitted. The Company is currently evaluating the new guidance and the impact on its future consolidated statements.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2023, FASB issued Accounting Standards Update 2023-09, Improvements to Income Tax Disclosures (ASU 2023-09). ASU 2023-09 includes requirements that an entity disclose specific categories in the rate reconciliation and provide additional information for reconciling items that are greater than five percent of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate. The standard also requires that entities disclose income (or loss) from continuing operations before income tax expense (or benefit) and income tax expense (or benefit) each disaggregated between domestic and foreign. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. The Company is currently assessing the impact of ASU 2023-09 on its disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2023, the FASB issued Accounting Standards Update 2023-07, Improvements to Reportable Segment Disclosures (ASU 2023-07). ASU 2023-07 includes requirements that an entity disclose the title of the chief operating decision maker (CODM) and on an interim and annual basis, significant segment expenses and the composition of other segment items for each segment’s reported profit. The standard also permits disclosure of additional measures of segment profit. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company is currently assessing the impact of ASU 2023-07 on its disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of <i>Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</i> (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p> <p id="xdx_80F_eus-gaap--LesseeOperatingLeasesTextBlock_z0R5mWNx6zB6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2 – <span id="xdx_82C_z88V41uYnbWa">Leases</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">The Louisville Facility Lease</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 28, 2021, the Company entered into an agreement to lease <span id="xdx_907_eus-gaap--AreaOfLand_iI_uSquareFoot_c20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zfqwEDGTimla" title="Area of land">11,491</span> square feet of office and manufacturing space (the “New Facility Lease”), in Louisville, CO. <span id="xdx_90C_eus-gaap--LesseeOperatingLeaseDescription_c20210726__20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zX3XKvOmIXvd" title="Operating lease term description">The New Facility lease commenced on November 1, 2021 and continues through January 31, 2027.</span> From November 2021 through January 2022, the monthly rent was abated. Beginning February 2022, the monthly rent is $<span id="xdx_905_eus-gaap--PaymentsForRent_c20210726__20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zInrTBi3lO74" title="Lease rental expense">10,055</span> and will increase by <span id="xdx_90B_ecustom--IncreaseInRentPercent_dp_uPure_c20210726__20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zExNCeaLVvX4" title="Increase in rent percent">3</span>% annually every November through the end of the New Facility Lease term. Pursuant to the New Facility Lease, the Company made a security deposit of $<span id="xdx_901_eus-gaap--SecurityDeposit_iI_c20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zvzWfA3ZCzd8" title="Security deposit">14,747</span>. The Company has the option to renew the New Facility Lease for an additional <span id="xdx_90F_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dc_c20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zosmGKlfmLBa" title="Lease renew term">five years</span>. Additionally, the Company pays the actual amounts for property taxes, insurance, and common area maintenance. The New Facility Lease agreement contains customary events of default, representations, warranties, and covenants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon commencement of the New Facility Lease, the Company recognized on the balance sheet an operating lease right-of-use asset and lease liability in the amount of $<span id="xdx_90E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zYj1vD8dFt28" title="Operating lease ROU"><span id="xdx_900_eus-gaap--OperatingLeaseLiability_iI_c20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_ztnGiAdw3Inf" title="Operating lease liability">582,838</span></span>. The lease liability was initially measured as the present value of the unpaid lease payments at commencement and the ROU asset was initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The renewal option to extend the New Facility Lease is not included in the right-of-use asset or lease liability, as the option is not reasonably certain to be exercised. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal period in its lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--LeaseCostTableTextBlock_ziQzAmIgc8Q9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s operating and finance right-of-use assets and lease liabilities are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zTrO1W2q1MX9" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Lease Cost</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20240331_z5zJ9eA0UNN4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of</p> <p style="margin-top: 0; margin-bottom: 0">March 31, 2024</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zId8VfnMrSP8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Operating lease right-of-use asset</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">328,792</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zyKXLu3ep0nl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Operating lease liability, current</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">128,839</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zNzVBeQ54YVi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating lease liability, long-term</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">228,927</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining lease term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240331_z3JSqddiBOpe" title="Remaining lease term">2.8</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Discount rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20240331_zY8CiJLNxoZj" title="Discount rate">3.63</span></td><td style="text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the</p> <p style="margin-top: 0; margin-bottom: 0">Three Months</p> <p style="margin-top: 0; margin-bottom: 0">Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31, 2024</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Cash paid for operating lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingLeasePayments_c20240101__20240331_zm6wOWpjnpyi" style="width: 20%; text-align: right" title="Cash paid for operating lease">32,001</td><td style="width: 1%; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zVkk8LQgMiM4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zYKW2IU13LT4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future annual minimum under non-cancellable operating leases as of March 31, 2024 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zdzT2C1PgrH8" style="display: none">Schedule of Future Annual Minimum Lease Payments</span> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify">As of March 31, 2024</td><td> </td> <td colspan="2" id="xdx_49D_20240331_zfLzY2YgTBB7"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Years ended December 31,</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_maLOLLPzDPL_z6EtbQDnqrik" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">2024 (excluding the three months ended March 31, 2024)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">96,643</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzDPL_zrpprgWkiuNa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">132,503</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzDPL_zamIxxfosGQ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">136,473</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearTwo_iI_maLOLLPzDPL_zbm3dajSJ4h7" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,654</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzDPL_zwoErld1I6m4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Total minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">377,273</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zDxt7HUj91xd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Less imputed interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(19,507</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--OperatingLeaseLiability_iTI_zrUDhuAqbNq1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Present value of minimum lease payments</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">357,766</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zZvFU5DzRI37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 11491 The New Facility lease commenced on November 1, 2021 and continues through January 31, 2027. 10055 0.03 14747 P5Y 582838 582838 <p id="xdx_89F_eus-gaap--LeaseCostTableTextBlock_ziQzAmIgc8Q9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s operating and finance right-of-use assets and lease liabilities are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zTrO1W2q1MX9" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Lease Cost</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20240331_z5zJ9eA0UNN4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of</p> <p style="margin-top: 0; margin-bottom: 0">March 31, 2024</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zId8VfnMrSP8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Operating lease right-of-use asset</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">328,792</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zyKXLu3ep0nl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Operating lease liability, current</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">128,839</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zNzVBeQ54YVi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating lease liability, long-term</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">228,927</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining lease term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240331_z3JSqddiBOpe" title="Remaining lease term">2.8</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Discount rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20240331_zY8CiJLNxoZj" title="Discount rate">3.63</span></td><td style="text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the</p> <p style="margin-top: 0; margin-bottom: 0">Three Months</p> <p style="margin-top: 0; margin-bottom: 0">Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31, 2024</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Cash paid for operating lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingLeasePayments_c20240101__20240331_zm6wOWpjnpyi" style="width: 20%; text-align: right" title="Cash paid for operating lease">32,001</td><td style="width: 1%; text-align: left"> </td></tr> </table> 328792 128839 228927 P2Y9M18D 0.0363 32001 <p id="xdx_895_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zYKW2IU13LT4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future annual minimum under non-cancellable operating leases as of March 31, 2024 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zdzT2C1PgrH8" style="display: none">Schedule of Future Annual Minimum Lease Payments</span> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify">As of March 31, 2024</td><td> </td> <td colspan="2" id="xdx_49D_20240331_zfLzY2YgTBB7"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Years ended December 31,</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_maLOLLPzDPL_z6EtbQDnqrik" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">2024 (excluding the three months ended March 31, 2024)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">96,643</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzDPL_zrpprgWkiuNa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">132,503</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzDPL_zamIxxfosGQ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">136,473</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearTwo_iI_maLOLLPzDPL_zbm3dajSJ4h7" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,654</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzDPL_zwoErld1I6m4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Total minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">377,273</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zDxt7HUj91xd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Less imputed interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(19,507</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--OperatingLeaseLiability_iTI_zrUDhuAqbNq1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Present value of minimum lease payments</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">357,766</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 96643 132503 136473 11654 377273 19507 357766 <p id="xdx_80F_eus-gaap--InventoryDisclosureTextBlock_z9k1FUjZFEN4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 3 – <span id="xdx_82D_zn2LGYywe8Vk">Inventory</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z3R0qaAbDdO6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zXbfltsdin55" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Inventory</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_499_20240331_zvREajFpm7na" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20231231_zinkZk2hTMZ6" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINztRx_zBw4RwPzQsnl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Finished goods</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">355,138</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">366,844</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryRawMaterials_iI_maINztRx_zqSvGG74PyQ6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Raw materials</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">121,814</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">122,258</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InventoryValuationReserves_iNI_di_msINztRx_zbep8Z4XirEg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Allowance for excess &amp; obsolete inventory</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(231,058</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(192,698</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--InventoryNet_iTI_mtINztRx_zXcbRtPijLlk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Inventory, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">245,894</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">296,404</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zvMKO4S985L7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overhead expenses of $<span id="xdx_900_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20240101__20240331_zTFJb8EA6Fpk" title="Overhead expenses">11,475</span> and $<span id="xdx_901_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20230101__20231231_ztaqT3ED3lT5" title="Overhead expenses">13,679</span> were included in the inventory balance as of March 31, 2024, and December 31, 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses included approximately $<span id="xdx_901_ecustom--PrepaidInventoryExpenses_iI_c20240331_z8HzPUsdrIYg" title="Prepaid inventory expenses">13,000</span> and $<span id="xdx_905_ecustom--PrepaidInventoryExpenses_iI_c20231231_z5oBZjc7R0N9" title="Prepaid inventory expenses">6,000</span> in advance payments for inventory as of March 31, 2024, and December 31, 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_896_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z3R0qaAbDdO6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zXbfltsdin55" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Inventory</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_499_20240331_zvREajFpm7na" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20231231_zinkZk2hTMZ6" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINztRx_zBw4RwPzQsnl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Finished goods</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">355,138</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">366,844</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryRawMaterials_iI_maINztRx_zqSvGG74PyQ6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Raw materials</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">121,814</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">122,258</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InventoryValuationReserves_iNI_di_msINztRx_zbep8Z4XirEg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Allowance for excess &amp; obsolete inventory</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(231,058</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(192,698</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--InventoryNet_iTI_mtINztRx_zXcbRtPijLlk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Inventory, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">245,894</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">296,404</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 355138 366844 121814 122258 231058 192698 245894 296404 11475 13679 13000 6000 <p id="xdx_802_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z6ijgjhNDHta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 4 – <span id="xdx_829_z4Xxf9l1mmYc">Property and Equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--PropertyPlantAndEquipmentTextBlock_zyslKy1zYRLc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zrhgfEXeaYy6" style="display: none">Schedule of Property and Equipment</span> </span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20240331_z3BHfkXvtlL9" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_499_20231231_z7S2kDA8xcsl" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zxXqfLtuMaZ9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Furniture and equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">249,511</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">275,994</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zvLt1lU3XOz" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Vehicles</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzCtH_zbogspuIHJab" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, gross</span> </span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">264,511</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">290,994</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzCtH_zmzvkycRCfvc" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(245,492</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(252,436</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzCtH_z3Xv6gfhYsY3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">19,019</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">38,558</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zIImANdbNV8h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense was $<span id="xdx_904_eus-gaap--Depreciation_c20240101__20240331_zIhWqoV51to1" title="Depreciation expenses">6,914</span> for the three months ended March 31, 2024. For the three months ended March 31, 2024, $<span id="xdx_900_eus-gaap--Depreciation_c20240101__20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zS8UE4aazcTj" title="Depreciation">535</span> was allocated to cost of sales, $<span id="xdx_902_eus-gaap--Depreciation_c20240101__20240331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__custom--InventoryMember_zT5FF3F5kFKa" title="Depreciation expenses">134</span> was allocated to inventory with the remainder recorded as selling, general, and administrative expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--PropertyPlantAndEquipmentTextBlock_zyslKy1zYRLc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zrhgfEXeaYy6" style="display: none">Schedule of Property and Equipment</span> </span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20240331_z3BHfkXvtlL9" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_499_20231231_z7S2kDA8xcsl" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zxXqfLtuMaZ9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Furniture and equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">249,511</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">275,994</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zvLt1lU3XOz" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Vehicles</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzCtH_zbogspuIHJab" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, gross</span> </span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">264,511</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">290,994</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzCtH_zmzvkycRCfvc" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(245,492</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(252,436</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzCtH_z3Xv6gfhYsY3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">19,019</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">38,558</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 249511 275994 15000 15000 264511 290994 245492 252436 19019 38558 6914 535 134 <p id="xdx_806_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zRbyPavzyzeh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 5 – <span id="xdx_82F_zim2VBCQvWJ7">Accounts Payable and Accrued Liabilities</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zL7R7TSQRIxh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable and accrued liabilities consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zPBpuEp88Xsg" style="display: none">Schedule of Accounts Payable and Accrued Liabilities</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20240331_zX2T3deL9jI5" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20231231_zAnKZmR4tPY" style="font-weight: bold">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--AccountsPayableCurrent_iI_maAPAALztwN_zFF05D8mzon6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accounts payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">101,591</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">183,359</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccruedSalesCommissionCurrent_iI_maAPAALztwN_zJaQjPbWcQ07" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales commissions payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,706</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,710</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_maAPAALztwN_zRA7Gle8DwS1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued payroll liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143,165</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">189,829</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_maAPAALztwN_zc1kQGJlQrc8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product warranty accrual</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">99,470</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">191,338</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maAPAALztwN_zGBTX5oL2nSc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,944</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">58,488</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_mtAPAALztwN_zEZjjVwCE524" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">361,876</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">624,724</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_ztGOuCmTnq2d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zL7R7TSQRIxh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable and accrued liabilities consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zPBpuEp88Xsg" style="display: none">Schedule of Accounts Payable and Accrued Liabilities</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20240331_zX2T3deL9jI5" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20231231_zAnKZmR4tPY" style="font-weight: bold">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--AccountsPayableCurrent_iI_maAPAALztwN_zFF05D8mzon6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accounts payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">101,591</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">183,359</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccruedSalesCommissionCurrent_iI_maAPAALztwN_zJaQjPbWcQ07" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales commissions payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,706</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,710</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_maAPAALztwN_zRA7Gle8DwS1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued payroll liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143,165</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">189,829</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_maAPAALztwN_zc1kQGJlQrc8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product warranty accrual</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">99,470</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">191,338</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maAPAALztwN_zGBTX5oL2nSc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,944</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">58,488</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_mtAPAALztwN_zEZjjVwCE524" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">361,876</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">624,724</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 101591 183359 1706 1710 143165 189829 99470 191338 15944 58488 361876 624724 <p id="xdx_802_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zObeRvjLiNx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 6 – <span id="xdx_827_z7v8qjahjmm6">Commitments and Contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Litigation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 20, 2023, Sweet Cut Grow, LLC and Green Ice, LLC (collectively, “Claimant”) a client of the Company with which it had an equipment contract and engineering contract, filed a demand for arbitration asserting claims for breach of contract, breach of warranty, and unjust enrichment, and a demand for $<span id="xdx_90B_eus-gaap--LossContingencyDamagesSoughtValue_c20231020__20231020_zsbf7w0kTp05" title="Damages sought value">1,049,280</span> in damages, plus interest (“Claims”). The Company continues to deny all the Claims and has asserted a counterclaim. The Company believes Claimant is owed nothing as the Company fulfilled all its obligations under the contracts to Claimant, and further, that the negligence of a third-party supplier is the basis of the Claims. We intend to generally defend the claims on the basis that we promptly addressed all problems, and that any issues with defective HVAC equipment are the responsibility of our third-party equipment manufacturer. The Company’s equipment contract with Claimant requires the parties to arbitrate their disputes under the rules of the American Arbitration Association (“AAA”). The arbitration will be heard in Denver, Colorado. The matter is in the preliminary phase. The parties will pay their own legal fees and expenses. The Company intends to defend itself vigorously, believing there are no merits to the claims as currently presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given the current uncertainty around estimability and success of claims, we have not recorded an accrual for any potential loss related to this matter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Leases</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has a lease agreement for its manufacturing and office space. Refer to <i>Note 2 Leases</i> above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other Commitments</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 1049280 <p id="xdx_807_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zGWuECsu1ZRe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7 – <span id="xdx_82B_zLKMl8Sxnozf">Stockholders’ Equity</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, the Company had <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20240331_z4IPiwjZpOu2" title="Common stock, shares authorized">200,000,000</span> shares of common stock and <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20240331_zrIMqotzWsDa" title="Preferred stock, shares authorized">25,000,000</span> shares of preferred stock authorized at a $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240331_z1hOLb3yp7be" title="Common stock par value">0.00001</span> par value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, <span id="xdx_901_eus-gaap--CommonStockSharesIssued_iI_c20240331_zMuexMfx7T17" title="Common stock, shares issued"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_c20240331_zkWbK9pvqRdj" title="Common stock, shares outstanding">8,212,737</span></span> shares of common stock were issued and outstanding and <span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_do_c20240331_zFLkE2rccZN4" title="Preferred stock, shares issued"><span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20240331_zs0eRidZJfki" title="Preferred stock, shares outstanding">no</span></span> shares of preferred stock were issued and outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Directors Remuneration</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 3, 2023, the Company issued an RSU grant of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230103__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zsPOwJA2cmw1" title="Number of stock options issued">29,758</span> shares of common stock under the 2021 Equity Incentive Plan to each of its four independent directors. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors effective January 17, 2022 and vested immediately on the grant date. A total of <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20230103__20230103__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zevHQM0heJG9" title="Number of shares vested in period">119,032</span> shares of the Company’s common stock were issued in settlement of the RSUs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 2, 2024, the Company issued an RSU grant of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20240102__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zDeVLENO6VHj" title="Number of stock options issued">45,455</span> shares of common stock under the 2021 Equity Incentive Plan to three of its four independent directors. Mr. Shipley declined to receive the RSUs which he was entitled to receive. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors effective January 17, 2022 and vested immediately on the grant date. A total of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20240102__20240102__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z34oQGwLJPjf" title="Number of shares vested in period">136,365</span> shares of the Company’s common stock were issued in settlement of the RSUs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revised Compensation Plan for Directors</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On January 17, 2022, the Board of Directors revised the previously adopted compensation plan. This plan supersedes the plan adopted on August 20, 2021. The Plan is effective retroactively for the current independent directors and for independent directors elected or appointed after the Effective Date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At the time of initial election or appointment, each independent director received an equity retention award in the form of restricted stock units (“RSUs”). The aggregate value of the RSUs at the time of grant was to be $<span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedPeriod_c20220112__20220117__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zCollq8raqZ5" title="Share based compensation arrangement payment">25,000</span>, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20220112__20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z2j0ruqSF8Rb" title="Vesting rights description">Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, on the first business day of January each year, each independent director will also receive an equity retention award in the form of RSUs. The aggregate value of the RSUs at the time of grant will be $<span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedPeriod_c20220112__20220117__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zWEfZKyhjCZ" title="Share based compensation arrangement payment">25,000</span>, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. These RSUs will be fully vested at date of grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is no additional compensation paid to members of any committee of the Board. Interested (i.e. Executive directors) serving on the Board do not receive compensation for their Board service.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All independent directors, Messrs. Shipley, Etten, Reisner, and Mariathasan are subject to the Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each independent director is responsible for the payment of any and all income taxes arising with respect to the issuance of any equity awarded under the plan, including the exercise of any non-qualified stock options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 200000000 25000000 0.00001 8212737 8212737 0 0 29758 119032 45455 136365 25000 Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date. 25000 <p id="xdx_80D_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zqcpMjZLIuZ" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 8 – <span id="xdx_820_zlfRt0xbRo66">Equity Incentive Plans</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2017 Equity Incentive Plan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the Company’s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the “2017 Equity Plan”), the Board of Directors (the “Board”) (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zuualAOZkUvl" title="Number of options to purchase shares">333,333</span> shares of the Company’s common stock (“Plan Shares”) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2024, no shares or options were issued and <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z1pM6nqqJ9Jh" title="Number of shares option forfeited">6,134</span> options were forfeited under the 2017 Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, of the <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zhTslNSQU188" title="Number of shares authorized">333,333</span> shares authorized under the 2017 Plan for equity awards, <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zMoHRHaaDwD5" title="Number of shares issued">163,692</span> shares have been issued, awards relating to <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zvYID1Rsjf4j" title="Number of option remain outstanding">139,378</span> options remain outstanding, and <span id="xdx_902_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zI3XL8GkpGId" title="Shares available for future equity awards">30,263</span> shares remain available for future equity awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2021 Equity Incentive Plan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the “2021 Equity Plan”), which was approved by the stockholders on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210322__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zFJc25U0Hf5a" title="Number of shares grant in period">666,667</span> shares of common stock. The 2021 Equity Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), non-qualified stock options, stock appreciation rights (“SARs”), restricted stock awards and restricted stock unit awards and other equity linked awards to our employees, consultants, and directors. If an equity award (i) expires or otherwise terminates without having been exercised in full or (ii) is settled in cash (<i>i.e.</i>, the holder of the award receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant to this Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zx9JBI3AkhZ6" title="Shares issued during the period">136,365</span> shares of its common stock in settlement of restricted stock units issued to three of its independent directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted on January 17, 2022.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonQualifiedStockOptionMember_zsAWeXzDLJi3" title="Number of option remain forfeited">34,563</span> non-qualified stock options were forfeited that had previously been issued under the 2021 Equity Incentive Plan.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, of the <span id="xdx_90E_ecustom--ShareBasedCompensationArrangemenByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20240331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_z0xFj8QX7wah" title="Number of shares authorized">666,667</span> shares authorized under the 2021 Equity Plan, <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zcq5SjQkryi8" title="Number of shares issued">268,933</span> shares have been issued in settlement of restricted stock units, awards relating to <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonQualifiedStockOptionMember_z8xYBq7lrIY5" title="Number of option remain outstanding">138,252</span> non-qualified stock options, and <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--IncentiveStockOptionMember_zBvihLO8WBx5" title="Number of option remain outstanding">40,816</span> incentive stock options remain outstanding, and <span id="xdx_90E_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20240331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zDoSRg3eeJJa" title="Shares available for future equity awards">218,665</span> shares remain available for future equity awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There was $<span id="xdx_908_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20240331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zkJWOILAzwY5" title="Unrecognized compensation expense">3,429</span> in unrecognized compensation expense for unvested non-qualified as of March 31, 2024 which will be recognized over approximately the next <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtM_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zA2FPjtyyGZ7" title="Weighted average remaining contractual term">12</span> months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Non-Qualified and Incentive Stock Options</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenAndTwoThousandTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zN0miwXaRjK1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended March 31, 2024, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_z5BtrLZ27RBh" style="display: none">Schedule of Stock Option Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Number of</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Options</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Average</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Exercise</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Price</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Average</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Contractual</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Term</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Value</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">Outstanding, December 31, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zv6pQoYZKPnh" style="width: 12%; text-align: right" title="Number of Options, Outstanding"><span style="font-family: Times New Roman, Times, Serif">302,022</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_znKrCrycMQU" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Outstanding"><span style="font-family: Times New Roman, Times, Serif">5.87</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_ztTBEpzLhR44" title="Weighted Average Remaining Contractual Term">6.6</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zmB0O3O9vFB8" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Outstanding">       <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0772">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zQ5ME2BdB8W7" style="text-align: right" title="Number of Options, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0774">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z4vKPu8b8zwd" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0776">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z6l1K1trmVlh" style="text-align: right" title="Number of Options, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0778">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zy5ZDyt2T3dg" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0780">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zGOxcFmxeuDi" style="text-align: right" title="Number of Options, Forfeited"><span style="font-family: Times New Roman, Times, Serif">(40,697</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zMGiwjxOZwlb" style="text-align: right" title="Weighted Average Exercise Price, Forfeited"><span style="font-family: Times New Roman, Times, Serif">3.36</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zfQz0payoBI2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0786">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zl0jnj7Vppkj" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0788">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding, March 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z0MiUR1ftLs4" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding"><span style="font-family: Times New Roman, Times, Serif">261,325</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zxnz1pMS9Cec" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding"><span style="font-family: Times New Roman, Times, Serif">6.26</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zDvNP9nIjH16" title="Weighted Average Remaining Contractual Term">7.2</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvaqyaqfdBs1" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0796">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable, March 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zIKLo2obuFSk" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable"><span style="font-family: Times New Roman, Times, Serif">256,325</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zfdNSQxtdNDg" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable"><span style="font-family: Times New Roman, Times, Serif">6.34</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zQMMt0DGYTya" title="Weighted Average Remaining Contractual Term, Exercisable">7.2</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zA6ozjxe7Leh" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A5_z4NpIJBdyLzj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hsrt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenAndTwoThousandTwentyOneEquityPlanMember_zuFn5GNB05tg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the three months ended March 31, 2024, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B2_z8iffuNeoz7c" style="display: none">Summary of Non-vested Non-qualified Stock Option Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Number of</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Options</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Average</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Grant-Date</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Fair Value</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Value</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Grant-Date</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Fair Value</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December 31, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqwI89ukIfm1" style="width: 12%; text-align: right" title="Number of Options Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif">10,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zv3tmnRdeTx8" style="width: 12%; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif">2.18</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zLGLiKpK9lqi" style="width: 12%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning">     <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zoR8hxf4Urek" style="width: 12%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif">21,800</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zrQe0KSw0R28" style="text-align: right" title="Number of Options Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0816">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zZcCZwCtHnA6" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0818">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValues_pp0p0_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_znUQobDq7F3h" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0820">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z2o2VMltfa65" style="text-align: right" title="Number of Options Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif">(5,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zsXuqUqWet0d" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif">2.18</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_iN_pp0p0_di_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zc1TlM072PJb" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif">(10,900</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zjBNTHXwU7l9" style="text-align: right" title="Number of Options Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0828">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_ze2XtKuinaZh" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0830">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_iN_pp0p0_di_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zGT8v7Ukmmy" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0832">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zMUX11cTNog8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0834">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zmmhAsdJJG1k" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0836">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired_iN_pp0p0_di_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zyF54IwVsG6f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0838">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Nonvested, March 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zQ4aaSBBnfvc" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif">5,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zKSxCTiIyh4d" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested Ending"><span style="font-family: Times New Roman, Times, Serif">2.18</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pdp0_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zL3ePXoiwKga" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0844">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z9H7l6PfOYFc" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif">10,900</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A6_z9ODnKb6SiDa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three months ended March 31, 2024 and March 31, 2023, the Company recorded $<span id="xdx_905_eus-gaap--ShareBasedCompensation_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zyggQ36b90kd" title="Compensation expense">1,969</span> and $<span id="xdx_901_eus-gaap--ShareBasedCompensation_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zLD3Y2i9npN2" title="Compensation expense">45,778</span> as compensation expense related to vested options issued to employees and consultants, net of forfeitures, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenAndTwoThousandTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zKQ1xql7Zam4" style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the non-qualified stock options granted to directors under the 2017 and 2021 Equity Plans, during the three months ended March 31, 2024, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zzEGmL2ZRrgc" style="display: none">Schedule of Stock Option Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Number of</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Options</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Average</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Exercise Price</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Average</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Contractual</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Term</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Value ($000)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">Outstanding, December 31, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2NpYpmgiwd2" style="width: 12%; text-align: right" title="Number of Options, Outstanding Beginning"><span style="font-family: Times New Roman, Times, Serif">57,122</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zQTRApBds186" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"><span style="font-family: Times New Roman, Times, Serif">9.44</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zhGKIHt0NVX2" title="Weighted Average Remaining Contractual Term, Beginning">5.0</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zFnwRGm7PYGh" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">     <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0860">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zHNjRj95MKSg" style="text-align: right" title="Number of Options, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0862">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zXjzBaT3wqEk" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zfEVe2tRVxWg" style="text-align: right" title="Number of Options, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0866">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zmDRfoN4a3n4" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0868">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/Cancelled</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zxPONO3mzHk2" style="text-align: right" title="Number of Options, Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0870">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zpYsPMuUk9sa" style="text-align: right" title="Weighted Average Exercise Price, Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0872">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_znxG8eTWleWf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0874">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zkBDtXUVeJjf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0876">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding, March 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zx9VcVInbw09" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif">57,122</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zpJiPV9YMut3" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif">9.44</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zNa1vs4uJWJ9" title="Weighted Average Remaining Contractual Term, Outstanding Ending">4.7</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zyxV09kifTwb" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0884">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable, March 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zVrmdgLqsNh6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif">57,122</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z8ta4tkPEUB" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif">9.44</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zJKEuvP162xk" title="Weighted Average Remaining Contractual Term, Exercisable Ending">4.7</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zFbcIOU3sIw9" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0892">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A8_zMNw1Xh02Wb2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_do_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zmekMLBNcpFe" title="Number of shares issued">no</span> non-vested, non-qualified stock options issued to directors under the 2017 Equity Plan and the 2021 Equity Plan, for the three months ended March 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2024 and March 31, 2023, the Company incurred <span id="xdx_90C_eus-gaap--ShareBasedCompensation_do_c20240101__20240331__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_znBvZTFpUWCe" title="Share based compensation"><span id="xdx_90A_eus-gaap--ShareBasedCompensation_do_c20230101__20230331__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zoz7jNmOsWXh" title="Share based compensation">no</span></span> compensation expense related to options issued to directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Restricted Stock Units</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 2, 2024, the Company issued a total of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20240102__20240102__srt--TitleOfIndividualAxis__custom--ThreeDirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zoei2OTYg18f" title="Number of shares vested in period">136,365</span> restricted stock units (RSUs) under the 2021 Equity Plan to three of its independent directors. These RSUs vested upon grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2024 and March 31, 2023, the Company recorded $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zCC6BxN25eD9">75,000</span> and $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z3j5uBNPBde5">101,316</span>, respectively, as compensation expense related to vested RSUs issued to directors.</span></p> <p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_za3325iNb3Mj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BC_zHoF3WzXkAM5" style="display: none">Schedule of Restricted Units Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Number of</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Units</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Average</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Grant-Date</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Fair Value</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Value</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"></span></td><td></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Outstanding, December 31, 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zs1bVlzVHYD5" style="text-align: right" title="Number of Units Outstanding, beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0906">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z0okAbCV0B37" style="text-align: right" title="Weighted Average Grant-Date Fair Value Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0908">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zWHxgkHd3t42" style="text-align: right" title="Aggregate Intrinsic Value Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0910">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 46%"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zAwvwNuN7Xr" style="width: 14%; text-align: right" title="Number of Units, Granted"><span style="font-family: Times New Roman, Times, Serif">136,365</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zYdAuhlfOWob" style="width: 14%; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"><span style="font-family: Times New Roman, Times, Serif">0.55</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOVhnQsnIne2" style="width: 14%; text-align: right" title="Aggregate Intrinsic Value Outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif">27,274</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vested and settled with share issuance</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zaXH3FRz44b1" style="text-align: right" title="Number of Units, Vested and settled with share issuance"><span style="font-family: Times New Roman, Times, Serif">(136,365</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zuN0RSVO2qv7" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested and settled with share issuance"><span style="font-family: Times New Roman, Times, Serif">0.55</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOLvMBdW52E1" style="text-align: right" title="Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0922">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/canceled</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zVK23g4FxrC4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Units, Forfeited/canceled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0924">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zJSrPz8X1hx9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited/Canceled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0926">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zyaCqdJW4Yv5" style="padding-bottom: 1.5pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, Forfeited/canceled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0928">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding, March 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zdYuZon857z6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Units Outstanding, ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0930">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3mbgGbzEBN6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant-Date Fair Value Outstanding,ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0932">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zxgadB0AwTB4" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0934">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A4_zyE7JHSfSrei" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 333333 6134 333333 163692 139378 30263 666667 136365 34563 666667 268933 138252 40816 218665 3429 P12M <p id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenAndTwoThousandTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zN0miwXaRjK1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended March 31, 2024, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_z5BtrLZ27RBh" style="display: none">Schedule of Stock Option Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Number of</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Options</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Average</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Exercise</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Price</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Average</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Contractual</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Term</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Value</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">Outstanding, December 31, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zv6pQoYZKPnh" style="width: 12%; text-align: right" title="Number of Options, Outstanding"><span style="font-family: Times New Roman, Times, Serif">302,022</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_znKrCrycMQU" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Outstanding"><span style="font-family: Times New Roman, Times, Serif">5.87</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_ztTBEpzLhR44" title="Weighted Average Remaining Contractual Term">6.6</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zmB0O3O9vFB8" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Outstanding">       <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0772">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zQ5ME2BdB8W7" style="text-align: right" title="Number of Options, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0774">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z4vKPu8b8zwd" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0776">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z6l1K1trmVlh" style="text-align: right" title="Number of Options, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0778">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zy5ZDyt2T3dg" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0780">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zGOxcFmxeuDi" style="text-align: right" title="Number of Options, Forfeited"><span style="font-family: Times New Roman, Times, Serif">(40,697</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zMGiwjxOZwlb" style="text-align: right" title="Weighted Average Exercise Price, Forfeited"><span style="font-family: Times New Roman, Times, Serif">3.36</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zfQz0payoBI2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0786">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zl0jnj7Vppkj" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0788">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding, March 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z0MiUR1ftLs4" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding"><span style="font-family: Times New Roman, Times, Serif">261,325</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zxnz1pMS9Cec" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding"><span style="font-family: Times New Roman, Times, Serif">6.26</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zDvNP9nIjH16" title="Weighted Average Remaining Contractual Term">7.2</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvaqyaqfdBs1" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0796">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable, March 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zIKLo2obuFSk" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable"><span style="font-family: Times New Roman, Times, Serif">256,325</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zfdNSQxtdNDg" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable"><span style="font-family: Times New Roman, Times, Serif">6.34</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zQMMt0DGYTya" title="Weighted Average Remaining Contractual Term, Exercisable">7.2</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zA6ozjxe7Leh" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 302022 5.87 P6Y7M6D 40697 3.36 261325 6.26 P7Y2M12D 256325 6.34 P7Y2M12D <p id="xdx_898_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hsrt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenAndTwoThousandTwentyOneEquityPlanMember_zuFn5GNB05tg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the three months ended March 31, 2024, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B2_z8iffuNeoz7c" style="display: none">Summary of Non-vested Non-qualified Stock Option Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Number of</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Options</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Average</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Grant-Date</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Fair Value</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Value</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Grant-Date</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Fair Value</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December 31, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqwI89ukIfm1" style="width: 12%; text-align: right" title="Number of Options Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif">10,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zv3tmnRdeTx8" style="width: 12%; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif">2.18</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zLGLiKpK9lqi" style="width: 12%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning">     <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zoR8hxf4Urek" style="width: 12%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif">21,800</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zrQe0KSw0R28" style="text-align: right" title="Number of Options Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0816">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zZcCZwCtHnA6" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0818">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValues_pp0p0_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_znUQobDq7F3h" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0820">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z2o2VMltfa65" style="text-align: right" title="Number of Options Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif">(5,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zsXuqUqWet0d" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif">2.18</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_iN_pp0p0_di_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zc1TlM072PJb" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif">(10,900</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zjBNTHXwU7l9" style="text-align: right" title="Number of Options Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0828">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_ze2XtKuinaZh" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0830">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_iN_pp0p0_di_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zGT8v7Ukmmy" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0832">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zMUX11cTNog8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0834">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zmmhAsdJJG1k" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0836">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired_iN_pp0p0_di_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zyF54IwVsG6f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0838">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Nonvested, March 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zQ4aaSBBnfvc" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif">5,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zKSxCTiIyh4d" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested Ending"><span style="font-family: Times New Roman, Times, Serif">2.18</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pdp0_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zL3ePXoiwKga" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0844">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z9H7l6PfOYFc" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif">10,900</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 10000 2.18 21800 5000 2.18 10900 5000 2.18 10900 1969 45778 <p id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenAndTwoThousandTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zKQ1xql7Zam4" style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the non-qualified stock options granted to directors under the 2017 and 2021 Equity Plans, during the three months ended March 31, 2024, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zzEGmL2ZRrgc" style="display: none">Schedule of Stock Option Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Number of</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Options</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Average</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Exercise Price</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Average</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Contractual</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Term</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Value ($000)</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">Outstanding, December 31, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2NpYpmgiwd2" style="width: 12%; text-align: right" title="Number of Options, Outstanding Beginning"><span style="font-family: Times New Roman, Times, Serif">57,122</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zQTRApBds186" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"><span style="font-family: Times New Roman, Times, Serif">9.44</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zhGKIHt0NVX2" title="Weighted Average Remaining Contractual Term, Beginning">5.0</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zFnwRGm7PYGh" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">     <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0860">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zHNjRj95MKSg" style="text-align: right" title="Number of Options, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0862">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zXjzBaT3wqEk" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zfEVe2tRVxWg" style="text-align: right" title="Number of Options, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0866">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zmDRfoN4a3n4" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0868">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/Cancelled</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zxPONO3mzHk2" style="text-align: right" title="Number of Options, Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0870">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zpYsPMuUk9sa" style="text-align: right" title="Weighted Average Exercise Price, Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0872">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_znxG8eTWleWf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0874">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zkBDtXUVeJjf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0876">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding, March 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zx9VcVInbw09" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif">57,122</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zpJiPV9YMut3" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif">9.44</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zNa1vs4uJWJ9" title="Weighted Average Remaining Contractual Term, Outstanding Ending">4.7</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zyxV09kifTwb" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0884">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable, March 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zVrmdgLqsNh6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif">57,122</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z8ta4tkPEUB" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif">9.44</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zJKEuvP162xk" title="Weighted Average Remaining Contractual Term, Exercisable Ending">4.7</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240101__20240331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zFbcIOU3sIw9" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0892">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 57122 9.44 P5Y 57122 9.44 P4Y8M12D 57122 9.44 P4Y8M12D 0 0 0 136365 75000 101316 <p id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_za3325iNb3Mj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BC_zHoF3WzXkAM5" style="display: none">Schedule of Restricted Units Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Number of</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Units</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Average</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Grant-Date</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Fair Value</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Value</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"></span></td><td></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Outstanding, December 31, 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zs1bVlzVHYD5" style="text-align: right" title="Number of Units Outstanding, beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0906">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z0okAbCV0B37" style="text-align: right" title="Weighted Average Grant-Date Fair Value Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0908">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zWHxgkHd3t42" style="text-align: right" title="Aggregate Intrinsic Value Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0910">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 46%"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zAwvwNuN7Xr" style="width: 14%; text-align: right" title="Number of Units, Granted"><span style="font-family: Times New Roman, Times, Serif">136,365</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zYdAuhlfOWob" style="width: 14%; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"><span style="font-family: Times New Roman, Times, Serif">0.55</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOVhnQsnIne2" style="width: 14%; text-align: right" title="Aggregate Intrinsic Value Outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif">27,274</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vested and settled with share issuance</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zaXH3FRz44b1" style="text-align: right" title="Number of Units, Vested and settled with share issuance"><span style="font-family: Times New Roman, Times, Serif">(136,365</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zuN0RSVO2qv7" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested and settled with share issuance"><span style="font-family: Times New Roman, Times, Serif">0.55</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOLvMBdW52E1" style="text-align: right" title="Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0922">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/canceled</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zVK23g4FxrC4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Units, Forfeited/canceled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0924">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zJSrPz8X1hx9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited/Canceled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0926">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zyaCqdJW4Yv5" style="padding-bottom: 1.5pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, Forfeited/canceled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0928">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding, March 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zdYuZon857z6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Units Outstanding, ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0930">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3mbgGbzEBN6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant-Date Fair Value Outstanding,ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0932">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20240101__20240331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zxgadB0AwTB4" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0934">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 136365 0.55 27274 136365 0.55 <p id="xdx_80D_ecustom--WarrantsDisclosureTextBlock_zlnlLNGheFCa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 9 - <span id="xdx_82D_zt8fGG65TCf4">Warrants</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_zOuAF7ANLtx1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B1_zJRhDP5p1pT3" style="display: none">Schedule of Outstanding Warrants to Purchase Common Stock</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Exercise</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Remaining Life</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Exercisable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In Months</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20240101__20240331_zgyPDMAoflxe" style="width: 9%; text-align: right" title="Warrants Outstanding, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif">7,623,772</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iS_c20240101__20240331_zkN4XNjQlFg1" style="width: 9%; text-align: right" title="Warrants Exercisable, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif">7,623,772</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20240101__20240331_z1yCQ1isPmHd" style="width: 9%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif">5.14</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20240101__20240331_zz1GNAJIgm95" title="Weighted Average Life of Outstanding Warrants in Months, Beginning Balance">37</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20240101__20240331_zfO30kpQPSh3" style="width: 9%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance">   <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0948">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20240101__20240331_zeeIFpzY3Br8" style="text-align: right" title="Warrants Outstanding. Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0950">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted_c20240101__20240331_zBLOyrA1JYV1" style="text-align: right" title="Warrants Exercisable, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0952">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceGranted_c20240101__20240331_zgmLaUAG2b94" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0954">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms_c20240101__20240331_zAse7p3aVm6b" title="Weighted Average Life of Outstanding Warrants in Months, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0956">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20240101__20240331_zXOjWljYHRYg" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0958">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_ecustom--ClassOfWarrantOrRightExercised_iN_di_c20240101__20240331_zEJ4ncvj01cg" style="text-align: right" title="Warrants Outstanding, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0960">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised_c20240101__20240331_zl5dKtbqaQVj" style="text-align: right" title="Warrants Exercisable, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0962">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20240101__20240331_zncPEbd9rwT1" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0964">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms_c20240101__20240331_z3nVqSzaU6Oa" title="Weighted Average Life of Outstanding Warrants in Months, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised_pp0p0_c20240101__20240331_zb3AC4mPnOVi" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0968">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_pp0p0_c20240101__20240331_zXXbnO97YTya" style="text-align: right" title="Warrants Outstanding, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0970">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations_pp0p0_c20240101__20240331_zN0V6d6H9Lvc" style="text-align: right" title="Warrants Exercisable, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0972">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20240101__20240331_zzECZ7VAX0gl" style="text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0974">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExpiredWeightedAverageRemainingContractualTerms_c20240101__20240331_zEmQFBKaC9Dg" title="Weighted Average Life of Outstanding Warrants in Months, Expired"><span style="-sec-ix-hidden: xdx2ixbrl0976">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations_pp0p0_c20240101__20240331_zcyJkQoZwtnb" style="text-align: right" title="Aggregate Intrinsic Value, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0978">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at March 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20240101__20240331_zXgCFtrJgGqd" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance"><span style="font-family: Times New Roman, Times, Serif">7,623,772</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20240101__20240331_zzlr1GrOFjQ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Exercisable, Ending Balance"><span style="font-family: Times New Roman, Times, Serif">7,623,772</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20240101__20240331_z2mUqdRTKWf4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Ending Balance"><p style="margin-top: 0; margin-bottom: 0"></p> <p style="margin-top: 0; margin-bottom: 0"> <span style="font-family: Times New Roman, Times, Serif">5.14</span></p></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20240101__20240331_zEpzhGumk0Tj" title="Weighted Average Life of Outstanding Warrants in Months, Ending Balance">34</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20240101__20240331_zCKHYCTZM125" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0988">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A1_zSQweDoPprZ" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zM7i8BxYth82" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information about warrants outstanding at March 31, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B1_zDX7zGBf9io5" style="display: none">Schedule of Warrants Outstanding</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted Average</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Exercisable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Months Outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_z2Ao0VQa5LOj" style="width: 21%; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif">9.45</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zb0rz1lxdil7" style="width: 21%; text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">192,982</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zwBuaM4Resjg" style="width: 22%; text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif">192,982</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 22%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20240101__20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_z9029yRAD739" title="Weighted average remaining contractual terms (in Months)">6</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zEHhAcgSQzZk" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif">10.40</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zNfyEKCdLBLi" style="text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">34,737</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zZnDUpSHlMzl" style="text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif">34,737</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20240101__20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zHEpkKKEKd59" title="Weighted average remaining contractual terms (in Months)">7</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_z8Yu492Qlzm4" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif">5.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zwmCrSlnPnr3" style="text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">7,105,496</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zWLZSCzTwR78" style="text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif">7,105,496</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20240101__20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zMXjHNujWLtk" title="Weighted average remaining contractual terms (in Months)">35</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeFourMember_zYP0016kMUQd" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif">5.16</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeFourMember_zyYOobN40Z48" style="text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">290,557</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeFourMember_zbpJ5qgiPYug" style="text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif">290,557</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20240101__20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeFourMember_zObYk6VnkAme" title="Weighted average remaining contractual terms (in Months)">35</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20240331_zkyQZu3uGA0f" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">7,623,772</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20240331_zx34sojLHKI7" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif">7,623,772</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20240101__20240331_zH7B47mIre13" title="Weighted Average Life of Outstanding Warrants in Months">34</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AE_zyC1J9ZI0yDc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_89C_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_zOuAF7ANLtx1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B1_zJRhDP5p1pT3" style="display: none">Schedule of Outstanding Warrants to Purchase Common Stock</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Exercise</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Remaining Life</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Exercisable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In Months</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2023</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20240101__20240331_zgyPDMAoflxe" style="width: 9%; text-align: right" title="Warrants Outstanding, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif">7,623,772</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iS_c20240101__20240331_zkN4XNjQlFg1" style="width: 9%; text-align: right" title="Warrants Exercisable, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif">7,623,772</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20240101__20240331_z1yCQ1isPmHd" style="width: 9%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif">5.14</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20240101__20240331_zz1GNAJIgm95" title="Weighted Average Life of Outstanding Warrants in Months, Beginning Balance">37</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20240101__20240331_zfO30kpQPSh3" style="width: 9%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance">   <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0948">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20240101__20240331_zeeIFpzY3Br8" style="text-align: right" title="Warrants Outstanding. Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0950">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted_c20240101__20240331_zBLOyrA1JYV1" style="text-align: right" title="Warrants Exercisable, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0952">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceGranted_c20240101__20240331_zgmLaUAG2b94" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0954">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms_c20240101__20240331_zAse7p3aVm6b" title="Weighted Average Life of Outstanding Warrants in Months, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0956">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20240101__20240331_zXOjWljYHRYg" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0958">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_ecustom--ClassOfWarrantOrRightExercised_iN_di_c20240101__20240331_zEJ4ncvj01cg" style="text-align: right" title="Warrants Outstanding, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0960">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised_c20240101__20240331_zl5dKtbqaQVj" style="text-align: right" title="Warrants Exercisable, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0962">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20240101__20240331_zncPEbd9rwT1" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0964">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms_c20240101__20240331_z3nVqSzaU6Oa" title="Weighted Average Life of Outstanding Warrants in Months, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised_pp0p0_c20240101__20240331_zb3AC4mPnOVi" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0968">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_pp0p0_c20240101__20240331_zXXbnO97YTya" style="text-align: right" title="Warrants Outstanding, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0970">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations_pp0p0_c20240101__20240331_zN0V6d6H9Lvc" style="text-align: right" title="Warrants Exercisable, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0972">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20240101__20240331_zzECZ7VAX0gl" style="text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0974">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExpiredWeightedAverageRemainingContractualTerms_c20240101__20240331_zEmQFBKaC9Dg" title="Weighted Average Life of Outstanding Warrants in Months, Expired"><span style="-sec-ix-hidden: xdx2ixbrl0976">-</span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations_pp0p0_c20240101__20240331_zcyJkQoZwtnb" style="text-align: right" title="Aggregate Intrinsic Value, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0978">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at March 31, 2024</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20240101__20240331_zXgCFtrJgGqd" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance"><span style="font-family: Times New Roman, Times, Serif">7,623,772</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20240101__20240331_zzlr1GrOFjQ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Exercisable, Ending Balance"><span style="font-family: Times New Roman, Times, Serif">7,623,772</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20240101__20240331_z2mUqdRTKWf4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Ending Balance"><p style="margin-top: 0; margin-bottom: 0"></p> <p style="margin-top: 0; margin-bottom: 0"> <span style="font-family: Times New Roman, Times, Serif">5.14</span></p></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20240101__20240331_zEpzhGumk0Tj" title="Weighted Average Life of Outstanding Warrants in Months, Ending Balance">34</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20240101__20240331_zCKHYCTZM125" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0988">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 7623772 7623772 5.14 P37M 7623772 7623772 5.14 P34M <p id="xdx_893_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zM7i8BxYth82" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information about warrants outstanding at March 31, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B1_zDX7zGBf9io5" style="display: none">Schedule of Warrants Outstanding</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td colspan="2" style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted Average</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Exercisable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Months Outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_z2Ao0VQa5LOj" style="width: 21%; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif">9.45</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zb0rz1lxdil7" style="width: 21%; text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">192,982</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zwBuaM4Resjg" style="width: 22%; text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif">192,982</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 22%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20240101__20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_z9029yRAD739" title="Weighted average remaining contractual terms (in Months)">6</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zEHhAcgSQzZk" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif">10.40</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zNfyEKCdLBLi" style="text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">34,737</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zZnDUpSHlMzl" style="text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif">34,737</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20240101__20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zHEpkKKEKd59" title="Weighted average remaining contractual terms (in Months)">7</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_z8Yu492Qlzm4" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif">5.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zwmCrSlnPnr3" style="text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">7,105,496</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zWLZSCzTwR78" style="text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif">7,105,496</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20240101__20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zMXjHNujWLtk" title="Weighted average remaining contractual terms (in Months)">35</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeFourMember_zYP0016kMUQd" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif">5.16</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeFourMember_zyYOobN40Z48" style="text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">290,557</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeFourMember_zbpJ5qgiPYug" style="text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif">290,557</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20240101__20240331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeFourMember_zObYk6VnkAme" title="Weighted average remaining contractual terms (in Months)">35</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20240331_zkyQZu3uGA0f" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif">7,623,772</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20240331_zx34sojLHKI7" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif">7,623,772</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20240101__20240331_zH7B47mIre13" title="Weighted Average Life of Outstanding Warrants in Months">34</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 9.45 192982 192982 P6M 10.40 34737 34737 P7M 5.00 7105496 7105496 P35M 5.16 290557 290557 P35M 7623772 7623772 P34M <p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_zHqRjhVpmYi6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 10 – <span id="xdx_820_zxsx5stjvcHk">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, the Company has U.S. federal and state net operating losses (“NOLs”) of approximately $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_c20240331_z4qHYbDQl4rk" title="Operating loss carryforward">29,757,000</span>, of which $<span id="xdx_906_ecustom--NetOperatingLossCarryForwardExpectedToExpireAmount_iI_c20240331_zmVw6CpofUnd" title="Net operating loss carry forward expected to expire amount">11,196,000</span> will expire, if not utilized, in the years <span id="xdx_90F_ecustom--NetOperatingLossExpirationTerm_c20240101__20240331_zetqlwHfK5i6" title="Net operating loss expiration term">2034 through 2037</span>, however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to <span id="xdx_907_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_dp_uPure_c20240331_zRDFTHdhPGYi" title="NOLs usage against taxable income, percentage">80</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company’s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OwnershipMember_zWi9eQTnuPG7" title="Percentage of ownership change">50</span>% within a <span id="xdx_906_ecustom--NolsCarryforwardsTermDescription_c20240101__20240331_zXGlOPUIGBqj" title="NOLs carryforwards term">three-year period</span>. In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), and corresponding provisions of state law, if a corporation undergoes an “ownership change,” which is generally defined as a greater than <span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OwnershipMember_zMkBKxp0msk1" title="Percentage of ownership change">50</span>% change, by value, in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. Our sale of securities, both in September 2021 and February 2022, will need to be considered for determination of any “ownership change” that we have undergone during a determination period. If an ownership change occurs and our ability to use our net operating loss carryforwards is materially limited, it would harm our future bottom-line operating results by effectively increasing our future tax obligations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes that recovery is not likely, the Company establishes a valuation allowance. Management’s judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against the net deferred tax assets. The Company recorded a full valuation allowance as of March 31, 2024 and December 31, 2023. Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions that are consistent with the Company’s plans. Should the actual amounts differ from the Company’s estimates, the carrying value of the Company’s deferred tax assets could be materially impacted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 29757000 11196000 2034 through 2037 0.80 0.50 three-year period 0.50 <p id="xdx_80D_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zbKiWL5jKETd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 11 – <span id="xdx_823_zVY6ScI4dpTa">Related Party Transactions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Agreements and Transaction with a Company Director</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company entered into a manufacturer representative agreement with RSX Enterprises (“RSX”) in March 2021 to become a non-exclusive representative for the Company to assist in marketing and soliciting orders. James R. Shipley, one of our independent directors, has a significant ownership interest in RSX.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada and Mexico and may receive a commission for qualified customer leads. The agreement had an initial term through December 31, 2021 with automatic one-year renewal terms unless notice is given 90 days prior to each annual expiration. During the three months ended March 31, 2024 and March 31, 2023, the Company paid $<span id="xdx_900_eus-gaap--PaymentsForCommissions_c20240101__20240331_zPGaJkpaRsW4" title="Payments for commissions">0</span> and $<span id="xdx_900_eus-gaap--PaymentsForCommissions_c20230101__20230331_z89U0dgYiMfi" title="Payments for commissions">18,273</span>, respectively, in commissions under this agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 13, 2022, the Company entered into an agreement with Lone Star Bioscience, Inc. (Lone Star) to provide engineering design services. Nicholas Etten, one of our independent directors, is the Chief Executive Officer of Lone Star. The balance due under this agreement totaled $<span id="xdx_904_eus-gaap--Deposits_iI_c20221013__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zeQuGhJvpkfj" title="Proceeds fom deposit">2,500</span> with $<span id="xdx_902_eus-gaap--Deposits_iI_c20221231__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zcZVpiE0lXL6" title="Proceeds fom deposit">1,250</span> received as a deposit in 2022. Another agreement for engineering services was signed on December 20, 2022, in the amount of $<span id="xdx_901_eus-gaap--Deposits_iI_c20221220__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_znoDkT51DVO5" title="Proceeds fom deposit">10,900</span>. We entered into positive change orders in March 2023 of $<span id="xdx_90E_eus-gaap--IncreaseDecreaseInDueToRelatedParties_c20230301__20230331__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zCcbRXYnoBXf" title="Increased related party sales">3,577</span> increasing the total of the second sales order to $<span id="xdx_908_ecustom--ProceedsFromRelatedPartySales_c20230301__20230331__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z3uQZGdnsBkb" title="Proceeds from related party sales">14,477</span>. During the three months ended March 31, 2023, the Company received $<span id="xdx_909_eus-gaap--PaymentsForDeposits_c20230101__20230331_zPXuXNO8Hk6a" title="Payments for deposit">14,035</span> in cash payments for these contracts. Revenue of $<span id="xdx_901_eus-gaap--Revenues_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zv5J6htrBO1b" title="Revenue">16,977</span> was recorded in the three months ended March 31, 2023 in respect of these agreements. <span id="xdx_90C_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_do_c20240101__20240331__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zBKqfu8AZfI9" title="Related party transaction">No</span> transactions were recorded in the three months ended March 31, 2024 in respect of this agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 18273 2500 1250 10900 3577 14477 14035 16977 0 <p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_zACF2oaPVEy7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 12 – <span id="xdx_82C_zfK0u6QFOvkb">Subsequent Events</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 855, <i>Subsequent Events</i>, the Company has evaluated all subsequent events through the date the financial statements were available to be issued. No material subsequent events occurred after March 31, 2024, other than as set out below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As previously disclosed, on <span id="xdx_907_eus-gaap--SubsequentEventDescription_c20240101__20240331_zkijUPzuFhEe" title="Subsequent event description">April 10, 2023 the Company received notice from The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between February 24, 2023, through April 6, 2023, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2).</span> The notice indicated that the Company may submit an update to its existing plan to regain compliance with the Listing Rule no later than October 9, 2023, and, following receipt of the update, Nasdaq would consider granting an extension of 180 calendar days to regain compliance. On October 11, 2023, Nasdaq formally determined to grant the Company a second 180-day compliance period, which allowed the Company until April 7, 2024, to satisfy the Listing Rule 5550(a)(2) deficiency. During that time, the Company was unable to satisfy the Listing Rule 5550(a)(2) deficiency.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 9, 2024, the Company received a second notice from Nasdaq indicating that the Listings Qualifications Staff would be delisting the shares of common stock and common stock warrants from Nasdaq at the opening of business on April 18, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission, which would remove the Company’s securities from listing and registration on The Nasdaq Stock Market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 16, 2024, the Company filed an appeal with Nasdaq’s Listing Committee, which temporarily stays the delisting of the Company’s securities and the filing of the Form 25-NSE, pending the decision of the Nasdaq’s Listing Committee. As part of this process the Company will be provided a hearing, at which it will be asked to provide a plan to regain compliance and a commitment to effect a reverse stock split, if necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result, until further notice, the Company’s shares and common stock warrants continue to trade on the Nasdaq under the tickers “CEA” and “CEADW”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 2, 2024, the employment services of Mr. Ian Patel under his employment agreement were ended, with the effective date of contract termination being June 4, 2024. Mr. Patel had served as the Chief Financial Officer of the Company.</span></p> April 10, 2023 the Company received notice from The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between February 24, 2023, through April 6, 2023, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2).